COVENTRY GROUP, 485BPOS, 2000-03-01

COVENTRY GROUP
485BPOS, 2000-03-01

Previous: NAVISTAR FINANCIAL RETAIL RECEIVABLES CORPORATION, 424B5, 2000-03-01

Next: LIBERTY FUNDS TRUST VI, N-30D, 2000-03-01

<PAGE> 1
As filed with the Securities and Exchange Commission on March 1, 2000

Registration No. 33-44964
Investment Company Act File No. 811-6526

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 2054 9

-------------------------------------

FORM N-1A

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 / X /
Pre-Effective Amendment No. __ / /

Post-Effective Amendment No. 66 / X /

and/or

REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 / X /

AMENDMENT NO. 68 / X /

(Check appropriate box or boxes)

THE COVENTRY GROUP
(Exact Name of Registrant as Specified in Charter)
3435 Stelzer Road, Columbus, Ohio 43219
(Address of Principal Executive Office)
Registrant's Telephone Number: (614) 470-8000
-------------------------------------

Jane A. Kanter, Esq.
Dechert Price & Rhoads
1775 Eye Street, NW
Washington, DC 20006

-------------------------------------
(Name and Address of Agent for Services)
Copies to:

Walter B. Grimm
BISYS Fund Services
3435 Stelzer Road
Columbus, Ohio 43219

It is proposed that this filing will become effective immediately after filing
pursuant to paragraph (b) of Rule 485.

<PAGE> 2

QUESTIONS?
Call 1-877-945-3863 or your
investment representative.

WILLAMETTE
TECHNOLOGY
FUND

[WILLAMETTE ASSET MANAGERS LOGO]
---------------

PROSPECTUS DATED MARCH 1, 2000

---------------
AS WITH ALL MUTUAL FUNDS, THE SECURITIES AND EXCHANGE COMMISSION HAS NOT
APPROVED THE FUND'S SECURITIES OR DETERMINED WHETHER THIS PROSPECTUS IS
ACCURATE OR COMPLETE. ANYONE WHO TELLS YOU OTHERWISE IS COMMITTING A
CRIME.

<PAGE> 3

WILLAMETTE TECHNOLOGY FUND TABLE OF CONTENTS

<TABLE>
<S> <C> <C> <C>
[ICON] RISK/RETURN SUMMARY AND FUND EXPENSES

Carefully review this 3 Willamette Technology Fund
important section, which
summarizes the Fund's
investments, risks, past
performance, and fees.

[ICON] INVESTMENT OBJECTIVE, STRATEGIES AND RISKS

Review this section for 5 Investment Objective, Policies and Strategies
details on investment 6 Principal Risks of Investing in the Fund
strategies and risks.

[ICON] SHAREHOLDER INFORMATION

Review this section for 7 Pricing of Fund Shares
details on how shares are 7 Purchasing and Adding to Your Shares
valued, how to purchase, 10 Selling Your Shares
sell and exchange shares, 11 General Policies on Selling Shares
related charges, and 12 Distribution Arrangements/Sales Charges
payments of dividends and 14 Exchanging Your Shares
distributions. 15 Dividends, Distributions and Taxes

[ICON] FUND MANAGEMENT

Review this section for 16 The Investment Adviser and Sub-Adviser
details on the people and 16 The Distributor and Administrator
organizations who oversee
the Fund.

[ICON] FINANCIAL HIGHLIGHTS

The Fund commenced 17 Financial Highlights
operations on March 1, 2000 17 Appendix A: Related Performance
and has no performance
record.
</TABLE>

2
<PAGE> 4

WILLAMETTE
[ICON] RISK/RETURN SUMMARY AND FUND EXPENSES TECHNOLOGY FUND

INVESTMENT OBJECTIVE The Fund seeks to provide long-term growth of capital.

PRINCIPAL The Fund invests primarily in common stocks of companies
INVESTMENT STRATEGIES that the Sub-Adviser believes have or will develop products,
processes or services that will provide or benefit from
technological developments, with a focus on computer,
communications and internet technologies and services. The
Fund's Sub-Adviser will select companies that it believes
have strong management, strong competitive position,
prospects for above-average growth in revenues and a sound
balance sheet. Investments may include development stage and
small capitalization and foreign companies.

PRINCIPAL Because the value of the Fund's investments will fluctuate
INVESTMENT RISKS with market conditions, so will the value of your investment
in the Fund. You could lose money on your investment in the
Fund, or the Fund could underperform other investments.
Because the Fund invests primarily in technology stocks, it
is particularly exposed to risks affecting that industry,
including the significant effects of competitive pressures.
Additionally, the Fund is non-diversified, which means it
can invest heavily in a few issuers. Thus, it is more
susceptible than a diversified fund would be to events
affecting single portfolio companies. The Fund's investments
in small cap stocks may display greater price volatility
than stocks of larger companies. The Fund may invest a
portion of its assets in foreign securities which can carry
additional risks such as changes in currency exchange rates,
a lack of adequate company information and political
instability. Finally, the Fund's securities lending
activities expose it to risks of default by the borrower. As
with any new fund, there is a risk that the Fund may not
grow to a viable size and may have to be liquidated at a
time that is not opportune for investors.

WHO MAY Consider investing in the Fund if you are:
WANT TO INVEST? - investing for a long-term goal such as retirement (five
year investment horizon);
- looking to add a growth component to your portfolio;
- willing to accept higher risks of investing in a
non-diversified portfolio of technology, small cap and REIT
issuers.

This Fund will not be appropriate for someone:
- seeking monthly income;
- pursuing a short-term goal or investing emergency
reserves;
- seeking safety of principal.

FUND PERFORMANCE Because the Fund commenced operations only on March 1, 2000,
it does not have a record of performance. Performance
information for another fund managed by the Sub-Adviser in a
manner substantially identical to the Fund is included in
Appendix A.
</TABLE>

3
<PAGE> 5

RISK/RETURN SUMMARY AND FUND EXPENSES

FEES AND EXPENSES

<TABLE>
<S> <C>
SHAREHOLDER TRANSACTION FEES
(FEES PAID BY YOU DIRECTLY)
Maximum Sales Charge (Load) on Purchases 5.75%(1)
Maximum Deferred Sales Charge (Load) None
ANNUAL FUND OPERATING EXPENSES (EXPENSES
PAID FROM FUND ASSETS)

Management Fee(2,3) 1.20%
Distribution and Service (12b-1) fee 0.50%
Other Expenses 1.28%
Total Fund Operating Expenses 2.98%
</TABLE>

(1) Lower sales charges are available
depending upon the amount invested. See
"Distribution Arrangements."

(2) The Adviser pays fees of the Sub-Adviser
out of its Management Fee from the Fund.

(3) The Adviser plans to waive 0.20% of its
Management Fee, but may terminate this
waiver at any time.

EXPENSE EXAMPLE

<TABLE>
<S> <C> <C> <C> <C>
1 3 5 10
YEAR YEARS YEARS YEARS
TECHNOLOGY FUND $859 $1,443 $2,052 $3,684
</TABLE>

As an investor in the
Fund, you will pay the
following fees and
expenses. Shareholder
transaction fees are paid
from your account. Annual
Fund operating expenses
are paid out of Fund
assets, and are reflected
in the share price.

Use this table to compare
fees and expenses with those
of other funds. It
illustrates the amount of
fees and expenses you would
pay, assuming the following:

- $10,000 investment;

- 5% annual return;

- redemption at the end of
each period;

- no changes in the Fund's
operating expenses.

Because this example is
hypothetical and for
comparison purposes only,
your actual costs are likely
to be different.

4
<PAGE> 6

[ICON] INVESTMENT OBJECTIVE, STRATEGIES AND RISKS

WILLAMETTE TECHNOLOGY FUND

INVESTMENT OBJECTIVE

The Fund's investment objective is to provide long term growth of capital.

POLICIES AND STRATEGIES

The Fund, under normal market conditions, will invest primarily (at least 65%
of the value of its total assets) in common stocks of companies that the
Fund's Sub-Adviser believes either have, or will develop, products, processes
or services that will provide or will benefit significantly from
technological innovations, advances and improvements. These may include:

- Inexpensive computing power, such as personal computers;

- Improved methods of communications, such as satellite transmission; and

- Technology-related services, such as internet-related marketing services.

The prime emphasis of the Fund is to identify companies that the Sub-Adviser
believes are positioned to benefit from technological advances in areas such
as semi-conductors, computers, software, communications and online services.
Companies in which the Fund invests may include development stage companies
(companies that do not have significant revenues) and small capitalization
companies.

The Sub-Adviser will select companies that it believes exhibit strong
management teams, a strong competitive position, above average growth in
revenues and a sound balance sheet.

Up to 25% of the Fund's total assets may be invested in securities of foreign
issuers that are either listed on a United States stock exchange or are
represented by American Depositary Receipts.

To generate additional income, the Fund may lend securities representing up
to one-third of the value of its total assets to broker-dealers, banks and
other institutions.

The Fund may invest in U.S. government obligations and money market
instruments; under abnormal market conditions, the Fund may invest without
limit in these securities, which may cause the Fund to fail to achieve its
investment objective.

5
<PAGE> 7

INVESTMENT OBJECTIVE, STRATEGIES AND RISKS

PRINCIPAL RISKS OF INVESTING IN THE FUND

An investment in the Fund is subject to investment risks, and you can lose
money on your investment. More specifically, the Fund may be affected by the
following types of risks:

COMMON STOCK RISK: The value of the equity securities held by the Fund, and
thus of the Fund's shares, can fluctuate -- at times dramatically. The prices
of equity securities are affected by various factors, including market
conditions, political and other events, and developments affecting the
particular issuer or its industry or geographic sector.

RISKS OF THE TECHNOLOGY SECTOR: Because the Fund invests primarily in
technology-related stocks, it is particularly susceptible to risks associated
with the technology industry. Competitive pressures may have a significant
effect on the financial condition of companies in that industry.

RISKS OF NON-DIVERSIFICATION: The Fund is non-diversified. This means that it
may invest a larger portion of its assets in a limited number of companies
than a diversified fund. Because a relatively high percentage of the Fund's
assets may be invested in the securities of a limited number of issuers that
will be in the same or related economic sectors, the Fund's portfolio may be
more susceptible to any single economic, technological or regulatory
occurrence than the portfolio of a diversified fund.

RISKS OF DEVELOPMENT STAGE AND SMALL CAP STOCKS: Stocks of development stage
and small capitalization companies involve substantial risk. These stocks
historically have experienced greater price volatility than stocks of more
established and larger capitalization companies, and they may be expected to
do so in the future.

FOREIGN SECURITIES RISK: Investments in securities of non-U.S. issuers have
special risks. These risks include international economic and political
developments, foreign government actions including restrictions on payments
to non-domestic persons such as the Fund, less regulation, less information,
currency fluctuations and interruptions in currency flow. Investments in
foreign securities also entail higher costs. The Fund's investments in
foreign securities may be in the form of sponsored or unsponsored American
Depositary Receipts ("ADRs"). Ownership of unsponsored depositary receipts
may not entitle the Fund to financial and other reports from the issuer of
the underlying security, and certain costs related to the receipts that would
otherwise be borne by the issuer of a sponsored depositary receipt may be
passed through, in whole or in part, to holders of unsponsored receipts.

SECURITIES LENDING RISK: Although the Fund's loans of portfolio securities
will be fully collateralized and marked to market throughout the period of
the loan, the Fund may experience delays in getting the securities returned
and may not receive mark-to-market payments if the borrower enters bankruptcy
or has other financial problems.

NEW FUND RISK: There can be no assurance that the Fund will grow to an
economically viable size, in which case Fund management may determine to
liquidate the Fund at a time that may not be opportune for shareholders.

6
<PAGE> 8

[ICON] SHAREHOLDER INFORMATION

PRICING OF FUND SHARES

----------------------------------------
HOW NAV IS CALCULATED
The NAV is calculated by
adding the total value of
the Fund's investments and
other assets, subtracting
its liabilities and then
dividing that figure by the
number of outstanding
shares of the Fund:

NAV =
Total Assets - Liabilities
---------------------------
Number of Shares

Outstanding
Per share net asset value (NAV) for
the Fund is determined and its shares
are priced at the earlier of the close
of regular trading on the New York
Stock Exchange or 4:00 p.m. Eastern
time on the days the Exchange is open.
Your order for purchase, sale or
exchange of shares is priced at the
next NAV calculated after your order
is accepted by the Fund plus any
applicable sales charge as noted in
the section on "Distribution
Arrangements/Sales Charges." This is
what is known as the offering price.
The Fund's securities are generally
valued at current market prices. If
market quotations are not available,
prices will be based on fair value as
determined by the Fund's Trustees.

PURCHASING AND ADDING TO YOUR SHARES
You may purchase the Fund
through the Distributor or
through investment
representatives, who may
charge additional fees and
may require higher minimum
investments or impose other
limitations on buying and
selling shares. If you
purchase shares through an
investment representative,
that party is responsible
for transmitting orders by
close of business and may
have an earlier cut-off
time for purchase and sale
requests. Consult your
investment representative
for specific information.

<TABLE>
<CAPTION>
MINIMUM MINIMUM
INITIAL SUBSEQUENT
ACCOUNT TYPE
ACCOUNT TYPE INVESTMENT INVESTMENT
<S> <C> <C>
Regular $1,000 $100
-----------------------------------------------
Retirement $ 250 $ --
-----------------------------------------------
Automatic Investment
Plan $ 250 $ 25
</TABLE>

All purchases must be in U.S. dollars.
A fee will be charged for any checks
that do not clear. Third-party checks
are not accepted.
The Fund may waive its minimum
purchase requirement and the
Distributor may reject a purchase
order if it considers it in the best
interest of the Fund and its
shareholders.

7
<PAGE> 9

SHAREHOLDER INFORMATION

PURCHASING AND ADDING TO YOUR SHARES
CONTINUED

INSTRUCTIONS FOR OPENING OR ADDING TO AN ACCOUNT

BY REGULAR MAIL

Initial Investment:

1. Carefully read and complete the application. Establishing your account
privileges now saves you the inconvenience of having to add them later.

2. Make check, bank draft or money order payable to "Willamette Funds."

3. Mail to: The Willamette Funds, P.O. Box 182301, Columbus, OH 43218-2301

Subsequent:

1. Use the investment slip attached to your account statement. Or, if
unavailable,

2. Include the following information on a piece of paper:
- Fund name;
- Amount invested;
- Account name;
- Account number.
Include your account number on your check.

3. Mail to: The Willamette Funds, P.O. Box 182301, Columbus, OH 43218-2301.

BY OVERNIGHT SERVICE

SEE INSTRUCTIONS 1-2 ABOVE FOR SUBSEQUENT INVESTMENTS.

3. Send to: The Willamette Funds,
Attn: Shareholder Services, 3435 Stelzer Road, Columbus, OH 43219

BY WIRE TRANSFER

Note: Your bank may charge a wire transfer fee.

Prior to wiring funds and in order to ensure that wire orders are invested
promptly, investors must call the Fund at 1-877-945-3863 to obtain
instructions regarding the bank account number to which the funds should be
wired and other pertinent information.

You can add to your account by using the convenient options described below.
The Fund reserves the right to change or eliminate these privileges at any
time with 60 days notice.

QUESTIONS?
Call 1-877-945-3863 or
your
investment
representative.

8
<PAGE> 10

SHAREHOLDER INFORMATION

PURCHASING AND ADDING TO YOUR SHARES
CONTINUED

AUTOMATIC INVESTMENT PLAN

You can make automatic investments in the Fund from your bank account.
Automatic investments can be as little as $25, once you've invested the $250
minimum required to open the account.

To invest regularly from your bank account:

- Complete the Automatic Investment Plan portion on your Account Application.
Make sure you note:

- Your bank name, address and ABA number;

- Your checking or savings account number;

- The amount you wish to invest automatically (minimum $25);

- How often you want to invest (every month, twice a month, 4 times a year
or once a year);

- Attach a voided personal check or savings deposit slip.
-----------------------------------------------------------------------------

DIVIDENDS AND DISTRIBUTIONS

All dividends and distributions will be automatically reinvested unless you
request otherwise. There are no sales charges for reinvested dividends and
distributions. Dividends from net investment income, if any, are declared and
paid annually and distributions of capital gains, if any, are distributed at
least annually.

DISTRIBUTIONS ARE MADE ON A PER SHARE BASIS REGARDLESS OF HOW LONG YOU HAVE
OWNED YOUR SHARES. THEREFORE, IF YOU INVEST SHORTLY BEFORE THE DISTRIBUTION
DATE, SOME OF YOUR INVESTMENT WILL BE RETURNED TO YOU IN THE FORM OF A
DISTRIBUTION.
-----------------------------------------------------------------------------

9
<PAGE> 11

SHAREHOLDER INFORMATION

SELLING YOUR SHARES

INSTRUCTIONS FOR SELLING SHARES
You may sell your shares
at any time. Your sales
price will be the next NAV
after your sell order is
received by the Fund, its
transfer agent, or your
investment representative.
Normally you will receive
your proceeds within a
week after your request is
received. See the section
"General Policies on
Selling Shares".

BY TELEPHONE (unless you have declined telephone sales privileges)

1. Call 1-877-945-3863 with instructions as to how you wish to receive your
funds (mail, check or wire). Note: IRA redemptions must be requested by
mail.

BY MAIL

1. Call 1-877-945-3863 to request redemption forms or write a letter of
instruction indicating:
- your Fund and account number;
- amount you wish to redeem;
- address where your check should be sent;
- account owner(s) signature.

2. Mail to: The Willamette Funds, P.O. Box 182301, Columbus, OH 43218-2301

WIRE TRANSFER

You must indicate this option on your application.

The Fund may charge a wire transfer fee.

Note: Your financial institution may also charge a separate fee.

Call 1-877-945-3863 to request a wire transfer.

If you call by 4 p.m. Eastern time or the close of the New York Stock
Exchange, whichever is earlier, your payment will normally be wired to your
bank on the next business day.

AUTOMATIC WITHDRAWAL PLAN

You can receive automatic payments from your account on a monthly, quarterly,
semi annual, or annual basis. The minimum withdrawal is $100. To activate
this feature:

- Make sure you have checked the appropriate box on the Account
Application.
Or call 1-877-945-3863;

- A minimum balance of $12,000 is required;

- Include a voided personal check;

- Note minimum balance considerations (see "Closing of Small Accounts"
below).

WITHDRAWING MONEY FROM YOUR FUND INVESTMENT
As a mutual fund shareholder, you are
technically selling shares when you request
a withdrawal in cash. This is also known as
redeeming shares or a redemption of shares.
10
<PAGE> 12

SHAREHOLDER INFORMATION

GENERAL POLICIES ON SELLING SHARES

REDEMPTIONS IN WRITING REQUIRED

You must request redemption in writing in the following situations:

1. Redemptions from Individual Retirement Accounts ("IRAs").

2. Redemption requests requiring a signature guarantee which include each of
the following:

- Redemptions Over $50,000;

- Your account registration or the name(s) in your account has changed
within the last 10 business days;

- The check is not being mailed to the address on your account;

- The check is not being made payable to the owner of the account;

- The redemption proceeds are being transferred to another Fund account
with a different registration.

A signature guarantee can be obtained from a financial institution, such as a
bank, broker-dealer, credit union, clearing agency, or savings association.

VERIFYING TELEPHONE REDEMPTIONS

The Fund makes every effort to insure that telephone redemptions are only
made by authorized shareholders. All telephone calls are recorded for your
protection and you will be asked for information to verify your identity.
Given these precautions, unless you have specifically indicated on your
application that you do not want the telephone redemption feature, you may be
responsible for any fraudulent telephone orders. If appropriate precautions
have not been taken, the Transfer Agent may be liable for losses due to
unauthorized transactions.

REDEMPTIONS WITHIN 10 BUSINESS DAYS OF INITIAL INVESTMENT

When you have made your initial investment by check, you cannot redeem any
portion of it until the Transfer Agent is satisfied that the check has
cleared (which may require up to 10 business days). You can avoid this delay
by purchasing shares with a certified check or wire transfer.

REFUSAL OF REDEMPTION REQUEST

Payment for shares may be delayed under extraordinary circumstances or as
permitted by the SEC in order to protect remaining shareholders.

REDEMPTION IN KIND

The Fund reserves the right to make payment in securities rather than cash,
known as "redemption in kind." This could occur under extraordinary
circumstances, such as a very large redemption that could affect the Fund's
operations (for example, more than 1% of the Fund's net assets). If the Fund
deems it advisable for the benefit of all shareholders, redemption in kind
will consist of securities equal in market value to your shares. When you
convert these securities to cash, you will pay brokerage charges.

CLOSING OF SMALL ACCOUNTS

If your account falls below $500, the Fund may ask you to increase your
balance. If it is still below $500 after 60 days, the Fund may close your
account and send you the proceeds at the current NAV.

UNDELIVERABLE REDEMPTION CHECKS

For any shareholder who chooses to receive distributions in cash: If
distribution checks (1) are returned and marked as "undeliverable" or (2)
remain uncashed for six months, your account will be changed automatically so
that all future distributions are reinvested in your account. Checks that
remain uncashed for six months will be canceled and the money reinvested in
the Fund.

11
<PAGE> 13

SHAREHOLDER INFORMATION

DISTRIBUTION ARRANGEMENTS/SALES CHARGES

This section describes the sales charges and fees you will pay as an investor
in the Fund and ways to qualify for reduced sales charges.

Sales Charge (Load) Front-end sales charge; reduced sales charges available.
Distribution (12b-1) Subject to annual distribution and shareholder (12b-1) Fee
and Service Fees servicing fees of up to 0.50% of the Fund's total assets.
</TABLE>

CALCULATION OF SALES CHARGES

Shares of the Fund are sold at their public offering price. This price
includes the initial sales charge. Therefore, part of the money you invest
will be used to pay the sales charge. The remainder is invested in Fund
shares. The sales charge decreases with larger purchases. There is no sales
charge on reinvested dividends and distributions.

The current sales charge rates for the Fund are as follows:

<TABLE>
<S> <C> <C> <C>
AMOUNT OF SALES
CHARGE REALLOWED TO
DEALERS AS A
SALES CHARGE SALES CHARGE PERCENTAGE OF YOUR
YOUR AS A % OF AS A % OF PUBLIC OFFERING
INVESTMENT OFFERING PRICE YOUR INVESTMENT PRICE**
Less than $50,000 5.75% 6.10% 5.00%
$50,000 but less than $100,000 5.00% 5.26% 4.25%
$100,000 but less than $250,000 4.00% 4.17% 3.60%
$250,000 but less than $500,000 3.00% 3.09% 2.70%
$500,000 but less than $750,000 2.50% 2.56% 2.25%
$750,000 but less than 1.25% 1.27% 1.10%
$1,000,000
$1,000,000 and above* 0.00% 0.00% 0.00%
</TABLE>

* In the case of investments of $1 million or more, a 1.00% redemption fee
will be assessed on shares redeemed within 12 months of purchase (excluding
shares purchased with reinvested dividends and/or distributions).

** The Distributor may reallow up to 100% of the sales charge to Phillips &
Company Securities, Inc. and Willamette Securities, Inc., affiliates of the
Adviser. The staff of the Securities and Exchange Commission has indicated
that dealers who receive more than 90% of the sales charge may be considered
underwriters. The Distributor, at its expense, may provide additional
compensation to dealers in connection with sales of shares of the Fund.

12
<PAGE> 14

SHAREHOLDER INFORMATION

DISTRIBUTION ARRANGEMENTS/SALES CHARGES
CONTINUED

SALES CHARGE REDUCTIONS

Reduced sales charges are available to shareholders with investments of
$50,000 or more. In addition, you may qualify for reduced sales charges under
the following circumstances.

LETTER OF INTENT: You inform the Fund in writing that you intend to purchase
enough shares over a 13-month period to qualify for a reduced sales charge.
You must include a minimum of 5% of the total amount you intend to purchase
with your letter of intent.

RIGHTS OF ACCUMULATION: When the value of shares you already own plus the
amount you intend to invest reaches the amount needed to qualify for reduced
sales charges, your added investment will qualify for the reduced sales
charge.

COMBINATION PRIVILEGE: Combine accounts of multiple Willamette Funds or
accounts of immediate family household members (spouse and children under 21)
to achieve reduced sales charges.

SALES CHARGE WAIVERS

The sales charge will not apply to purchases of shares by: (a) trust,
investment management and other fiduciary accounts managed by the Adviser or
Sub-Adviser pursuant to a written agreement; (b) any person purchasing shares
with the proceeds of a distribution from a trust, investment management or
other fiduciary account managed by the Adviser or Sub-Adviser pursuant to a
written agreement; (c) BISYS or any of its affiliates; (d) Trustees or
officers of the Fund; (e) directors or officers of BISYS, the Adviser,
Sub-Adviser or affiliates or bona fide full-time employees of the foregoing
(including members of their immediate families and their retirement accounts
or plans); shares purchased by retirement accounts or plans for which there
is a written service agreement between the Group and the plan sponsor, so
long as such shares are purchased through the Fund; or (g) any person
purchasing shares within an approved asset allocation program sponsored by a
financial services organization. The sales charge also does not apply to
shares sold to representatives of selling brokers and members of their
immediate families that have signed a selling group agreement with the Fund.
In addition, the sales charge does not apply to sales to bank trust
departments, acting on behalf of one or more clients, of shares having an
aggregate value equal to or exceeding $200,000. Finally, up to 50% of
applicable sales charges may be waived for customers of Phillips & Co.
Securities, Inc. and Willamette Securities, Inc., both broker-dealer
affiliates of the Adviser.

DISTRIBUTION AND SERVICE (12b-1) FEES

The Fund is permitted to pay annually up to 0.50% of its average daily net
assets in 12b-1 fees. 12b-1 fees compensate the Distributor and other dealers
and investment representatives for services and expenses relating to the sale
and distribution of the Fund's shares and/or for providing shareholder
services. 12b-1 fees are paid from Fund assets on an ongoing basis, and will
increase the cost of your investment.

The Distributor may use up to 0.25% of the 12b-1 fee for shareholder
servicing.

Long-term shareholders may pay indirectly more than the equivalent of the
maximum permitted front-end sales charge due to the recurring nature of 12b-1
distribution and service fees.

13
<PAGE> 15

SHAREHOLDER INFORMATION

EXCHANGING YOUR SHARES

You can exchange your shares in the Fund for shares of another Willamette
Fund, usually without paying additional sales charges (see "Notes" below). No
transaction fees are charged for exchanges.

You must meet the minimum investment requirements for the Fund into which you
are exchanging. Exchanges from one Fund to another are taxable.

INSTRUCTIONS FOR EXCHANGING SHARES

Exchanges may be made by sending a written request to The Willamette Funds,
P.O. Box 182301, Columbus, OH 43218-2301 or by calling 1-877-945-3863. Please
provide the following information:
- Your name and telephone number;
- The exact name on your account and account number;
- Taxpayer identification number (usually your Social Security number);
- Dollar value or number of shares to be exchanged;
- The name of the Fund from which the exchange is to be made;
- The name of the Fund into which the exchange is being made.

See "Selling your Shares" for important information about telephone
transactions.

NOTES ON EXCHANGES

To prevent disruption in the management of the Fund, due to market timing
strategies, exchange activity may be limited to 4 exchanges within a calendar
year.
- The registration and tax identification numbers of the two accounts must
be identical.
- The Exchange Privilege may be changed or eliminated at any time upon a
60-day notice to shareholders.

INDIVIDUAL RETIREMENT ACCOUNT ("IRA")

An IRA enables individuals, even if they participate in an employer-sponsored
retirement plan, to establish their own retirement programs. IRA
contributions may be tax-deductible and earnings are tax-deferred. Under the
Tax Reform Act of 1986, the tax deductibility of IRA contributions is
restricted or eliminated for individuals who participate in certain employer
pension plans and whose annual income exceeds certain limits. Existing IRAs
and future contributions up to the IRA maximums, whether deductible or not,
still earn income on a tax-deferred basis. Exchanges from one Fund to another
are not taxable.

All IRA distribution requests must be made in writing to BISYS Fund Services.
Any additional deposits to an IRA must distinguish the type and year of the
contribution.

For more information on an IRA call the Fund at 1-877-945-3863. Shareholders
are advised to consult a tax adviser regarding IRA contribution and
withdrawal requirements and restrictions.

14
<PAGE> 16

SHAREHOLDER INFORMATION

DIVIDENDS, DISTRIBUTIONS AND TAXES

Any income the Fund receives in the form of dividends is paid out, less
expenses, to its shareholders. Income dividends, if any, are declared, and
usually paid, annually. Capital gains for the Fund, if any, are distributed
at least annually.

Dividends and distributions will be automatically paid in additional shares
of the Fund unless the shareholder elects to receive either of these amounts
in cash. This election is made in the Application Form, and any change must
be made in writing to the Fund at P.O. Box 182301, Columbus, Ohio 43218-2301
and will be effective for payments having a record date after the Fund's
receipt of this notice. If payments made in cash are returned marked
"Undeliverable" or remain uncashed for six months, the cash election will be
automatically changed to provide for automatic reinvestment. Undeliverable or
returned checks will be cancelled and the amounts payable on those checks
will be reinvested in additional shares of the Fund at the net asset value on
the date of cancellation.

Dividends and distributions are treated in the same manner for federal income
tax purposes whether you receive them in cash or in additional shares.

Dividends are taxable as ordinary income. If the Fund designates a
distribution as a long-term capital gains distribution, it will be taxable to
you at your long-term capital gains rate, regardless of how long you have
owned your Fund shares.

Some dividends are taxable in the calendar year in which they are declared,
even though your account statement may reflect them as being distributed in
the following year.

You will be notified in January each year about the federal tax status of any
distributions made by the Fund. Depending on your residence for tax purposes,
distributions also may be subject to state and local taxes, including
withholding taxes.

An exchange of Fund shares is considered a sale, and any related gains may be
subject to applicable taxes.

Foreign shareholders may be subject to special withholding requirements.
There is a tax penalty on certain pre-retirement distributions from
retirement accounts. Consult your tax adviser about the federal, state and
local tax consequences in your particular circumstances.

The Fund is required to withhold 31% of taxable dividends, capital gains
distributions and redemptions paid to shareholders who have not provided the
Fund with their certified taxpayer identification number in compliance with
IRS rules or shareholders that are subject to back-up withholding. To avoid
withholding, make sure you provide your correct Tax Identification Number
(Social Security Number for most investors) on your account application.

15
<PAGE> 17

[ICON]
FUND MANAGEMENT

THE INVESTMENT ADVISER AND SUB-ADVISER

Willamette Asset Managers, Inc., 220 NW 2nd Avenue, Suite 950, Portland,
Oregon 97209, is the investment adviser for the Fund. The Adviser is an
affiliate of Phillips & Company Securities Inc. ("Phillips"), and Willamette
Securities, Inc., each, a registered broker-dealer. The Adviser is entitled
to receive fees, computed daily and paid monthly, at an annual rate of 1.20%
of the Fund's average daily net assets. Out of its fees from the Fund, the
Adviser pays fees to the Sub-Adviser, accrued daily and paid monthly, at an
annual rate of 0.50% of the Fund's average daily net assets.

U.S. Bank National Association, acting through its First American Asset
Management division, provides portfolio management services to the Fund, as
Sub-Adviser. The Sub-Adviser provides investment management services to
individuals and institutions, including corporations, foundations, pensions
and retirements plans, and other registered investment companies. As of
December 31, 1999, the Sub-Adviser had more than $78 billion in assets under
management, including investment company assets of approximately $33 billion.

A team of persons associated with the Sub-Adviser is responsible for
day-to-day management of the Fund.

THE DISTRIBUTOR AND ADMINISTRATOR

BISYS Fund Services Limited Partnership is the Fund's distributor and BISYS
Fund Services Ohio, Inc. is the Fund's administrator. The address is 3435
Stelzer Road, Columbus, OH 43219.

The Statement of Additional Information has more detailed information about
the Fund's service providers.

CAPITAL STRUCTURE

The Coventry Group was organized as a Massachusetts business trust on January
8, 1992 and overall responsibility for the management of the Funds is vested
in the Board of Trustees. Shareholders are entitled to one vote for each full
share held and a proportionate fractional vote for any fractional shares held
and will vote in the aggregate and not by series except as otherwise
expressly required by law.

16
<PAGE> 18

[ICON] FINANCIAL HIGHLIGHTS

FINANCIAL HIGHLIGHTS

The Fund had not yet commenced operations as of the date of this Prospectus
and thus does not present per share financial highlight information.
APPENDIX A

RELATED PERFORMANCE

The Fund's investment objectives and policies are substantially similar to
those of First American Technology Fund ("FATF"), a series of First American
Investment Funds, Inc., which, like the Fund, is managed by a team of the
Sub-Adviser. The following chart compares the performance of FATF, from its
inception on April 4, 1994 through December 31, 1999, with that of the S&P
Technology Composite Index, an index of technology stocks. Note that these
performance results are those of FATF. They are not results of the Fund and
should not be interpreted as indicative of the future performance of the
Fund. Not only will there be differences in market conditions and investment
opportunities for the Fund going forward, but the level of the Fund's
expenses is likely to be different.

The following figures represent total returns for FATF for the periods
indicated. They reflect the reinvestment of all dividends and capital gains
distributions at net asset value. They do not reflect the deduction of any
front end sales charge. They also reflect total operating expenses of 1.15%,
which are lower than expenses projected for the Fund and which reflect
waivers of certain fees. Returns for FATF would be reduced if there were no
fee waivers and if a front-end sales charge were deducted. (Note that the
Fund imposes a front-end sales charge and is expected to have higher
expenses.)

<TABLE>
<S> <C> <C> <C> <C> <C>
SINCE
INCEPTION
YTD 1 YEAR 3 YEAR 5 YEAR 4/4/94

First American Technology Fund 191.79% 191.79% 60.48% 48.05% 45.53%
S&P Technology Composite Index* 75.13% 75.13% 56.32% 50.82% 45.85%
</TABLE>

* An unmanaged index comprised of technology stocks in the S&P 500 (an
unmanaged index of large capitalization stocks).

17
<PAGE> 19

[This Page Intentionally Left Blank]

<PAGE> 20

[This Page Intentionally Left Blank]

<PAGE> 21

For more information about the Fund, the following documents are available free
upon request:

ANNUAL/SEMI-ANNUAL REPORTS:

The Fund's annual and semi-annual reports to shareholders will contain
additional information on the Fund's investments. In the annual report, you will
find a discussion of the market conditions and investment strategies that
significantly affected the Fund's performance during its last fiscal year.

STATEMENT OF ADDITIONAL INFORMATION (SAI):

The SAI provides more detailed information about the Fund, including its
operations and investment policies. It is incorporated by reference and is
legally considered a part of this prospectus.

YOU CAN RECEIVE FREE COPIES OF REPORTS AND THE SAI, OR REQUEST OTHER INFORMATION
AND DISCUSS YOUR QUESTIONS ABOUT THE FUND BY CONTACTING A BROKER THAT SELLS THE
FUND, OR CONTACT THE FUND AT:

THE WILLAMETTE FUNDS

P.O. BOX 182301

COLUMBUS, OHIO 43218-2301

TELEPHONE: 1-877-945-3863

You can review the Fund's reports and SAIs at the Public Reference Room of
the Securities and Exchange Commission. You can receive text-only copies:

- For a fee, by writing the Public Reference Section of the Commission,
Washington, D.C. 20549-0102 or calling 1-202-942-8090, or by email to
[email protected].

- Free from the Commission's Website at http://www.sec.gov.

Investment Company Act file no. 811-6526.

WIL 3/1/2000

<PAGE> 22

QUESTIONS?
Call 1-877-945-3863 or your
investment representative.

WILLAMETTE

PHARMACEUTICAL
&
BIO-TECHNOLOGY

FUND

[WILLAMETTE ASSET MANAGERS LOGO]
---------------

PROSPECTUS DATED MARCH 1, 2000

<PAGE> 23

WILLAMETTE PHARMACEUTICAL AND BIO-TECHNOLOGY FUND TABLE OF CONTENTS

<TABLE>
<S> <C> <C> <C>
[ICON] RISK/RETURN SUMMARY AND FUND EXPENSES

Carefully review this 3 Willamette Pharmaceutical and Bio-Technology Fund
important section, which
summarizes the Fund's
investments, risks, past
performance, and fees.

[ICON] INVESTMENT OBJECTIVE, STRATEGIES AND RISKS

Review this section for 5 Investment Objective, Policies and Strategies
details on investment 6 Principal Risks of Investing in the Fund
strategies and risks.

[ICON] SHAREHOLDER INFORMATION

[ICON] FUND MANAGEMENT

Review this section for 16 The Investment Adviser and Sub-Adviser
details on the people and 16 The Distributor and Administrator
organizations who oversee
the Fund.

[ICON] FINANCIAL HIGHLIGHTS

The Fund commenced 17 Financial Highlights
operations on July 1, 2000
and does not yet have a
performance record.
</TABLE>

2
<PAGE> 24
[ICON]

WILLAMETTE
PHARMACEUTICAL AND
RISK/RETURN SUMMARY AND FUND EXPENSES BIO-TECHNOLOGY FUND

INVESTMENT OBJECTIVE The Fund seeks to provide long-term growth of capital.

PRINCIPAL The Fund invests primarily in common stocks of companies in
INVESTMENT STRATEGIES the pharmaceutical and bio-technology business, which
includes companies that derive at least 50% of their assets,
revenues or profits from pharmaceuticals, medical
technology, healthcare services and administration,
diagnostics, medical equipment and supplies and medical
research and development. The Fund's Sub-Adviser will invest
in companies believed to have above-average potential for
growth in revenues and earnings because of new or unique
products, services, increasing demand, market position or
exceptional management. Investments may include development
stage companies, small companies, real estate investment
trusts ("REITs") and foreign securities.

PRINCIPAL INVESTMENT RISKS Because the value of the Fund's investments will fluctuate
with market conditions, so will the value of your investment
in the Fund. You could lose money on your investment in the
Fund, or the Fund could underperform other investments.
Because the Fund invests primarily in securities of the
pharmaceutical and bio-technology industry, it is
particularly exposed to risks affecting that industry.
Additionally, the Fund is non-diversified, which means it
can invest heavily in a few issuers. Thus, it is more
susceptible than a diversified fund would be to events
affecting single portfolio companies. The Fund's investments
in small cap stocks may display greater price volatility
than stocks of larger companies. The Fund's investments in
REITs expose it to real estate related risks, such as
interest rate fluctuation and developments affecting
property values generally or in particular areas. As with
any new fund, there is a risk that the Fund may not grow to
a viable size and may have to be liquidated at a time that
is not opportune for investors. The Fund may invest a
portion of its assets in foreign securities which can carry
additional risks such as changes in currency exchange rates,
a lack of adequate company information and political
instability. Finally, the Fund's securities lending
activities expose it to risks of default by the borrower.

This Fund will not be appropriate for someone:
- seeking monthly income;
- pursuing a short-term goal or investing emergency
reserves;
- seeking safety of principal.

FUND PERFORMANCE Because the Fund commenced operations only on July 1, 2000,
it does not have a record of performance.
</TABLE>

- -

3
<PAGE> 25

RISK/RETURN SUMMARY AND FUND EXPENSES

FEES AND EXPENSES

Management Fee(2,3) 1.20%
Distribution and Service (12b-1) fee 0.50%
Other Expenses 1.47%
Total Fund Operating Expenses 3.17%
</TABLE>

(1) Lower sales charges are available
depending upon the amount invested. See
"Distribution Arrangements."

(2) The Adviser pays fees of the Sub-Adviser
out of its Management Fee from the Fund.

(3) The Adviser plans to waive 0.20% of its
Management Fee, but may terminate this
waiver at any time.

EXPENSE EXAMPLE

<TABLE>
<S> <C> <C> <C> <C>
1 3 5 10
YEAR YEARS YEARS YEARS
PHARMACEUTICAL AND
BIO-TECHNOLOGY FUND $877 $1,496 $2,139 $3,851
</TABLE>

Use this table to compare
fees and expenses with those
of other funds. It
illustrates the amount of
fees and expenses you would
pay, assuming the following:

- $10,000 investment;

- 5% annual return;

- redemption at the end of
each period;

- no changes in the Fund's
operating expenses.

Because this example is
hypothetical and for
comparison purposes only,
your actual costs are likely
to be different.

4
<PAGE> 26
[ICON]

INVESTMENT OBJECTIVE, STRATEGIES AND RISKS

WILLAMETTE PHARMACEUTICAL AND BIO-TECHNOLOGY FUND

INVESTMENT OBJECTIVE

The Fund's investment objective is to provide long term growth of capital.

POLICIES AND STRATEGIES

The Fund, under normal market conditions, will invest primarily (at least 65%
of the value of its total assets) in common stocks of companies that develop,
produce or distribute products or services connected with pharmaceuticals or
bio-technology, and that derive at least 50% of their assets, revenues or
profits from those products or services at the time of the Fund's investment.

Examples of products or services connected with pharmaceuticals or
bio-technology include:

- Pharmaceuticals;

- Healthcare services and administration;

- Diagnostics;

- Medical equipment and supplies;

- Medical technology; and

- Medical research and development.

The Fund's Sub-Adviser will invest in companies it believes have the
potential for above average growth in revenue and earnings as a result of new
or unique products, processes or services; increasing demand for a company's
products or services; established market leadership; or exceptional
management.

The Fund's investments may include development stage companies (companies
that do not have significant revenues) and small capitalization companies.
The Fund may also invest in REITs that finance medical care facilities. REITs
are publicly traded corporations or trusts that acquire, hold and manage real
estate.

Up to 25% of the Fund's total assets may be invested in securities of foreign
issuers that are either listed on a United States stock exchange or are
represented by American Depositary Receipts.

To generate additional income, the Fund may lend securities representing up
to one-third of the value of its total assets to broker-dealers, banks and
other institutions.

5
<PAGE> 27

INVESTMENT OBJECTIVE, STRATEGIES AND RISKS

PRINCIPAL RISKS OF INVESTING IN THE FUND

An investment in the Fund is subject to investment risks, and you can lose
money on your investment. More specifically, the Fund may be affected by the
following types of risks:

RISKS OF THE PHARMACEUTICAL AND BIO-TECHNOLOGY SECTOR: Because the Fund
invests primarily in stocks related to pharmaceuticals and bio-technology, it
is particularly susceptible to risks associated with these industries. Many
products and services in these industries may become rapidly obsolete due to
technological and scientific advances. In addition, governmental regulation
may have a material effect on the demand for products and services in these
industries.

RISKS OF NON-DIVERSIFICATION: The Fund is non-diversified. This means that it
may invest a larger portion of its assets in a limited number of companies
than a diversified fund. Because a relatively high percentage of the fund's
assets may be invested in the securities of a limited number of issuers that
will be in the same or related economic sectors, the Fund's portfolio may be
more susceptible to any single economic, technological or regulatory
occurrence than the portfolio of a diversified fund.

RISKS OF REITS: REITs will be affected by changes in the values of and
incomes from the properties they own or the credit quality of the mortgages
they hold. REITs are dependent on specialized management skills that may
affect their ability to generate cash flow for operating purposes and to make
distributions to shareholders or unitholders.

NEW FUND RISK. There can be no assurance that the Fund will grow to an
economically viable size, in which case Fund management may determine to
liquidate the Fund at a time that may not be opportune for shareholders.

6
<PAGE> 28
[ICON]
SHAREHOLDER INFORMATION

PRICING OF FUND SHARES

NAV =
Total Assets - Liabilities
----------------------------------------
Number of Shares
Outstanding
Per share net asset value (NAV) for
the Fund is determined and its shares
are priced at the earlier of the close
of regular trading on the New York
Stock Exchange or 4:00 p.m. Eastern
time on the days the Exchange is open.

Your order for purchase, sale or
exchange of shares is priced at the
next NAV calculated after your order
is accepted by the Fund plus any
applicable sales charge as noted in
the section on "Distribution
Arrangements/Sales Charges." This is
what is known as the offering price.

The Fund's securities are generally
valued at current market prices. If
market quotations are not available,
prices will be based on fair value as
determined by the Fund's Trustees.

<TABLE>
<CAPTION>
MINIMUM MINIMUM
INITIAL SUBSEQUENT
ACCOUNT TYPE INVESTMENT INVESTMENT
<S> <C> <C>
Regular $1,000 $100
-----------------------------------------------
Retirement $ 250 $ --
-----------------------------------------------
Automatic
Investment Plan $ 250 $ 25
</TABLE>

All purchases must be in U.S. dollars.
A fee will be charged for any checks
that do not clear. Third-party checks
are not accepted.

The Fund may waive its minimum
purchase requirement and the
Distributor may reject a purchase
order if it considers it in the best
interest of the Fund and its
shareholders.

7
<PAGE> 29

SHAREHOLDER INFORMATION

PURCHASING AND ADDING TO YOUR SHARES
CONTINUED

INSTRUCTIONS FOR OPENING OR ADDING TO AN ACCOUNT

BY REGULAR MAIL

Initial Investment:

1. Carefully read and complete the application. Establishing your account
privileges now saves you the inconvenience of having to add them later.

2. Make check, bank draft or money order payable to "Willamette Funds."

3. Mail to: The Willamette Funds, P.O. Box 182301, Columbus, OH 43218-2301

Subsequent:

1. Use the investment slip attached to your account statement. Or, if
unavailable,

2. Include the following information on a piece of paper:
- Fund name;
- Amount invested;
- Account name;
- Account number.
Include your account number on your check.

3. Mail to: The Willamette Funds, P.O. Box 182301, Columbus, OH 43218-2301.

BY OVERNIGHT SERVICE

SEE INSTRUCTIONS 1-2 ABOVE FOR SUBSEQUENT INVESTMENTS.

3. Send to: The Willamette Funds,
Attn: Shareholder Services, 3435 Stelzer Road, Columbus, OH 43219

BY WIRE TRANSFER

Note: Your bank may charge a wire transfer fee.

You can add to your account by using the convenient options described below.
The Fund reserves the right to change or eliminate these privileges at any
time with 60 days notice.

QUESTIONS?
Call 1-877-945-3863 or
your
investment
representative.

8
<PAGE> 30

SHAREHOLDER INFORMATION

PURCHASING AND ADDING TO YOUR SHARES
CONTINUED

AUTOMATIC INVESTMENT PLAN

You can make automatic investments in the Fund from your bank account.
Automatic investments can be as little as $25, once you've invested the $250
minimum required to open the account.

To invest regularly from your bank account:

* Complete the Automatic Investment Plan portion on your Account Application.
Make sure you note:

- Your bank name, address and ABA number;

- Your checking or savings account number;

- The amount you wish to invest automatically (minimum $25);

- How often you want to invest (every month, twice a month, 4 times a year
or once a year);

- Attach a voided personal check or savings deposit slip.
-----------------------------------------------------------------------------

DIVIDENDS AND DISTRIBUTIONS

All dividends and distributions will be automatically reinvested unless you
request otherwise. There are no sales charges for reinvested dividends and
distributions. Dividends from net investment income are declared and paid
annually and distributions of capital gains are distributed at least
annually.

9
<PAGE> 31

SHAREHOLDER INFORMATION

SELLING YOUR SHARES

BY TELEPHONE (unless you have declined telephone sales privileges)

1. Call 1-877-945-3863 with instructions as to how you wish to receive your
funds (mail, check or wire). Note: IRA redemptions must be requested by
mail.

BY MAIL

2. Mail to: The Willamette Funds, P.O. Box 182301, Columbus, OH 43218-2301

WIRE TRANSFER

You must indicate this option on your application.

The Fund may charge a wire transfer fee.

Note: Your financial institution may also charge a separate fee.

Call 1-877-945-3863 to request a wire transfer.

If you call by 4 p.m. Eastern time or the close of the New York Stock
Exchange, whichever is earlier, your payment will normally be wired to your
bank on the next business day.

AUTOMATIC WITHDRAWAL PLAN

You can receive automatic payments from your account on a monthly, quarterly,
semi annual, or annual basis. The minimum withdrawal is $100. To activate
this feature:

- Make sure you have checked the appropriate box on the Account
Application.
Or call 1-877-945-3863;

- A minimum balance of $12,000 is required;

- Include a voided personal check;

- Note minimum balance considerations (see "Closing of Small Accounts,"
below.)

WITHDRAWING MONEY FROM YOUR FUND INVESTMENT

As a mutual fund shareholder, you are
technically selling shares when you request
a withdrawal in cash. This is also known as
redeeming shares or a redemption of shares.
10
<PAGE> 32

SHAREHOLDER INFORMATION

GENERAL POLICIES ON SELLING SHARES

REDEMPTIONS IN WRITING REQUIRED
You must request redemption in writing in the following situations:

1. Redemptions from Individual Retirement Accounts ("IRAs").
2. Redemption requests requiring a signature guarantee which include each of
the following:
- Redemptions Over $50,000;
- Your account registration or the name(s) in your account has changed
within the last 10 business days;
- The check is not being mailed to the address on your account;
- The check is not being made payable to the owner of the account;
- The redemption proceeds are being transferred to another Fund account
with a different registration.

A signature guarantee can be obtained from a financial institution, such as a
bank, broker-dealer, credit union, clearing agency, or savings association.

VERIFYING TELEPHONE REDEMPTIONS
The Fund makes every effort to insure that telephone redemptions are only
made by authorized shareholders. All telephone calls are recorded for your
protection and you will be asked for information to verify your identity.
Given these precautions, unless you have specifically indicated on your
application that you do not want the telephone redemption feature, you may be
responsible for any fraudulent telephone orders. If appropriate precautions
have not been taken, the Transfer Agent may be liable for losses due to
unauthorized transactions.

REDEMPTIONS WITHIN 10 BUSINESS DAYS OF INITIAL INVESTMENT
When you have made your initial investment by check, you cannot redeem any
portion of it until the Transfer Agent is satisfied that the check has
cleared (which may require up to 10 business days). You can avoid this delay
by purchasing shares with a certified check or wire transfer.

REFUSAL OF REDEMPTION REQUEST
Payment for shares may be delayed under extraordinary circumstances or as
permitted by the SEC in order to protect remaining shareholders.

REDEMPTION IN KIND
The Fund reserves the right to make payment in securities rather than cash,
known as "redemption in kind." This could occur under extraordinary
circumstances, such as a very large redemption that could affect the Fund's
operations (for example, more than 1% of the Fund's net assets). If the Fund
deems it advisable for the benefit of all shareholders, redemption in kind
will consist of securities equal in market value to your shares. When you
convert these securities to cash, you will pay brokerage charges.

CLOSING OF SMALL ACCOUNTS
If your account falls below $500, the Fund may ask you to increase your
balance. If it is still below $500 after 60 days, the Fund may close your
account and send you the proceeds at the current NAV.

UNDELIVERABLE REDEMPTION CHECKS
For any shareholder who chooses to receive distributions in cash: If
distribution checks (1) are returned and marked as "undeliverable" or (2)
remain uncashed for six months, your account will be changed automatically so
that all future distributions are reinvested in your account. Checks that
remain uncashed for six months will be canceled and the money reinvested in
the Fund.

11
<PAGE> 33

SHAREHOLDER INFORMATION

DISTRIBUTION ARRANGEMENTS/SALES CHARGES

This section describes the sales charges and fees you will pay as an investor
in the Fund and ways to qualify for reduced sales charges.

Sales Charge (Load) Front-end sales charge; reduced sales charges available.
Distribution (12b-1) Subject to annual distribution and shareholder (12b-1) fee
and Service Fees servicing fees of up to 0.50% of the Fund's total assets.
</TABLE>

CALCULATION OF SALES CHARGES
Shares of the Fund are sold at their public offering price. This price
includes the initial sales charge. Therefore, part of the money you invest
will be used to pay the sales charge. The remainder is invested in Fund
shares. The sales charge decreases with larger purchases. There is no sales
charge on reinvested dividends and distributions.

The current sales charge rates for the Fund are as follows:

12
<PAGE> 34

SHAREHOLDER INFORMATION

DISTRIBUTION ARRANGEMENTS/SALES CHARGES
CONTINUED

SALES CHARGE REDUCTIONS

Reduced sales charges are available to shareholders with investments of
$50,000 or more. In addition, you may qualify for reduced sales charges under
the following circumstances.

COMBINATION PRIVILEGE: Combine accounts of multiple Willamette Funds or
accounts of immediate family household members (spouse and children under 21)
to achieve reduced sales charges.

SALES CHARGE WAIVERS

The sales charge will not apply to purchases of Shares by: (a) trust,
investment management and other fiduciary accounts managed by the Adviser or
Sub-Adviser pursuant to a written agreement; (b) any person purchasing Shares
with the proceeds of a distribution from a trust, investment management or
other fiduciary account managed by the Adviser or Sub-Adviser pursuant to a
written agreement; (c) BISYS or any of its affiliates; (d) Trustees or
officers of the Fund; (e) directors or officers of BISYS, the Adviser,
Sub-Adviser or affiliates or bona fide full-time employees of the foregoing
(including members of their immediate families and their retirement accounts
or plans); shares purchased by retirement accounts or plans for which there
is a written service agreement between the Group and the plan sponsor, so
long as such Shares are purchased through the Fund; or (g) any person
purchasing shares within an approved asset allocation program sponsored by a
financial services organization. The sales charge also does not apply to
shares sold to representatives of selling brokers and members of their
immediate families that have signed a selling group agreement with the Fund.
In addition, the sales charge does not apply to sales to bank trust
departments, acting on behalf of one or more clients, of Shares having an
aggregate value equal to or exceeding $200,000. Finally, up to 50% of
applicable sales charges may be waived for customers of Phillips & Co.
Securities, Inc. and Willamette Securities, Inc., both broker-dealer
affiliates of the Adviser.

DISTRIBUTION AND SERVICE (12b-1) FEES

The Fund is permitted to pay annually up to 0.50% of its average daily net
assets in 12b-1 fees. 12b-1 fees compensate the Distributor and other dealers
and investment representatives for services and expenses relating to the sale
and distribution of a Fund's shares and/or for providing shareholder
services. 12b-1 fees are paid from Fund assets on an ongoing basis, and will
increase the cost of your investment.

The Distributor may use up to 0.25% of the 12b-1 fee for shareholder
servicing.

Long-term shareholders may pay indirectly more than the equivalent of the
maximum permitted front-end sales charge due to the recurring nature of 12b-1
distribution and service fees.

13
<PAGE> 35

SHAREHOLDER INFORMATION

EXCHANGING YOUR SHARES

You can exchange your shares in the Fund for shares of another Willamette
Fund, usually without paying additional sales charges (see "Notes" below). No
transaction fees are charged for exchanges.

You must meet the minimum investment requirements for the Fund into which you
are exchanging. Exchanges from one Fund to another are taxable.

INSTRUCTIONS FOR EXCHANGING SHARES

See "Selling your Shares" for important information about telephone
transactions.

NOTES ON EXCHANGES

INDIVIDUAL RETIREMENT ACCOUNT ("IRA")

All IRA distribution requests must be made in writing to BISYS Fund Services.
Any additional deposits to an IRA must distinguish the type and year of the
contribution.

For more information on an IRA call the Fund at 1-877-945-3863. Shareholders
are advised to consult a tax adviser regarding IRA contribution and
withdrawal requirements and restrictions.

14
<PAGE> 36

SHAREHOLDER INFORMATION

DIVIDENDS, DISTRIBUTIONS AND TAXES

Any income the Fund receives in the form of dividends is paid out, less
expenses, to its shareholders. Income dividends are declared, and usually
paid, annually. Capital gains for the Fund are distributed at least annually.

Dividends and distributions are treated in the same manner for federal income
tax purposes whether you receive them in cash or in additional shares.

Some Dividends are taxable in the calendar year in which they are declared,
even though your account statement may reflect them as being distributed in
the following year.

You will be notified in January each year about the federal tax status of
distributions made by the Fund. Depending on your residence for tax purposes,
distributions also may be subject to state and local taxes, including
withholding taxes.

An exchange of Fund shares is considered a sale, and any related gains may be
subject to applicable taxes.

15
<PAGE> 37

[ICON]

FUND MANAGEMENT

THE INVESTMENT ADVISER AND SUB-ADVISER

U.S. Bank National Association, acting through its First American Asset
Management division, provides portfolio management services to the Fund, as
Sub-Adviser. The Sub-Adviser provides investment management services to
individual and institutions, including corporations, foundations, pensions
and retirements plans, and other registered investment companies. As of
November 30, 1999, the Sub-Adviser had more than $78 billion in assets under
management, including investment company assets of approximately $33 billion.

A team of persons associated with the Sub-Adviser is responsible for
day-to-day management of the Fund.

THE DISTRIBUTOR AND ADMINISTRATOR

BISYS Fund Services Limited Partnership is the Fund's distributor and BISYS
Fund Services Ohio, Inc. is the Fund's administrator. The address is 3435
Stelzer Road, Columbus, OH 43219.

The Statement of Additional Information has more detailed information about
the Fund's service providers.

CAPITAL STRUCTURE

16
<PAGE> 38

[ICON]
FINANCIAL HIGHLIGHTS

FINANCIAL HIGHLIGHTS

The Fund had not yet commenced operations as of the date of this Prospectus
and thus does not present per share financial highlight information.

17
<PAGE> 39

[This Page Intentionally Left Blank]
<PAGE> 40

[This Page Intentionally Left Blank]
<PAGE> 41

For more information about the Fund, the following documents are available free
upon request:

ANNUAL/SEMI-ANNUAL REPORTS:

STATEMENT OF ADDITIONAL INFORMATION (SAI):

The SAI provides more detailed information about the Fund, including its
operations and investment policies. It is incorporated by reference and is
legally considered a part of this prospectus.

YOU CAN RECEIVE FREE COPIES OF REPORTS AND THE SAI, OR REQUEST OTHER INFORMATION
AND DISCUSS YOUR QUESTIONS ABOUT THE FUND BY CONTACTING A BROKER THAT SELLS THE
FUND, OR CONTACT THE FUND AT:

THE WILLAMETTE FUNDS

P.O. BOX 182301

COLUMBUS, OHIO 43218-2301

TELEPHONE: 1-877-945-3863

You can review the Fund's reports and SAIs at the Public Reference Room of
the Securities and Exchange Commission. You can receive text-only copies:

- For a fee, by writing the Public Reference Section of the Commission,
Washington, D.C. 20549-0102 or calling 1-202-942-8090, or by email to
[email protected].

- Free from the Commission's Website at http://www.sec.gov.

Investment Company Act file no. 811-6526.

WIL 3/1/2000

<PAGE> 42

WILLAMETTE VALUE FUND
WILLAMETTE SMALL CAP GROWTH FUND
WILLAMETTE PHARMACEUTICAL AND BIO-TECHNOLOGY FUND
WILLAMETTE TECHNOLOGY FUND

Investment Portfolios of

The Coventry Group

Statement of Additional Information

March 1, 2000

This Statement of Additional Information is not a prospectus, but should be
read in conjunction with the prospectuses for the Willamette Value Fund,
Willamette Small Cap Growth Fund, Willamette Pharmaceutical and Bio-Technology
Fund and Willamette Technology Fund ("Funds") dated July 31, 1999, January 29,
2000, March 1, 2000 and March 1, 2000, respectively ("Prospectuses"). Each Fund
is a separate investment portfolio of The Coventry Group (the "Group"), an
open-end management investment company. This Statement of Additional Information
is incorporated in its entirety into the Prospectuses. Copies of the
Prospectuses may be obtained by writing the Funds at 3435 Stelzer Road,
Columbus, Ohio 43219, or by telephoning toll free (877) 945-3863.

Note: The Willamette Pharmaceutical & Bio-Technology Fund is not expected to be
offered to the public until July 1, 2000.

<PAGE> 43

TABLE OF CONTENTS
-----------------

Page
----

THE COVENTRY GROUP . . . . . . . . . . . . . . . . . . . . . . . 1
INVESTMENT OBJECTIVE AND POLICIES . . . . . . . . . . . . . . . . 1
Additional Information on Portfolio Instruments . . . . 1
Investment Restrictions . . . . . . . . . . . . . . . . 15
Portfolio Turnover . . . . . . . . . . . . . . . . . . . 17
Personal Trading Policies. . . . . . . . . . . . . . . . 17
NET ASSET VALUE . . . . . . . . . . . . . . . . . . . . . . . . . 17
ADDITIONAL PURCHASE AND REDEMPTION INFORMATION . . . . . . . . . 19
Matters Affecting Redemption . . . . . . . . . . . . . . 19
MANAGEMENT OF THE GROUP . . . . . . . . . . . . . . . . . . . . . 20
Trustees and Officers . . . . . . . . . . . . . . . . . 20
Control Persons and Principal Holders of Securities 24
Investment Adviser and Sub-Adviser . . . . . . . . . . . 24
Portfolio Transactions . . . . . . . . . . . . . . . . . 26
Banking Laws . . . . . . . . . . . . . . . . . . . . . . 28
Administrator . . . . . . . . . . . . . . . . . . . . . 28
Distributor . . . . . . . . . . . . . . . . . . . . . . 32
Custodian . . . . . . . . . . . . . . . . . . . . . . . 35
Transfer Agency and Fund Accounting Services . . . . . . 36
Independent Auditors . . . . . . . . . . . . . . . . . . 37
Legal Counsel . . . . . . . . . . . . . . . . . . . . . 37
ADDITIONAL INFORMATION . . . . . . . . . . . . . . . . . . . . . 37
Description of Shares . . . . . . . . . . . . . . . . . 37
Vote of a Majority of the Outstanding Shares . . . . . . 38
Additional Tax Information . . . . . . . . . . . . . . . 38
Yields and Total Returns . . . . . . . . . . . . . . . . 48
Performance Comparisons . . . . . . . . . . . . . . . . 51
Principal Shareholders . . . . . . . . . . . . . . . . . 52
Miscellaneous . . . . . . . . . . . . . . . . . . . . . 52
FINANCIAL STATEMENTS . . . . . . . . . . . . . . . . . . . . . . 53
APPENDIX . . . . . . . . . . . . . . . . . . . . . . . . . . . . A-1

<PAGE> 44

STATEMENT OF ADDITIONAL INFORMATION

THE COVENTRY GROUP

The Coventry Group (the "Group") is an open-end management investment
company which issues its Shares in separate series. Each series of Shares
relates to a separate portfolio of assets. This Statement of Additional
Information deals with the portfolios called Willamette Value Fund ("Value
Fund"), Willamette Small Cap Growth Fund ("Growth Fund"), Willamette
Pharmaceutical and Bio-Technology Fund ("Pharmaceutical Fund") and Willamette
Technology Fund ("Technology Fund") (collectively, "Funds"). Willamette Asset
Managers, Inc. ("Adviser") serves as investment adviser to each of the Funds.
The Bank of New York ("BONY") manages the assets of Growth Fund and U.S. Bank
National Association ("U.S. Bank"), through its First American Asset Management
Division, manages the assets of Pharmaceutical Fund and Technology Fund (BONY
and U.S. Bank are each a "Sub-Adviser"). Much of the information contained in
this Statement of Additional Information expands upon subjects discussed in the
Prospectuses of the Funds. Capitalized terms not defined herein are defined in
the Prospectuses. No investment in Shares of the Funds should be made without
first reading the Prospectuses.

INVESTMENT OBJECTIVE AND POLICIES

Additional Information on Portfolio Instruments
- -----------------------------------------------

The following policies supplement the investment objective and policies of
the Funds as set forth in the Prospectuses.

EQUITY SECURITIES. The Funds may invest in common stocks, which include the
common stock of any class or series of domestic or foreign corporations or any
similar equity interest, such as a trust or partnership interest. These
investments may or may not pay dividends and may or may not carry voting rights.
Common stock occupies the most junior position in a company's capital structure.

CONVERTIBLE SECURITIES. The Funds may invest in convertible securities,
including debt securities or preferred stock that may be converted into common
stock or that carry the right to purchase common stock. Convertible securities
entitle the holder to exchange the securities for a specified number of shares
of common stock, usually of the same company, at specified prices within a
certain period of time. They also entitle the holder to receive interest or
dividends until the holder elects to exercise the conversion privilege.

The terms of any convertible security determine its ranking in a company's
capital structure. In the case of subordinated convertible debentures, the
holder's claims on assets and earnings are generally subordinate to the claims
of other creditors, and senior to the claims of preferred and common
stockholders. In the case of convertible preferred stock, the holder's claims on
assets and earnings are subordinate to the claims of all creditors and are
senior to the claims of common stockholders. As a result of their ranking in a
company's capitalization, convertible securities that are rated by nationally
recognized statistical rating organizations are generally rated below other
obligations of the company and many convertible securities are not rated. The
Fund does not have any rating criteria applicable to its investments in any
securities, convertible or otherwise.

<PAGE> 45

UNITED STATES GOVERNMENT OBLIGATIONS. The Funds may invest in obligations
issued or guaranteed by the United States Government, or by its agencies or
instrumentalities. Obligations issued or guaranteed by federal agencies or
instrumentalities may or may not be backed by the "full faith and credit" of the
United States. Securities that are backed by the full faith and credit of the
United States include Treasury bills, Treasury notes, Treasury bonds, and
obligations of the Government National Mortgage Association, the Farmers Home
Administration, and the Export-Import Bank. In the case of securities not backed
by the full faith and credit of the United States, the Funds must look
principally to the agency issuing or guaranteeing the obligation for ultimate
repayment and may not be able to assert a claim against the United States itself
in the event the agency or instrumentality does not meet its commitments.
Securities that are not backed by the full faith and credit of the United States
include, but are not limited to, obligations of the Tennessee Valley Authority,
the Federal National Mortgage Association and the United States Postal Service,
each of which has the right to borrow from the United States Treasury to meet
its obligations, and obligations of the Federal Farm Credit System and the
Federal Home Loan Banks, both of whose obligations may be satisfied only by the
individual credits of each issuing agency.

FOREIGN GOVERNMENT OBLIGATIONS. The Funds may invest in short-term
obligations of foreign sovereign governments or of their agencies,
instrumentalities, authorities or political subdivisions. These securities may
be denominated in United States dollars or in another currency. See "Foreign
Investment Risk."

BANK OBLIGATIONS. Each Fund may invest in bank obligations such as bankers'
acceptances, certificates of deposit, and time deposits.

Growth Fund will invest in obligations only of banks with more than $2
billion in total assets that are (i) organized under the laws of the United
States or any state, (ii) foreign branches of these banks or of foreign banks of
equivalent size ("Euros") and (iii) United States branches of foreign banks of
equivalent size ("Yankees"). Growth Fund will not invest in obligations for
which the Sub-Adviser, or any of its affiliated persons, is the ultimate obligor
or accepting bank. Growth Fund may also invest in obligations of international
banking institutions designated or supported by national governments to promote
economic reconstruction, development or trade between nations (e.g., the
European Investment Bank, the Inter-American Development Bank, or the World
Bank).

Value Fund, Pharmaceutical Fund and Technology Fund may invest only in Bank
Instruments that are either issued by an institution having capital, surplus and
undivided profits over $100 million, or insured by the Bank Insurance Fund
("BIF") or the Savings Association Insurance Fund ("SAIF"). In addition to
domestic instruments such as bankers' acceptances and certificates of deposit,
Bank Instruments may include Eurodollar Certificates of Deposit ("ECDs"), Yankee
Certificates of Deposit ("Yankee CDs") and Eurodollar Time Deposits ("ETDs").

Bankers' acceptances are negotiable drafts or bills of exchange typically
drawn by an importer or exporter to pay for specific merchandise, which are
"accepted" by a bank, meaning, in effect, that the bank unconditionally agrees
to pay the face value of the instrument on maturity. Bankers' acceptances
invested in by Value Fund will be those guaranteed by domestic and foreign banks
having, at the time of investment, capital, surplus, and undivided profits in
excess of $100,000,000 (as of the date of their most recently published
financial statements).
<PAGE> 46

Certificates of deposit are negotiable certificates issued against funds
deposited in a commercial bank or a savings and loan association for a definite
period of time and earning a specified return.

COMMERCIAL PAPER. Commercial paper consists of unsecured promissory notes,
including Master Notes, issued by corporations. Issues of commercial paper
normally have maturities of less than nine months and fixed rates of return.
Master Notes, however, are obligations that provide for a periodic adjustment in
the interest rate paid and permit daily changes in the amount borrowed.

For Growth Fund, Pharmaceutical Fund and Technology Fund, Master Notes are
governed by agreements between the issuer and the respective Sub-Adviser acting
as agent, for no additional fee, in its capacity as Sub-Adviser to a Fund and as
fiduciary for other clients for whom it exercises investment discretion. The
monies loaned to the borrower come from accounts maintained with or managed by a
Sub-Adviser or its affiliates pursuant to arrangements with such accounts.
Interest and principal payments are credited to such accounts. A Sub-Adviser,
acting as a fiduciary on behalf of its clients, has the right to increase or
decrease the amount provided to the borrower under an obligation. The borrower
has the right to pay without penalty all or any part of the principal amount
then outstanding on an obligation together with interest to the date of payment.
Since these obligations typically provide that the interest rate is tied to the
Treasury bill auction rate, the rate on Master Notes is subject to change.
Repayment of Master Notes to participating accounts depends on the ability of
the borrower to pay the accrued interest and principal of the obligation on
demand which is continuously monitored by the Sub-Adviser. Master Notes
typically are not rated by credit rating agencies.

Value Fund may purchase commercial paper consisting of issues rated at the
time of purchase within the three highest rating categories by a nationally
recognized statistical rating organization (an "NRSRO"). Value Fund may also
invest in commercial paper that is not rated but is determined by the Adviser,
under guidelines established by the Group's Board of Trustees, to be of
comparable quality. Growth Fund has not established minimum rating requirements
for the Fund's investments. Pharmaceutical Fund and Technology Fund may purchase
commercial paper rated at the time of purchase within the two highest rating
categories by an NRSRO, or deemed by U.S. Bank to be of comparable quality.

OTHER FIXED INCOME SECURITIES. Other fixed income securities in which
Pharmaceutical Fund and Technology Fund may invest include nonconvertible
preferred stocks and nonconvertible corporate debt securities. Investments in
nonconvertible preferred stocks and nonconvertible corporate debt securities
will be limited to securities which are rated at the time of purchase not less
than BBB by Standard & Poor's or Baa by Moody's (or equivalent short-term
ratings), or which have been assigned an equivalent rating by another nationally
recognized statistical rating organization, or which are of comparable quality
in the judgment of the Sub-Adviser. Obligations rated BBB, Baa or their
equivalent, although investment grade, have speculative characteristics and
carry a somewhat higher risk of default that obligations rated in the higher
investment grade categories.

<PAGE> 47

Pharmaceutical Fund and Technology Fund may invest in short-term
investments (including repurchase agreements "collateralized fully," as provided
in Rule 2a-7 under the Investment Company act of 1940; interest-bearing or
discounted commercial paper, including dollar denominated commercial paper of
foreign issuers; and any other taxable and tax-exempt money market instruments,
including variable rate demand notes, that are "Eligible Securities" as defined
in Rule 2a-7, on a joint basis with other funds advised by U.S. Bank to the
extent permitted by an exemptive order issued by the Securities and Exchange
Commission.

VARIABLE AMOUNT MASTER DEMAND NOTES. Variable amount master demand notes
are unsecured demand notes that permit the indebtedness thereunder to vary and
provide for periodic readjustments in the interest rate according to the terms
of the instrument. They are also referred to as variable rate demand notes.
Because master demand notes are direct lending arrangements between a Fund and
the issuer, they are not normally traded. Although there is no secondary market
in the notes, a Fund may demand payment of principal and accrued interest at any
time or during specified periods not exceeding one year, depending upon the
instrument involved, and may resell the note at any time to a third party. The
Adviser or Sub-Adviser will consider the earning power, cash flow, and other
liquidity ratios of the issuers of such notes and will continuously monitor
their financial status and ability to meet payment on demand.

VARIABLE AND FLOATING RATE NOTES. A variable rate note is one whose terms
provide for the readjustment of its interest rate on set dates and which, upon
such readjustment, can reasonably be expected to have a market value that
approximates its par value. A floating rate note is one whose terms provide for
the readjustment of its interest rate whenever a specified interest rate changes
and which, at any time, can reasonably be expected to have a market value that
approximates its par value. Such notes are frequently not rated by credit rating
agencies. For Pharmaceutical Fund and Technology Fund, these notes must satisfy
the same quality standards as commercial paper investments. Growth Fund has no
minimum rating requirements. Unrated variable and floating rate notes purchased
by Value Fund will be determined by the Adviser under guidelines approved by the
Group's Board of Trustees to be of comparable quality at the time of purchase to
rated instruments eligible for purchase under the Fund's investment policies. In
making such determinations, the Adviser will consider the earning power, cash
flow and other liquidity ratios of the issuers of such notes (such issuers
include financial, merchandising, bank holding and other companies) and will
continuously monitor their financial condition. Although there may be no active
secondary market with respect to a particular variable or floating rate note
purchased by a Fund, a Fund may resell the note at any time to a third party.
The absence of an active secondary market, however, could make it difficult for
a Fund to dispose of a variable or floating rate note in the event the issuer of
the note defaulted on its payment obligations and a Fund could, as a result or
for other reasons, suffer a loss to the extent of the default. Variable or
floating rate notes may be secured by bank letters of credit.

<PAGE> 48

FOREIGN INVESTMENTS. The Funds may invest in certain obligations or
securities of foreign issuers, including American Depositary Receipts ("ADRs"),
European Depositary Receipts ("EDRs"), Global Depositary Receipts ("GDRs"),
other similar depositary receipts, Yankee Obligations, and U.S.
dollar-denominated securities issued by foreign branches of U.S. and foreign
banks. Growth Fund may invest up to 15% of its foreign investments in securities
that are not listed on a securities exchange or, in the case of debt securities,
that are not United States dollar-denominated. Foreign investments may subject a
Fund to investment risks that differ in some respects from those related to
investment in obligations of U.S. domestic issuers. Such risks include future
adverse political and economic developments, possible seizure, nationalization,
or expropriation of foreign investments, less stringent disclosure requirements,
the possible establishment of exchange controls or taxation at the source or
other taxes, and the adoption of other foreign governmental restrictions. Growth
Fund will not invest in foreign commercial paper that is subject to foreign
withholding tax at the time of purchase.

Additional risks include less publicly available information, less
government supervision and regulation of foreign securities exchanges, brokers
and issuers, the risk that companies may not be subject to the accounting,
auditing and financial reporting standards and requirements of U.S. companies,
the risk that foreign securities markets may have less volume and that therefore
many securities traded in these markets may be less liquid and their prices more
volatile than U.S. securities, and the risk that custodian and brokerage costs
may be higher. Foreign issuers of securities or obligations are often subject to
accounting treatment and engage in business practices different from those
respecting domestic issuers of similar securities or obligations. Foreign
branches of U.S. banks and foreign banks may be subject to less stringent
reserve requirements than those applicable to domestic branches of U.S. banks.
Certain of these investments may subject the Funds to currency fluctuation
risks.

DEPOSITARY RECEIPTS. A Fund's investments may include securities of foreign
issuers in the form of sponsored or unsponsored American Depositary Receipts
("ADRs"), Global Depositary Receipts ("GDRs") and European Depositary Receipts
("EDRs"). ADRs are depositary receipts typically issued by a United State bank
or trust company which evidence ownership of underlying securities issued by a
foreign corporation. EDRs and GDRs are typically issued by foreign banks or
trust companies, although they also may be issued by United States banks or
trust companies, and evidence ownership of underlying securities issued by
either a foreign or a United States corporation. Generally, depositary receipts
in registered form are designed for use in the United States securities market
and depositary receipts in bearer form are designed for use in securities
markets outside the United States. Depositary receipts may not necessarily be
denominated in the same currency as the underlying securities into which they
may be converted. Ownership of unsponsored depositary receipts may not entitle
the Fund to financial or other reports from the issuer of the underlying
security, to which it would be entitled as the owner of sponsored depositary
receipts.

<PAGE> 49

PREFERRED STOCK. Pharmaceutical Fund and Technology Fund may invest in
preferred stock. Preferred stock, unlike common stock, offers a stated dividend
rate payable from the issuer's earnings. Preferred stock dividends may be
cumulative or non-cumulative, participating, or auction rate. If interest rates
rise, the fixed dividend on preferred stocks may be less attractive, causing the
price of the preferred stocks to decline. Preferred stock may have mandatory
sinking fund provisions, as well as call/redemption provisions prior to
maturity, a negative feature when interest rates decline.

WHEN-ISSUED AND DELAYED DELIVERY SECURITIES. Growth Fund, Pharmaceutical
Fund and Technology Fund may purchase securities on a when-issued or delayed
delivery basis. Delivery of and payment for these securities may take as long as
a month or more after the date of the purchase commitment. The value of these
securities is subject to market fluctuation during this period and no interest
or income accrues to a Fund until settlement. The Funds will maintain with the
custodian a separate account with a segregated portfolio of liquid assets
consisting of cash, U.S. Government securities or other liquid high-grade debt
securities in an amount at least equal to these commitments. When entering into
a when-issued or delayed delivery transaction, a Fund will rely on the other
party to consummate the transaction; if the other party fails to do so, the Fund
may be disadvantaged. It is the current policy of the Funds not to enter into
when- issued commitments exceeding in the aggregate 25% of the market value of a
Fund's total assets, less liabilities other than the obligations created by
these commitments.

LOWER RATED OR UNRATED SECURITIES. Growth Fund has no minimum quality
requirements for its debt obligations. Securities rated Baa by Moody's Investors
Service ("Moody's) or BBB by Standard & Poors Corporation ("S&P"), or deemed of
comparable quality by the Sub-Adviser, may have speculative characteristics.
Securities rated below investment grade, i.e., below Baa or BBB, or deemed of
comparable quality by the Sub-Adviser, have higher yields but also involve
greater risks than higher rated securities. Under quidelines used by rating
agencies, securities rated below investment grade, or deemed of comparable
quality, have large uncertainties or major risk exposures in the event of
adverse conditions, which features outweigh any quality and protective
characteristics. Securities with the lowest ratings are considered to have
extremely poor prospects of ever attaining any real investment standing, to have
a current identifiable vulnerability to default, to be unlikely to have the
capacity to pay interest and repay principal when due in the event of adverse
business, financial or economic conditions, and/or to be in default or not
current in the payment of interest or principal. Such securities are considered
speculative with respect to the issuer's capacity to pay interest and repay
principal in accordance with the terms of the obligations. Accordingly, it is
possible that these types of factors could, in certain instances, reduce the
value of such securities held by the Fund with a commensurate effect on the
value of its shares.

<PAGE> 50

The secondary market for lower rated securities is not as liquid as that
for higher rated securities. This market is concentrated in relatively few
market makers and participants in the market are mostly institutional investors,
including insurance companies, banks, other financial institutions and
investment companies. In addition, the trading market for lower rated securities
is generally lower than that for higher-rated securities, and the secondary
markets could contract under adverse market or economic conditions independent
of any specific adverse changes in the condition of a particular issuer. These
factors may have an adverse effect on the Fund's ability to dispose of these
securities and may limit its ability to obtain accurate market quotations for
purposes of determining the value of its assets. If the Fund is not able to
obtain precise or accurate market quotations for a particular security, it will
become more difficult for the Fund's Trustees to value its portfolio, requiring
them to rely more on judgment. Less liquid secondary markets may also affect the
Fund's ability to sell securities at their fair value. In addition, the Fund may
invest up to 15% of its net assets, measured at the time of investment, in
illiquid securities, which may be more difficult to value and to sell at fair
value. If the secondary markets for high yield debt securities are affected by
adverse economic conditions, the proportion of the Fund's assets invested in
illiquid securities may increase.

In the case of corporate debt securities, while the market values of
securities rated below investment grade and comparable unrated securities tend
to react less to fluctuations in interest rate levels than do those of
higher-rated securities, the market values of certain of these securities also
tend to be more sensitive to individual corporate developments and changes in
economic conditions than higher-rated securities. Price volatility in these
securities will be reflected in the Fund's share value. In addition, such
securities generally present a higher degree of credit risk. Issuers of these
securities often are highly leveraged and may not have more traditional methods
of financing available to them, so that their ability to service their debt
obligations during an economic downturn or during sustained periods of rising
interest rates may be impaired. The risk of loss due to default by such issuers
is significantly greater than with investment grade securities because such
securities generally are unsecured and frequently are subordinated to the prior
payment of senior indebtedness.

A description of the quality ratings of prominent rating organizations is
contained in Appendix A.

HEDGING. Hedging is a means of transferring risk that an investor does not
wish to assume during an uncertain market environment. The Funds are permitted
to enter into these transactions solely: (a) to hedge against changes in the
market value of portfolio securities and against changes in the market value of
securities intended to be purchased or (b) to close out or offset existing
positions.

<PAGE> 51

Hedging activity in a Fund may include selling futures contracts on stock
indexes, options on stock index futures traded on a national exchange or board
of trade and options on securities and on stock indexes traded on national
securities exchanges or through private transactions directly with a
broker-dealer. A Fund may also hedge a portion of its portfolio by selling stock
index futures contracts or purchasing puts on these contracts to limit exposure
to an actual or anticipated market decline. A Fund may hedge against fluctations
in currency exchange rates, in connection with its investments in foreign
securities, by purchasing foreign forward currency exchange contracts. All
hedging transactions must be appropriate for reduction of risk; they cannot be
for speculation.

Under regulations of the Commodity Exchange Act of 1936, as amended
("Commodity Exchange Act"), an investment company registered under the 1940 Act
is exempt from the definition of "commodity pool operator", and, therefore, is
not subject to regulation under the Commodity Exchange Act, provided that the
entity agrees to restrict its investments in commodity futures and commodity
options contracts to: (i) bona fide hedging transactions within the meaning of
the Commodity Futures Trading Commission's regulations, without any limitation
on quantity, and (ii) other futures and options transactions in which the
aggregate initial margin and premiums do not exceed 5% of the liquidation value
of the entity's portfolio after taking into account unrealized profits and
unrealized losses on any such contracts. The Fund will use commodity futures and
commodity options contracts only in a manner consistent with these requirements.

FORWARD FOREIGN CURRENCY EXCHANGE CONTRACTS. A Fund may enter into forward
foreign currency exchange contracts in connection with its investments in
foreign securities. A forward contract may be used by a Fund only to hedge
against possible variations in exchange rates of currencies in countries in
which it may invest. A forward foreign currency exchange contract ("forward
contract") involves an obligation to purchase or sell a specific currency at a
future date, which may be any fixed number of days from the date of the contract
agreed upon by the parties, at a price set at the time of the contract. Forward
contracts are traded in the interbank market directly between currency traders
(usually large commercial banks) and their customers. A forward contract
generally has no deposit requirement, and no commissions are charged at any
stage for trades.

<PAGE> 52

FUTURES CONTRACTS. Each Fund may invest in futures contracts and options
thereon (stock index futures contracts, interest rate futures contracts or
currency futures contracts or options) to hedge or manage risks associated with
the Fund's securities investments. To enter into a futures contract, an amount
of cash and cash equivalents, equal to the market value of the futures contract,
is deposited in a segregated account with the Fund's Custodian and/or in a
margin account with a broker to collateralize the position and thereby ensure
that the use of such futures is unleveraged. Positions in futures contracts may
be closed out only on an exchange that provides a secondary market for such
futures. However, there can be no assurance that a liquid secondary market will
exist for any particular futures contract at any specific time. Thus, it may not
be possible to close a futures position. In the event of adverse price
movements, a Fund would continue to be required to make daily cash payments to
maintain its required margin. In such situations, if a Fund had insufficient
cash, it might have to sell portfolio securities to meet daily margin
requirements at a time when it would be disadvantageous to do so. In addition, a
Fund might be required to make delivery of the instruments underlying futures
contracts it holds. The inability to close options and futures positions also
could have an adverse impact on a Fund's ability to hedge or manage risks
effectively.

Successful use of futures by a Fund is also subject to the Adviser's or
Sub-Adviser's ability to predict movements correctly in the direction of the
market. There is typically an imperfect correlation between movements in the
price of the future and movements in the price of the securities that are the
subject of the hedge. In addition, the price of futures may not correlate
perfectly with movement in the cash market due to certain market distortions.
Due to the possibility of price distortion in the futures market and because of
the imperfect correlation between the movements in the cash market and movements
in the price of futures, a correct forecast of general market trends or interest
rate movements by the Adviser or Sub-Adviser may still not result in a
successful hedging transaction over a short time frame.

The trading of futures contracts is also subject to the risk of trading
halts, suspension, exchange or clearing house equipment failures, government
intervention, insolvency of a brokerage firm or clearing house or other
disruption of normal trading activity, which could at times make it difficult or
impossible to liquidate existing positions or to recover excess variation margin
payments.

<PAGE> 53

The purchase and sale of futures contracts or related options will not be a
primary investment technique of the Funds. A Fund will not purchase or sell
futures contracts (or related options thereon) if, immediately after the
transaction, the aggregate initial margin deposits and premiums paid by the Fund
on its open futures and options positions that do not constitute bona fide
hedging transactions, as defined by applicable rules, exceed 5% of the
liquidation value of the Fund after taking into account any unrealized profits
and unrealized losses on any such futures or related options contracts into
which it has entered.

STOCK INDEX FUTURES

A Fund may purchase and sell stock index futures contracts as a hedge
against changes resulting from market conditions in the values of securities
that are held in its portfolio or that it intends to purchase or when such
purchase or sale is economically appropriate for the reduction of risks inherent
in the ongoing management of the Fund. A stock index futures contract is an
agreement in which one party agrees to deliver to the other an amount of cash
equal to a specific dollar amount times the difference between the value of a
specific stock index at the close of the last trading day of the contract and
the price at which the agreement is made. When the contract is executed, each
party deposits with a broker, or in a segregated custodial account, a specified
percentage of the contract amount, called the initial margin, and during the
term of the contract, the amount of the deposit is adjusted based on the current
value of the futures contract by payments of variation margin to or from the
broker or segregated account. In the case of options on stock index futures, the
holder of the option pays a premium and receives the right, upon exercise of the
option at a specified price during the option period, to assume the option
writer's position in a stock index futures margin account; if exercised on the
last trading day, cash in an amount equal to the difference between the option
exercise price and the closing level of the relevant index on the expiration
date is delivered.

A Fund may hedge a portion of its portfolio by selling stock index futures
contracts or purchasing puts on these contracts to limit exposure to an actual
or anticipated market decline. This provides an alternative to liquidation of
securities positions. Conversely, during a market advance or when the investment
adviser anticipates an advance, a Fund may hedge a portion of its portfolio by
purchasing stock index futures, or options on these futures. This affords a
hedge against a Fund not participating in a market advance when it is not fully
invested and serves as a temporary substitute for the purchase of individual
securities which may later be purchased in a more advantageous manner. When a
Fund purchases stock index futures contracts, it will deposit, and
mark-to-market daily, an amount of liquid assets consisting of cash, U.S.
Government securities, or other liquid securities equal to the market value of
the futures contracts in a segregated account with its custodian. Alternatively,
a Fund may cover such positions by purchasing offsetting positions, or by using
a combination of offsetting positions and cash or liquid securities.

<PAGE> 54

A Fund's successful use of stock index futures contracts depends upon the
Adviser's or Sub-Adviser's ability to predict the direction of the market and is
subject to various additional risks. The correlation between movement in the
price of the stock index future and the price of the securities being hedged is
imperfect and the risk from imperfect correlation increases as the composition
of a Fund's portfolio diverges from the composition of the relevant index. In
addition, if a Fund purchases futures to hedge against market advances before it
can invest in common stock in an advantageous manner and the market declines,
there may be a loss on the futures contracts. In addition, the ability of a Fund
to close out a futures position or an option on futures depends on a liquid
secondary market. There is no assurance that liquid secondary markets will exist
for any particular futures contract or option on a futures contract at any
particular time. The risk of loss to a Fund is theoretically unlimited when the
Fund sells an uncovered futures contract because there is an obligation to make
delivery unless the contract is closed out, regardless of fluctuations in the
price of the underlying security. A Fund's ability to engage in hedging
activities may be limited by certain federal income tax considerations.

FOREIGN CURRENCY FUTURES TRANSACTIONS. Unlike forward foreign currency
exchange contracts, foreign currency futures contracts and options on foreign
currency futures contract are standardized as to amount and delivery period and
may be traded on boards of trade and commodities exchanges or directly with a
dealer which makes a market in such contracts and options. It is anticipated
that such contracts may provide greater liquidity and lower cost than forward
foreign currency exchange contracts. As part of their financial futures
transactions, the Funds may use foreign currency futures contracts and options
on such futures contracts. Through the purchase or sale of such contracts, the
Funds may be able to achieve many of the same objectives as through investing in
forward foreign currency exchange.

FOREIGN CURRENCY OPTIONS. A foreign currency option provides the option
buyer with the right to buy or sell a stated amount of foreign currency at the
exercise price at a specified date or during the option period. A call option
gives its owner the right, but not the obligation, to buy the currency, while a
put option gives its owner the right, but not the obligation, to sell the
currency. The option seller (writer) is obligated to fulfill the terms of the
option sold if it is exercised. However, either seller or buyer may close its
position during the option period in the secondary market for such options at
any time prior to expiration.

<PAGE> 55

A foreign currency call option rises in value if the underlying currency
appreciates. Conversely, a foreign currency put option rises in value if the
underlying currency depreciates. While purchasing a foreign currency option may
protect a Fund against an adverse movement in the value of a foreign currency,
it would not limit the gain which might result from a favorable movement in the
value of the currency. For example, if a Fund were holding securities
denominated in an appreciating foreign currency and had purchased a foreign
currency put to hedge against a decline in the value of the currency, it would
not have to exercise its put. In such an event, however, the amount of the
Fund's gain would be offset in part by the premium paid for the option.
Similarly, if a Fund entered into a contract to purchase a security denominated
in a foreign currency and purchased a foreign currency call to hedge against a
rise in the value of the currency between the date of purchase and the
settlement date, the Fund would not need to exercise its call if the currency
instead depreciated in value. In such a case, the Fund would acquire the amount
of foreign currency needed for settlement in the spot market at a lower price
than the exercise price of the option.

OPTIONS ON SECURITIES. A Fund may purchase put options only on equity
securities held in its portfolio and write call options and put options on
stocks only if they are covered, as described below, and such call options must
remain covered so long as the Fund is obligated as a writer. Option transactions
can be executed either on a national exchange or through a private transaction
with a broker-dealer (an "over-the-counter" transaction). Each Fund may write
(sell) "covered" call options and purchase options to close out options
previously written by it.

A call option gives the holder (buyer) the "right to purchase" a security
at a specified price (the exercise price) at any time until a certain date (the
expiration date). So long as the obligation of the writer of a call option
continues, he may be assigned an exercise notice by the broker-dealer through
whom such option was sold, requiring him to deliver the underlying security
against payment of the exercise price. This obligation terminates upon the
expiration of the call option, or such earlier time at which the writer effects
a closing purchase transaction by repurchasing an option identical to that
previously sold. To secure his obligation to deliver the underlying security in
the case of a call option, a writer is required to deposit in escrow the
underlying security or other assets in accordance with the rules of the Options
Clearing Corporation.

The purpose of writing covered call options is to generate additional
premium income for a Fund. This premium income will serve to enhance a Fund's
total return and will reduce the effect of any price decline of the security
involved in the option. Covered call options will generally be written on
securities which, in the opinion of the Adviser or Sub-Adviser, are not expected
to make any major price moves in the near future but which, over the long term,
are deemed to be attractive investments for the particular Fund.

<PAGE> 56

A Fund may only write call options that are "covered", meaning that it
either owns the underlying security or has an absolute and immediate right to
acquire that security, without additional cash consideration (or for additional
cash consideration held in a segregated account by its custodian), upon
conversion or exchange of other securities currently held in its portfolio. In
addition, a Fund will not permit the call to become uncovered prior to the
expiration of the option or termination through a closing purchase transaction
as described below. If a Fund writes a call option, the purchaser of the option
has the right to buy (and a Fund has the obligation to sell) the underlying
security at the exercise price throughout the term of the option. The initial
amount paid to a Fund by the purchaser of the option is the "premium". A Fund's
obligation to deliver the underlying security against payment of the exercise
price will terminate either upon expiration of the option or earlier if the Fund
is able to effect a "closing purchase transaction" through the purchase of an
equivalent option. There can be no assurance that a closing purchase transaction
can be effected at any particular time or at all. A Fund would not be able to
effect a closing purchase transaction after it had received notice of exercise.
A Fund will normally not write a covered call option if, as a result, the
aggregate market value of all portfolio securities covering all call options
would exceed 15% of the market value of its net assets.

Fund securities on which call options may be written will be purchased
solely on the basis of investment considerations consistent with a Fund's
investment objective. The writing of covered call options is a conservative
investment technique believed to involve relatively little risk (in contrast to
the writing of naked or uncovered options, which the Funds will not do), but
capable of enhancing a Fund's total return. When writing a covered call option,
a Fund, in return for the premium, gives up the opportunity for profit from a
price increase in the underlying security above the exercise price, but retains
the risk of loss should the price of the security decline. Unlike one who owns
securities not subject to an option, a Fund has no control over when it may be
required to sell the underlying securities, since it may be assigned an exercise
notice at any time prior to the expiration of its obligation as a writer. If a
call option which a Fund has written expires, the Fund will realize a gain in
the amount of the premium; however, such gain may be offset by a decline in the
market value of the underlying security during the option period. If the call
option is exercised, the Fund will realize a gain or loss from the sale of the
underlying security. The security covering the call will be maintained in a
segregated account of the Funds' Custodian.

The premium received is the market value of an option. The premium a Fund
will receive from writing a call option will reflect, among other things, the
current market price of the underlying security, the relationship of the
exercise price to such market price, the historical price volatility of the
underlying security, and the length of the option period. Once the decision to
write a call option has been made, the Adviser or Sub-Adviser, in determining
whether a particular call option should be written on a particular security,
will consider the reasonableness of the anticipated premium and the likelihood
that a liquid secondary market will exist for such option. The premium received
by a Fund for writing covered call options will be recorded as a liability in
the Fund's statement of assets and liabilities. This liability will be adjusted
daily to the option's current market value, which will be the latest sale price
at the time at which the net asset value per share of the Fund is computed
(close of the New York Stock Exchange), or, in the absence of such sale, the
latest asked price. The liability will be extinguished upon expiration of the
option, the purchase of an identical option in a closing transaction, or
delivery of the underlying security upon the exercise of the option.

<PAGE> 57

Closing transactions will be effected in order to realize a profit on an
outstanding call option, to prevent an underlying security from being called, or
to permit the sale of the underlying security. Furthermore, effecting a closing
transaction will permit a Fund to write another call option on the underlying
security with either a different exercise price or expiration date or both. If a
Fund desires to sell a particular security from its portfolio on which it has
written a call option, it will seek to effect a closing transaction prior to, or
concurrently with, the sale of the security. There is, of course, no assurance
that a Fund will be able to effect such closing transactions at a favorable
price. If a Fund cannot enter into such a transaction, it may be required to
hold a security that it might otherwise have sold, in which case it would
continue to be at market risk on the security. A Fund will pay transaction costs
in connection with the writing of options to close out previously written
options. Such transaction costs are normally higher than those applicable to
purchases and sales of portfolio securities.

Call options written by a Fund will normally have expiration dates of less
than nine months from the date written. The exercise price of the options may be
below, equal to, or above the current market values of the underlying securities
at the time the options are written. From time to time, a Fund may purchase an
underlying security for delivery in accordance with an exercise notice of a call
option assigned to it, rather than delivering such security from its portfolio.
In such cases, additional costs will be incurred.

A Fund will realize a profit or loss from a closing purchase transaction if
the cost of the transaction is less or more than the premium received from the
writing of the option. Because increases in the market price of a call option
will generally reflect increases in the market price of the underlying security,
any loss resulting from the repurchase of a call option is likely to be offset
in whole or in part by appreciation of the underlying security owned by a Fund.

In order to write a call option, a Fund is required to comply with the
rules of The Options Clearing Corporation and the various exchanges with respect
to collateral requirements. A Fund may not purchase call options on individual
stocks except in connection with a closing purchase transaction. It is possible
that the cost of effecting a closing transaction may be greater than the premium
received by a Fund for writing the option.

A Fund may also purchase put options so long as they are listed on an
exchange. If a Fund purchases a put option, it has the option to sell the
subject security at a specified price at any time during the term of the option.

Purchasing put options may be used as a portfolio investment strategy when
the Adviser or Sub-Adviser perceives significant short-term risk but substantial
long-term appreciation for the underlying security. The put option acts as an
insurance policy, as it protects against significant downward price movement
while it allows full participation in any upward movement. If a Fund is holding
a stock that the Adviser or Sub-Adviser feels has strong fundamentals, but for
some reason may be weak in the near term, it may purchase a listed put on such
security, thereby giving itself the right to sell such security at a certain
strike price throughout the term of the option. Consequently, a Fund will
exercise the put only if the price of such security falls below the strike price
of the put. The difference between the put's strike price and the market price
of the underlying security on the date a Fund exercises the put, less
transaction costs, will be the amount by which the Fund will be able to hedge
against a decline in the underlying security. If, during the period of the
option the market price for the underlying security remains at or above the
put's strike price, the put will expire worthless, representing a loss of the
price a Fund paid for the put, plus transaction costs. If the price of the
underlying security increases, the profit a Fund realizes on the sale of the
security will be reduced by the premium paid for the put option less any amount
for which the put may be sold.

<PAGE> 58

A Fund may write put options on a fully covered basis on a stock the Fund
intends to purchase. If a Fund writes a put option, the purchaser of the option
has the right to sell (and the Fund has the obligation to buy) the underlying
security at the exercise price throughout the term of the option. The initial
amount paid to a Fund by the purchaser of the option is the "premium". A Fund's
obligation to purchase the underlying security against payment of the exercise
price will terminate either upon expiration of the option or earlier if the Fund
is able to effect a "closing purchase transaction" through the purchase of an
equivalent option. There can be no assurance that a closing purchase transaction
can be effected at any particular time or at all. In all cases where a put
option is written, a Fund will segregate or put into escrow with its custodian,
or pledge to a broker as collateral any combination of "qualified securities"
(which consists of cash, U.S. Government securities or other liquid securities)
with a market value at the time the option is written of not less than 100% of
the exercise price of the put option multiplied by the number of options
contracts written times the option multiplier.

A Fund may purchase a call option in a stock it intends to purchase at some
point in the future. The purchase of a call option is viewed as an alternative
to the purchase of the actual stock. The number of option contracts purchased
multiplied by the exercise price times the option multiplier will not be any
greater than the number of shares that would have been purchased had the
underlying security been purchased. If a Fund purchases a call option, it has
the right but not the obligation to purchase (and the seller has the obligation
to sell) the underlying security at the exercise price throughout the term of
the option. The initial amount paid by a Fund to the seller of the call option
is known as the "premium". If during the period of the option the market price
of the underlying security remains at or below the exercise price, a Fund will
be able to purchase the security at the lower market price. The profit or loss a
Fund may realize on the eventual sale of a security purchased by means of the
exercise of a call option will be reduced by the premium paid for the call
option.

STOCK INDEX OPTIONS. Except as described below, a Fund will write call
options on indexes only if on such date it holds a portfolio of stocks at least
equal to the value of the index times the multiplier times the number of
contracts. When a Fund writes a call option on a broadly-based stock market
index, it will segregate or put into escrow with its custodian, or pledge to a
broker as collateral for the option, any combination of "qualified securities"
(which consists of cash, U.S. Government securities or other liquid securities)
with a market value at the time the option is written of not less than 100% of
the current index value times the multiplier times the number of contracts.

If a Fund has written an option on an industry or market segment index, it
will segregate or put into escrow with its custodian, or pledge to a broker as
collateral for the option, one or more "qualified securities", all of which are
stocks of issuers in such industry or market segment, with a market value at the
time the option is written of not less than 100% of the current index value
times the multiplier times the number of contracts.

<PAGE> 59

If at the close of business on any business day the market value of such
qualified securities so segregated, escrowed, or pledged falls below 100% of the
current index value times the multiplier times the number of contracts, a Fund
will so segregate, escrow or pledge an amount in cash, Treasury bills or other
liquid securities equal in value to the difference. In addition, when a Fund
writes a call on an index that is in-the-money at the time the call is written,
it will segregate with its custodian or pledge to the broker as collateral cash,
U.S. Government or other liquid securities equal in value to the amount by which
the call is in-the-money times the multiplier times the number of contracts. Any
amount segregated pursuant to the foregoing sentence may be applied to a Fund's
obligation to segregate additional amounts in the event that the market value of
the qualified securities falls below 100% of the current index value times the
multiplier times the number of contracts. However, if a Fund holds a call on the
same index as the call written where the exercise price of the call held is
equal to or less than the exercise price of the call written or greater than the
exercise price of the call written if the difference is maintained in cash,
short-term U.S. Government securities, or other liquid securities in a
segregated account with its custodian, it will not be subject to the
requirements described in this paragraph.

RISKS OF TRANSACTIONS IN STOCK OPTIONS. Purchase and sales of options
involves the risk that there will be no market in which to effect a closing
transaction. An option position may be closed out only on an exchange that
provides a secondary market for an option of the same series or if the
transaction was an over-the-counter transaction, through the original
broker-dealer. Although the Fund will generally buy and sell options for which
there appears to be an active secondary market, there is no assurance that a
liquid secondary market on an exchange will exist for any particular option, or
at any particular time, and for some options no secondary market on an exchange
may exist. If the Fund, as a covered call or put option writer, is unable to
effect a closing purchase transaction in a secondary market, it will not be able
to sell the underlying security until the option expires or it delivers or
purchases the underlying security upon exercise.

RISKS OF OPTIONS ON INDEXES. A Fund's purchase and sale of options on
indexes will be subject to risks described above under "Risks of Transactions in
Stock Options". In addition, the distinctive characteristic of options on
indexes creates certain risks that are not present with stock options.

Since the value of an index option depends upon the movements in the level
of the index, rather than the price of a particular stock, whether a Fund will
realize a gain or loss on the purchase or sale of an option on an index depends
upon movements in the level of stock prices in the stock market generally or in
an industry or market segment rather than movements in the price of a particular
stock. Accordingly, successful use by a Fund of options on indexes would be
subject to the Adviser's or Sub-Adviser's ability to correctly predict movements
in the direction of the stock market generally or of a particular industry. This
requires skills and techniques different than predicting changes in the price of
individual stocks.

Index prices may be distorted if trading of certain stocks included in the
index is interrupted. Trading in the index options also may be interrupted in
certain circumstances, such as if trading were halted in a substantial number of
stocks included in the index. If this occurred, a Fund would not be able to
close out options that it had purchased or written and, if restrictions on
exercise were imposed, might not be able to close out options that it had
purchased or written and, if restrictions on exercise were imposed, might not be
able to exercise an option that it was holding, which could result in
substantial losses to the Fund. It is the policy of each Fund to purchase or
write options only on indexes that include a number of stocks sufficient to
minimize the likelihood of a trading halt in the index, for example, the S&P 100
or S&P 500 index option.

<PAGE> 60

Trading in index options commenced in April 1993 with the S&P 100 option
(formerly called the CBOE 100). Since that time, a number of additional index
option contracts have been introduced, including options on industry indexes.
Although the markets for certain index option contracts have developed rapidly,
the markets for other index options are still relatively illiquid. The ability
to establish and close out positions on such options will be subject to the
development and maintenance of a liquid secondary market. It is not certain that
this market will develop in all index option contracts. Fund will not purchase
or sell index option contracts unless and until, in the Adviser's or
Sub-Adviser's opinion, the market for such options has developed sufficiently
that the risk in connection with these transactions is no greater than the risk
in connection with options on stock.

REIT SECURITIES. Pharmaceutical Fund may invest in securities of real
estate investment trusts ("REITs"). REITs are publicly traded corporations or
trusts that specialize in acquiring, holding and managing residential,
commercial or industrial real estate. A REIT is not taxed at the entity level on
income distributed to its shareholders or unitholders if it distributes to
shareholders or unitholders at least 95% of its taxable income for each taxable
year and complies with regulatory requirements relating to its organization,
ownership, assets and income.

REITs generally can be classified as Equity REITs, Mortgage REITs and
Hybrid REITs. An Equity REIT invests the majority of its assets directly in real
property and derives its income primarily from rents and from capital gains on
real estate appreciation which are realized through property sales. A Mortgage
REIT invests the majority of its assets in real estate mortgage loans and
services its income primarily from interest payments. A Hybrid REIT combines the
characteristics of an Equity REIT and a Mortgage REIT. Although the Fund can
invest in all three kinds of REITs, its emphasis is expected to be on
investments in Equity REITs.

Investments in the real estate industry involve particular risks. The real
estate industry has been subject to substantial fluctuations and declines on a
local, regional and national basis in the past and may continue to be in the
future. Real property values, and income from real property continue to be in
the future. Real property values and income from real property may decline due
to general and local economic conditions, overbuilding and increased
competition, increases in property taxes and operating expenses, changes in
zoning laws, casualty or condemnation losses, regulatory limitations on rents,
changes in neighborhoods and in demographics, increases in market interest
rates, or other factors. Factors such as these may adversely affect companies
which own and operate real estate directly, companies which lend to such
companies, and companies which service the real estate industry.

<PAGE> 61

Direct investments in REITs also involve risks. Equity REITs will be
affected by changes in the values of and income from the properties they own,
while Mortgage REITs may be affected by the credit quality of the mortgage loans
they hold. In addition, REITs are dependent on specialized management skills and
on their ability to generate cash flow for operating purposes and to make
distributions to shareholders or unitholders. REITs may have limited
diversification and are subject to risks associated with obtaining financing for
real property, as well as to the risk of self-liquidation. REITs also can be
adversely affected by their failure to qualify for tax-free pass-through
treatment of their income under the Internal Revenue Code of 1986, as amended,
or their failure to maintain an exemption from registration under the Investment
Company Act of 1940. By investing in REITs indirectly through the Fund, a
shareholder bears not only a proportionate share of the expenses of the Fund,
but also may indirectly bear similar expenses of some of the REITs in which it
invests.

RESTRICTED AND ILLIQUID SECURITIES. A Fund may acquire, in privately
negotiated transactions, securities that cannot be offered for public sale in
the United States without first being registered under the Securities Act of
1933 ("Securities Act"). Restricted securities are subject to restrictions on
resale under federal securities law. Because of these restrictions, a Fund may
not be able to readily resell these securities at a price equal to what it might
obtain for similar securities with a more liquid market. A Fund's valuation of
these securities will reflect this restricted liquidity. Under criteria
established by the Funds' Trustees, certain restricted securities sold pursuant
to Rule 144A under the Securities Act may be determined to be liquid. To the
extent that restricted securities are not determined to be liquid, each Fund
will limit its purchase, together with other illiquid securities including
non-negotiable time deposits, and repurchase agreements providing for settlement
in more than seven days after notice, to no more than 15% of its net assets.

Restricted securities in which a Fund may invest may include commercial
paper issued in reliance on the exemption from registration afforded by Section
4(2) of the Securities Act of 1933. Section 4(2) commercial paper is restricted
as to disposition under federal securities law, and is generally sold to
institutional investors, such as the Funds, who agree that they are purchasing
the paper for investment purposes and not with a view to public distribution.
Any resale by the purchaser must be in an exempt transaction. Section 4(2)
commercial paper is normally resold to other institutional investors like the
Funds through or with the assistance of the issuer or investment dealers who
make a market in Section 4(2) commercial paper, thus providing liquidity. The
Adviser believes that Section 4(2) commercial paper and possibly certain other
restricted securities which meet the criteria for liquidity established by the
Trustees of the Funds are quite liquid. The Funds intend, therefore, to treat
the restricted securities which meet the criteria for liquidity established by
the Trustees, including Section 4(2) commercial paper, as determined by the
Adviser, as liquid and not subject to the investment limitations applicable to
illiquid securities.

<PAGE> 62

SECURITIES OF OTHER INVESTMENT COMPANIES. The Funds may invest in
securities issued by the other investment companies. Each Fund intends to limit
its investments in accordance with applicable law. Among other things, such law
would limit these investments so that, as determined immediately after a
securities purchase is made by a Fund: (a) not more than 5% of the value of its
total assets will be invested in the securities of any one investment company;
(b) not more than 10% of the value of its total assets will be invested in the
aggregate in securities of investment companies as a group; and (c) not more
than 3% of the outstanding voting stock of any one investment company will be
owned by the Fund; and (d) not more than 10% of the outstanding voting stock of
any one closed-end investment company will be owned by the Fund together with
all other investment companies that have the same investment adviser. Under
certain sets of conditions, different sets of restrictions may be applicable. As
a shareholder of another investment company, a Fund would bear, along with other
shareholders, its pro rata portion of that company's expenses, including
advisory fees. These expenses would be in addition to the advisory and other
expenses that a Fund bears directly in connection with its own operations.
Investment companies in which a Fund may invest may also impose a sales or
distribution charge in connection with the purchase or redemption of their
Shares and other types of commissions or charges. Such charges will be payable
by the Fund and, therefore, will be borne directly by Shareholders.

Investment companies in which Pharmaceutical Fund and Technology Fund may
invest include money market funds, advised by U.S. Bank, subject to certain
restrictions contained in an exemptive order issued by the Securities and
Exchange Commission.

REPURCHASE AGREEMENTS. Securities held by a Fund may be subject to
repurchase agreements. These transactions permit a Fund to earn income for
periods as short as overnight. The Fund could receive less than the repurchase
price on any sale of such securities. Under the terms of a repurchase agreement,
a Fund would acquire securities from member banks of the Federal Deposit
Insurance Corporation and registered broker-dealers and other financial
institutions which the Adviser or Sub-Adviser deems creditworthy under
guidelines approved by the Group's Board of Trustees, subject to the seller's
agreement to repurchase such securities at a mutually agreed-upon date and
price. The repurchase price would generally equal the price paid by a Fund plus
interest negotiated on the basis of current short-term rates, which may be more
or less than the rate on the underlying portfolio securities. The seller under a
repurchase agreement will be required to maintain continually the value of
collateral held pursuant to the agreement at not less than the repurchase price
(including accrued interest). If the seller were to default on its repurchase
obligation or become insolvent, the Fund holding such obligation would suffer a
loss to the extent that the proceeds from a sale of the underlying portfolio
securities were less than the repurchase price under the agreement, or to the
extent that the disposition of such securities by the Fund were delayed pending
court action. Additionally, there is no controlling legal precedent confirming
that a Fund would be entitled, as against a claim by such seller or its receiver
or trustee in bankruptcy, to retain the underlying securities, although the
Board of Trustees of the Group believes that, under the regular procedures
normally in effect for custody of the Funds' securities subject to repurchase
agreements and under federal laws, a court of competent jurisdiction would rule
in favor of the Group if presented with the question. Securities subject to
repurchase agreements will be held by the Funds' custodian or another qualified
custodian or in the Federal Reserve/Treasury book-entry system. Repurchase
agreements are considered to be loans by a Fund under the 1940 Act.

<PAGE> 63

REVERSE REPURCHASE AGREEMENTS. Growth Fund is permitted to enter into
reverse repurchase agreements. In a reverse repurchase agreement, the Fund sells
a security and agrees to repurchase it at a mutually agreed upon date and at a
price reflecting the interest rate effective for the term of the agreement. This
may also be viewed as the borrowing of money by the Fund. Growth Fund will not
invest the proceeds of a reverse repurchase agreement for a period which exceeds
the duration of the reverse repurchase agreement. Growth Fund may not enter into
reverse repurchase agreements exceeding in the aggregate one-third of the market
value of its total assets, less liabilities other than the obligations created
by reverse repurchase agreements. Growth Fund will establish and maintain with
its custodian a separate account with a segregated portfolio of liquid assets
consisting of cash or liquid securities in an amount at least equal to its
purchase obligations under its repurchase agreements.

Reverse repurchase agreements involve the risk that the market value of the
securities retained by the Fund may decline below the price of the securities it
has sold but is obligated to repurchase under the agreement. In the event the
buyer of securities under a reverse repurchase agreement files for bankruptcy or
becomes insolvent, the Fund's use of proceeds from the agreement may be
restricted pending a determination by the other party or its trustee or receiver
whether to enforce the Fund's obligation to repurchase the securities.

LOANS OF PORTFOLIO SECURITIES. Each Fund may lend securities if such loans
are secured continuously by liquid assets consisting of cash, U.S. Government
securities or other liquid debt securities or by a letter of credit in favor of
the Fund at least equal at all times to 100% of the market value of the
securities loaned, plus accrued interest. While such securities are on loan, the
borrower will pay the Fund any income accruing thereon. Loans will be subject to
termination by the Fund in the normal settlement time, currently three Business
Days after notice, or by the borrower on one day's notice (as used herein,
"Business Day" shall denote any day on which the New York Stock Exchange and the
custodian are both open for business). Any gain or loss in the market price of
the borrowed securities that occurs during the term of the loan inures to the
lending Fund and its shareholders. The Funds may pay reasonable finders' and
custodial fees, including fees to a Sub-Adviser or its affiliate, in connection
with loans. In addition, the Funds will consider all facts and circumstances
including the creditworthiness of the borrowing financial institution, and the
Funds will not lend their securities to any director, officer, employee, or
affiliate of the Adviser, a Sub-Adviser, the Administrator or the Distributor,
unless permitted by applicable law. Loans of portfolio securities involve risks,
such as delays or an inability to regain the securities or collateral
adjustments in the event the borrower defaults or enters into bankruptcy.

<PAGE> 64

AFFILIATED TRANSACTIONS. The Funds are authorized to execute portfolio
transactions through, and to pay commissions to, Phillips & Company Securities,
Inc. ("Phillips"), a broker-dealer affiliated with the Adviser, and Piper
Jaffray Inc. and U.S. Bancorp Securities, broker-dealers affiliates of the
Sub-Adviser, and to purchase securities in underwritings in which these
broker-dealers are members of the underwriting syndicate. A Fund will not
acquire portfolio securities issued by, or enter into repurchase agreements or
reverse repurchase agreements with, the Adviser, the Distributor or their
affiliates.

Investment Restrictions
- -----------------------

The following are fundamental investment restrictions of each Fund and may
not be changed without approval by vote of a majority of the outstanding shares
of the Fund. For this purpose, such a majority vote means the lesser of (1) 67%
or more of the voting securities present at an annual or special meeting of
Shareholders, if holders of more than 59% of the outstanding voting securities
of a Fund are present of represented by proxy or (2) more than 50% of the
outstanding voting securities of the Fund.

Value Fund and Growth Fund have each elected to qualify as a diversified
series of the Trust. Pharmaceutical Fund and Technology Fund have each elected
to be non-diversified series of the Trust. Both Pharmaceutical Fund and
Technology Fund intend, however, to conduct their operations so as to qualify as
regulated investment companies under the Internal Revenue Code of 1986, as
amended. Additionally, none of the Funds may:

- borrow money, except as permitted under the Investment Company Act of
1940, as amended, and as interpreted or modified by regulatory authority
having jurisdiction, from time to time;

- issue senior securities, except as permitted under the Investment Company
Act of 1940, as amended, and as interpreted or modified by regulatory
authority having jurisdiction, from time to time;

- concentrate its investments in a particular industry, as that term is used
in the Investment Company Act of 1940, as amended, and as interpreted or
modified by regulatory authority having jurisdiction, from time to time,
provided that Pharmaceutical Fund will concentrate its investments in
pharmaceutical and bio-technology-related industries and Technology Fund
will concentrate its investments in technology-related industries.

- engage in the business of underwriting securities issued by others, except
to the extent that a Fund may be deemed to be an underwriter in connection
with the disposition of portfolio securities;

- purchase or sell real estate, which does not include securities of
companies which deal in real estate or mortgages or investments secured by
real estate or interests therein, except that each Fund reserves freedom
of action to hold and to sell real estate acquired as a result of the
Fund's ownership of securities;

<PAGE> 65

- purchase physical commodities or contracts relating to physical
commodities;

- make loans to other persons, except (i) loans of portfolio securities, and
(ii) to the extent that entry into repurchase agreements and the purchase
of debt instruments or interests in indebtedness in accordance with a
Fund's investment objective and policies may be deemed to be loans.

Portfolio Turnover
- ------------------

The portfolio turnover rate for each Fund is calculated by dividing the
lesser of the Fund's purchases or sales of portfolio securities for the year by
the monthly average value of the portfolio securities. The calculation excludes
all securities whose remaining maturities at the time of acquisition were one
year or less. The turnover rate for each Fund is not expected to exceed 75%.

Personal Trading Policies
- -------------------------

The Funds, the Adviser and Administrator, and the Distributor have adopted
Codes of Ethics under Rule 17j-1 under the Investment Company Act of 1940.
Consistent with requirements of that Rule, the Codes permit persons subject to
the Codes to invest in securities, including securities that may be purchased by
a Fund. The Codes and the Rule require these transactions to be monitored.

NET ASSET VALUE

The net asset value of Shares of each Fund is determined and the Shares are
priced as of the Valuation Time on each Business Day of the Company. A "Business
Day" constitutes any day on which the New York Stock Exchange (the "NYSE") is
open for trading and any other day except days on which there are not sufficient
changes in the value of a Fund's portfolio securities that the Fund's net asset
value might be materially affected and days during which no Shares are tendered
for redemption and no orders to purchase Shares are received. Currently, the
NYSE is closed on New Year's Day, Martin Luther King, Jr. Day, President's Day,
Good Friday, Memorial Day, Independence Day, Labor Day, Thanksgiving Day and
Christmas Day.

Portfolio equity securities for which market quotations are readily
available are valued based upon their last sales prices in their principal
market. Lacking any sales, these securities are valued at the mean between the
most recent bid and asked quotations. Debt securities with remaining maturities
of 60 days or less will be valued at their amortized cost. Other debt securities
are generally valued by pricing agents based on valuations supplied by
broker-dealers or calculated by electronic methods. Other securities and assets
for which quotations are not readily available, including restricted securities
and securities purchased in private transactions, are valued at their fair value
in the best judgment of the Adviser or Sub-Adviser under the supervision of the
Group's Board of Trustees.

<PAGE> 66

Among the factors that will be considered, if they apply, in valuing
portfolio securities held by a Fund are the existence of restrictions upon the
sale of the security by the Fund, the absence of a market for the security, the
extent of any discount in acquiring the security, the estimated time during
which the security will not be freely marketable, the expenses of registering or
otherwise qualifying the security for public sale, underwriting commissions if
underwriting would be required to effect a sale, the current yields on
comparable securities for debt obligations traded independently of any equity
equivalent, changes in the financial condition and prospects of the issuer, and
any other factors affecting fair value. In making valuations, opinions of
counsel may be relied upon as to whether or not securities are restricted
securities and as to the legal requirements for public sale.

As noted, the Group may use a pricing service to value certain portfolio
securities where the prices provided are believed to reflect the fair market
value of such securities. A pricing service would normally consider such factors
as yield, risk, quality, maturity, type of issue, trading characteristics,
special circumstances and other factors it deems relevant in determining
valuations of normal institutional trading units of debt securities and would
not rely exclusively on quoted prices. The methods used by the pricing service
and the valuations so established will be reviewed by the Group under the
general supervision of the Group's Board of Trustees. Several pricing services
are available, one or more of which may be used by the Adviser or Sub-Adviser
from time to time.

ADDITIONAL PURCHASE AND REDEMPTION INFORMATION

Matters Affecting Redemption
- ----------------------------

Fund Shares are sold on a continuous basis by BISYS Fund Services Limited
Partnership d/b/a BISYS Fund Services (the "Distributor") and BISYS Fund
Services has agreed to use appropriate efforts to solicit all purchase orders.

The Group may suspend the right of redemption or postpone the date of
payment for Shares with respect to a Fund during any period when (a) trading on
the New York Stock Exchange (the "Exchange") is restricted by applicable rules
and regulations of the Commission, (b) the Exchange is closed for other than
customary weekend and holiday closings, (c) the Commission has by order
permitted such suspension for the protection of security holders of the Group or
a Fund, or (d) the Commission has determined that an emergency exists as a
result of which (i) disposal by the Group or a Fund of securities owned by it is
not reasonably practical, or (ii) it is not reasonably practical for the Group
or a Fund to determine the fair value of its net assets.

The Group may redeem Shares of a Fund involuntarily if redemption appears
appropriate in light of the Group's responsibilities under the 1940 Act. See
"SHAREHOLDER INFORMATION" in the Prospectus.

<PAGE> 67

MANAGEMENT OF THE GROUP

Trustees and Officers
- ---------------------

Overall responsibility for management of the Group rests with its Board of
Trustees, which is elected by the Shareholders of the Group. The Trustees elect
the officers of the Group to supervise actively its day-to-day operations. The
names of the Trustees and officers of the Group, their addresses, ages and
principal occupations during the past five years are as follows:

Position(s)
Held With Principal Occupation
Name, Address and Age the Group During Past 5 Years
- --------------------- ----------- -------------------
<S> <C> <C>

Walter B. Grimm* President and Trustee From June 1992 to present,
3435 Stelzer Road employee of BISYS Fund Services,
Columbus, Ohio 43219 from 1987 to June 1992, President
Age: 53 of Leigh Investments (investment
firm).

Maurice G. Stark Trustee Retired. Until December 31,
505 King Avenue 1994, Vice President-Finance and
Columbus, Ohio 43201 Treasurer, Battelle Memorial
Age: 63 Institute (scientific research
and development service corporation).

Michael M. Van Buskirk Trustee From June 1991 to present,
37 West Broad Street Executive Vice President of The
Suite 1001 Ohio Bankers' Association (trade
Columbus, Ohio 43215 association.
Age:

John H. Ferring IV Trustee From 1979 to present,
105 Bolte Lane President and owner of Plaze, Inc.,
St. Clair, Missouri 63077 St. Clair, Missouri
Age: 46

R. Jeffrey Young Chairman and Trustee From 1993 to present,
3435 Stelzer Road employee of BISYS Fund Services.
Columbus, Ohio 43219
Age: 35
</TABLE>

<PAGE> 68

<S> <C> <C>
J. David Huber Vice President From June, 1987 to present,
3435 Stelzer Road employee of BISYS Fund Services.
Columbus, Ohio 43219
Age: 52

Jennifer J. Brooks Vice President From October, 1988 to present,
3435 Stelzer Road employee of BISYS Fund Services.
Columbus, Ohio 43219
Age: 33

Nadeem Yousaf Treasurer From August, 1999 to present,
3435 Stelzer Road employee of BISYS Fund Services;
Columbus, Ohio 43219 from March 1997 to June 1999, employee
Age: 30 of Investors Bank and Trust; from
October 1994 to March 1997,
employee of PricewaterhouseCoopers
LLP; from September 1990 to
February 1992, employee of KPMG
Peat Marwick.

George L. Stevens Secretary From September 1996 to present,
3435 Stelzer Road employee of BISYS Fund Services;
Columbus, Ohio 43219 from September 1995 to September
Age: 48 1996, Independent Consultant;
from September 1989 to September
1995, Senior Vice President, AmSouth
Bank, N.A.

Alaina V. Metz Assistant Secretary From 1995 to present, employee of
3435 Stelzer Road BISYS Fund Services; from May
Columbus, Ohio 43219 1989 to June 1995, employee of
Age: 31 Alliance Capital Management.

</TABLE>

- ----------------------------

* Mr. Grimm is considered to be an "interested person" of the Group as defined
in the 1940 Act.

As of the date of this Statement of Additional Information, the Group's
officers and Trustees, as a group, own less than 1% of either Fund's outstanding
Shares.

<PAGE> 69

The officers of the Group receive no compensation directly from the Group
for performing the duties of their offices. BISYS Fund Services Ohio, Inc.
receives fees from the Funds for acting as Administrator and BISYS Fund Services
L.P. receives fees pursuant to the Service and Distribution Plan. BISYS Fund
Services Ohio, Inc. receives fees from the Funds for acting as fund accountant
and BISYS Fund Services, Inc. receives fees for transfer agent services. Messrs.
Huber, Yousaf, Stevens, Grimm, Young, Ms. Metz and Ms. Brooks are employees of
BISYS.

Trustees of the Group not affiliated with BISYS Fund Services receive from
the Group an annual fee of $1,000, plus $2,250 for each regular meeting of the
Board of Trustees attended and $1,000 for each special meeting of the Board
attended in person and $500 for other special meetings of the Board attended by
telephone, and are reimbursed for all out-of-pocket expenses relating to
attendance at such meetings. Trustees who are affiliated with BISYS Fund
Services do not receive compensation from the Group.

For the fiscal year ended March 31, 1999, the Trustees received the
following compensation from the Group and from certain other investment
companies (if applicable) that have the same investment adviser as the Fund or
an investment adviser that is an affiliated person of the Group's investment
adviser:

Pension or Retirement Total Compensation From
Aggregate Compensation Benefits Accrued As Estimated Annual Benefits Registrant and Fund
Name of Trustee from the Fund Part of Fund Expenses Upon Retirement Complex Paid to Trustees
- --------------- ------------- --------------------- --------------- ------------------------
<S> <C> <C> <C> <C>

Walter B. Grimm $ 0 $ 0 $ 0 $ 0
Maurice G. Stark $166.09 $ 0 $ 0 $10,000
Michael Van Buskirk $166.09 $ 0 $ 0 $10,000
John H. Ferring IV $101.73 $ 0 $ 0 $ 5,750

</TABLE>

Mr. R. Jeffrey Young was not a Trustee during the period reported.

<PAGE> 70

Control Persons and Principal Holders of Securities
- ---------------------------------------------------

[Information on (a) 25% and (b) 5% beneficial owners of Fund shares to be
provided by amendment.]

Ownership of Fund shares by all officers and Trustees, as a group, totaled
less than 1%.

Investment Adviser and Sub-Advisers
- -----------------------------------

Investment advisory services for the Funds are provided by Willamette Asset
Managers, Inc., 220 NW 2nd Avenue, Suite 950, Portland, Oregon 97209. Pursuant
to Investment Advisory Agreements dated as of May 22, 1998 (Value Fund), April
1, 1999 (Growth Fund) and February 17, 2000 (Pharmaceutical Fund and Technology
Fund), the Adviser has agreed to provide investment advisory services to each
Fund as described in the Prospectuses. For the services provided pursuant to
each Advisory Agreement, each Fund pays the Adviser a fee computed daily and
paid monthly, at an annual rate, calculated as a percentage of the Fund's
average daily net assets, of 1.00% (Value Fund), 1.20% (Growth Fund), 1.20%
(Pharmaceutical Fund) and 1.20% (Technology Fund). The Adviser may periodically
waive all or a portion of its advisory fee to increase the net income of a Fund
available for distribution as dividends.

The Adviser provides general portfolio management and supervision for Value
Fund. For each of the other Funds, the Adviser provides overall management
supervision, but has retained a Sub-Adviser to provide portfolio management
services. Out of its fees from Growth Fund, Pharmaceutical Fund and Technology
Fund, the Adviser pays the fees of the Sub-Advisers.

Investment advisory fees earned by the Adviser for service to Value Fund
for the fiscal year ended March 31, 1999 totalled $90,295.33 and the Adviser
waived advisory fees in the amount of $27,500. The Adviser earned no fees from
Growth Fund, Pharmaceutical Fund or Technology Fund during that fiscal year
since Growth Fund's operations commenced on April 1, 1999, and operations of
Pharmaceutical Fund and Technology Fund had not yet commenced operations as of
the date of this Statement of Additional Information.

Unless sooner terminated, the Advisory Agreements will continue in effect
until May 22, 2000 (Value Fund), March 31, 2001 (Growth Fund), and February 17,
2002 (Pharmaceutical Fund and Technology Fund), respectively, and from year to
year thereafter, if such continuance is approved at least annually by the
Group's Board of Trustees or by vote of a majority of the outstanding Shares of
the applicable Fund (as defined under "INVESTMENT RESTRICTIONS,"above), and a
majority of the Trustees who are not parties to the Advisory Agreement or
interested persons (as defined in the 1940 Act) of any party to the Advisory
Agreement by votes cast in person at a meeting called for such purpose. Each
Advisory Agreement is terminable at any time on 60 days' written notice without
penalty by the Trustees, by vote of a majority of the outstanding Shares of the
particular Fund, or by the Adviser. Each Advisory Agreement also terminates
automatically in the event of any assignment, as defined in the 1940 Act.

<PAGE> 71

Each Advisory Agreement provides that the Adviser shall not be liable for
any error of judgment or mistake of law or for any loss suffered by the
applicable Fund in connection with the performance of the Advisory Agreement,
except a loss resulting from a breach of fiduciary duty with respect to the
receipt of compensation for services or a loss resulting from willful
misfeasance, bad faith, or gross negligence on the part of the Adviser in the
performance of its duties, or from reckless disregard by the Adviser of its
duties and obligations thereunder.

The Bank of New York (BONY), 48 Wall Street, New York, New York 10286,
provides portfolio management services, as Sub-Adviser, to Growth Fund pursuant
to a Sub-Investment Advisory Agreement with the Group and the Adviser, dated as
of April 1, 1999. For its services to Growth Fund, the Adviser pays BONY a fee
computed daily and paid monthly at an annual rate calculated as a percentage of
Growth Fund's average daily net assets, of 0.45%. As of March 31, 1999 Growth
Fund had not yet commenced operations, so the Sub-Adviser received no fees
during that fiscal year. U.S. Bank National Association (U.S. Bank), 601 Second
Avenue South, Minneapolis, Minnesota 55480, serves as Sub-Adviser to
Pharmaceutical Fund and Technology Fund pursuant to Sub-Investment Advisory
Agreements dated as of February 17, 2000. For its services to Pharmaceutical
Fund and Technology Fund, the Adviser pays U.S. Bank a fee computed daily and
paid monthly at an annual rate with respect to each of those Funds of 0.50%
calculated as a percentage of that Fund's average daily net assets. Subsequent
to such first year, the rate of fees payable by the Adviser to U.S. Bank with
respect to each of Pharmaceutical Fund and Technology Fund is 0.50%. Each
Sub-Investment Advisory Agreement will continue in effect, unless sooner
terminated, for two years from its effective date, and has provisions for
continuation and termination similar to those of the Investment Advisory
Agreements. Each Sub-Investment Advisory Agreement may also be terminated by the
Adviser. Health Fund and Technology Fund had not commenced operations as of
March 31, 2000, so no fees were paid to U.S. Bank during the fiscal year ended
March 31, 2000.

The Value Fund Advisory Agreement was approved by both the Trustees and the
independent Trustees at a meeting held February 28, 1998. The Growth Fund
Advisory Agreement and the Sub-Investment Advisory Agreement for Growth Fund
were so approved at a meeting held November 13, 1998. The Advisory Agreements
and Sub-Investment Advisory Agreements for Pharmaceutical Fund and Technology
Fund were so approved at a meeting held February 17, 2000.

Portfolio Transactions
- ----------------------

Pursuant to the Advisory Agreements and the Sub-Investment Advisory
Agreements, the Adviser and each Sub-Adviser determine, subject to the general
supervision of the Board of Trustees of the Group and in accordance with each
Fund's investment objective and restrictions, which securities are to be
purchased and sold by the Funds, and which brokers are to be eligible to execute
the Funds' portfolio transactions. Certain purchases and sales of portfolio
securities with respect to the Funds are principal transactions in which
portfolio securities are normally purchased directly from the issuer or from an
underwriter or market maker for the securities. Purchases from underwriters of
portfolio securities generally include a commission or concession paid by the
issuer to the underwriter, and purchases from dealers serving as market makers
may include the spread between the bid and asked price. Transactions on stock
exchanges involve the payment of negotiated brokerage commissions. Transactions
in the over-the-counter market are generally principal transactions with
dealers. With respect to the over-the-counter market, the Adviser and
Sub-Advisers, where possible, will deal directly with dealers who make a market
in the securities involved except in those circumstances where better price and
execution are available elsewhere.

<PAGE> 72

Investment decisions for the Funds are made independently from those for
other accounts managed by the Adviser and the Sub-Advisers. Any such account may
also invest in the same securities as a Fund. When a purchase or sale of the
same security is made at substantially the same time on behalf of a Fund and
another account, the transaction will be averaged as to price, and available
investments will be allocated as to amount in a manner which the Adviser or a
Sub-Adviser believes to be equitable to the applicable Fund and such other
account. In some instances, this investment procedure may adversely affect the
price paid or received by a Fund or the size of the position obtained by a Fund.
To the extent permitted by law, the Adviser or a Sub-Adviser may aggregate the
securities to be sold or purchased for a Fund with those to be sold or purchased
for the other accounts in order to obtain best execution.

For the fiscal year ended March 31, 1999, Value Fund paid brokerage
Commissions of $24,245.76. Growth Fund, Pharmaceutical Fund and Technology Fund
had not commenced operations as of March 31, 1999.

Administrator
- -------------

BISYS serves as administrator ("Administrator") to the Funds pursuant to a
Management and Administration Agreement dated May 22, 1998 (the "Administration
Agreement"). The Administrator assists in supervising all operations of the
Funds (other than those performed by the Adviser and Sub-Advisers under the
Advisory Agreements and Sub-Investment Advisory Agreements, the Custodian under
the Custodian Agreement and by BISYS Fund Services Ohio under the Funding
Accounting Agreement and BISYS Fund Services, Inc. under the Transfer Agency
Agreement). The Administrator is a broker-dealer registered with the Commission,
and is a member of the National Association of Securities Dealers, Inc. The
Administrator provides financial services to institutional clients.

Under the Administration Agreement, the Administrator has agreed to
maintain office facilities; furnish statistical and research data, clerical,
certain bookkeeping services and stationery and office supplies; prepare the
periodic reports to the Commission on Form N-SAR or any replacement forms
therefor; compile data for, prepare for execution by the Funds and file all of
the Funds' federal and state tax returns and required tax filings other than
those required to be made by the Funds' Custodian and Transfer Agent; prepare
compliance filings pursuant to state securities laws with the advice of the
Group's counsel; assist to the extent requested by the Funds with the Funds'
preparation of their Annual and Semi-Annual Reports to Shareholders and their
Registration Statement; compile data for, prepare and file timely Notices to the
Commission required pursuant to Rule 24f-2 under the 1940 Act; keep and maintain
the financial accounts and records of the Funds, including calculation of daily
expense accruals; and generally assist in all aspects of the Funds' operations
other than those performed by the Adviser, under the Advisory Agreements, by the
Sub-Advisers under the Sub-Investment Advisory Agreements, by the Custodian
under the Custodian Agreement or by BISYS Fund Services, Inc. under the Transfer
Agency Agreement or BISYS Fund Services Ohio, Inc. under the Fund Accounting
Agreement. Under the Administration Agreement, the Administrator may delegate
all or any part of its responsibilities thereunder.

The Administrator receives a fee from each Fund for its services as
Administrator and expenses assumed pursuant to the Administration Agreement, (1)
twenty one-hundredths of one percent (0.20%) of the Funds' average daily net
assets or (2) such other fee as may be agreed upon in writing by the Group and
the Administrator. The Administrator may periodically waive all or a portion of
its fee with respect to each Fund in order to increase the net income of the
Fund available for distribution as dividends.

<PAGE> 73

For the Fiscal year ended March 31, 1999, the Administrator was paid
administrative fees of $18,059.13 for services to Value Fund. Growth Fund,
Pharmaceutical Fund and Technology Fund had not commenced operations as of March
31, 1999.

Unless sooner terminated as provided therein, the Administration Agreement
will continue in effect until May 31, 2001. The Administration Agreement
thereafter shall be renewed automatically for successive three-year terms,
unless written notice not to renew is given by the non-renewing party to the
other party at least 60 days prior to the expiration of the then-current term.
The Administration Agreement is terminable with respect to a particular Fund
only upon mutual agreement of the parties to the Administration Agreement and
for cause (as defined in the Administration Agreement) by the party alleging
cause, on not less than 60 days' notice by the Group's Board of Trustees or by
the Administrator.

The Administration Agreement provides that the Administrator shall not be
liable for any error of judgment or mistake of law or any loss suffered by a
Fund in connection with the matters to which the Administration Agreement
relates, except a loss resulting from willful misfeasance, bad faith, or gross
negligence in the performance of its duties, or from the reckless disregard by
the Administrator of its obligations and duties thereunder.

Distributor
- -----------

BISYS Fund Services L.P. serves as distributor to the Funds pursuant to the
Distribution Agreement dated May 22, 1998, (the "Distribution Agreement").
Unless otherwise terminated, the Distribution Agreement will continue in effect
with respect to a Fund for an initial term of two years, and thereafter, if such
continuance is approved at least annually (i) by the Group's Board of Trustees
or by the vote of a majority of the outstanding Shares of the Fund and (ii) by
the vote of a majority of the Trustees of the Group who are not parties to the
Distribution Agreement or interested persons (as defined in the 1940 Act) of any
party to the Distribution Agreement, cast in person at a meeting called for the
purpose of voting on such approval. The Distribution Agreement will terminate
automatically in the event of any assignment, as defined in the 1940 Act.

In its capacity as Distributor, BISYS solicits orders for the sale of
Shares, advertises and pays the costs of advertising, office space and the
personnel involved in such activities. The Distributor receives no compensation
under the Distribution Agreement with the Group, but may receive compensation
from each Fund under the Service and Distribution Plan described below.

As described in the Prospectuses, the Group has adopted a Service and
Distribution Plan for each Fund (the "Plan") pursuant to Rule 12b-1 under the
1940 Act under which each Fund is authorized to compensate the Distributor for
payments it makes to banks, other institutions and broker-dealers, and for
expenses the Distributor and any of its affiliates or subsidiaries incur (with
all of the foregoing organizations being referred to as "Participating
Organizations") for providing administration, distribution or shareholder
service assistance. Payments to such Participating Organizations may be made
pursuant to agreements entered into with the Distributor. The Plan authorizes
each Fund to make payments to the Distributor in an amount not to exceed, on an
annual basis, 0.50% of the Fund's average daily net assets. Each Fund is
authorized to pay a Shareholder Service Fee of up to 0.25% of its average daily
net assets. As required by Rule 12b-1, the Plan was approved by the Board of
Trustees, including a majority of the Trustees who are not interested persons of
the Funds and who have no direct or indirect financial interest in the operation
of the Plan ("Independent Trustees") at meetings held on February 19, 1998
(Value Fund), November 13, 1998 (Growth Fund), and February 17, 2000
(Pharmaceutical Fund and Technology Fund). The Plan may be terminated with
respect to a Fund by vote of a majority of the Independent Trustees, or by vote
of a majority of the outstanding Shares of the Fund. The Trustees review
quarterly a written report of such costs and the purposes for which such costs
have been incurred. The Plan may be amended by vote of the Trustees including a
majority of the Independent Trustees, cast in person at a meeting called for
that purpose.

<PAGE> 74

However, any change in the Plan that would materially increase the distribution
cost to a Fund requires approval by that Fund's Shareholders. For so long as the
Plan is in effect, selection and nomination of the Independent Trustees shall be
committed to the discretion of such Independent Trustees. All agreements with
any person relating to the implementation of the Plan may be terminated at any
time on 60 days' written notice without payment of any penalty, by vote of a
majority of the Independent Trustees or, with respect to a Fund, by vote of a
majority of the outstanding Shares of that Fund. The Plan will continue in
effect with respect to a Fund for successive one-year periods, provided that
each such continuance is specifically approved (i) by the vote of a majority of
the Independent Trustees, and (ii) by the vote of a majority of the entire Board
of Trustees cast in person at a meeting called for that purpose. The Board of
Trustees has a duty to request and evaluate such information as may be
reasonably necessary for it to make an informed determination of whether the
Plan should be implemented or continued. In addition, for each Fund, the
Trustees, in approving the Plan, must determine that there is a reasonable
likelihood that the Plan will benefit the Fund and its Shareholders.

For the fiscal year ended March 31, 1999, the Distributor received $45,147
pursuant to the Plan for Value Fund, all of which was paid to Phillips & Company
Securities Inc., an affiliated broker dealer. As of March 31, 1999, Growth Fund,
Pharmaceutical Fund and Technology Fund had not yet commenced operations.

The Board of Trustees of the Group believes that the Plan is in the best
interests of each Fund since it encourages Fund growth. As the Fund grows in
size, certain expenses, and, therefore, total expenses per Share, may be reduced
and overall performance per Share may be improved.

Custodian
- ---------

Union Bank of California, 475 Sansome Street, San Francisco, California
94111, serves as the Funds' custodian.

Transfer Agency and Fund Accounting Services
- --------------------------------------------

BISYS Fund Services, Inc. serves as Transfer Agent and Dividend Disbursing
Agent ("BISYS Fund Services" or the "Transfer Agent") for the Funds, pursuant to
the Transfer Agency Agreement dated May 22, 1998. Pursuant to such Agreement,
the Transfer Agent, among other things, performs the following services in
connection with the Funds' Shareholders of record: maintenance of shareholder
records for each of the Funds' Shareholders of record; processing shareholder
purchase and redemption orders; processing transfers and exchanges of Shares of
the Funds on the shareholder files and records; processing dividend payments and
reinvestments; and assistance in the mailing of shareholder reports and proxy
solicitation materials. For such services the Transfer Agent receives a fee
based, in part, on the number of shareholders of record. In addition, BISYS Fund
Services Ohio, Inc. ("Fund accounting") provides certain fund accounting
services to the Funds pursuant to the Fund Accounting Agreement dated May 22,
1998. BISYS Fund Services Ohio receives a fee from each Fund for such services
in an amount computed daily and paid periodically at an annual rate of three
one-hundredths of one percent (.03%) of each Fund's average daily net assets
subject to a minimum of $35,000 per year. In addition, Fund Accounting shall be
reimbursed for reasonable out-of-pocket expenses. Under such Agreement,

<PAGE> 75

BISYS Fund Services Ohio maintains the accounting books and the records for each
Fund, including journals containing an itemized daily record of all purchases
and sales of portfolio securities, all receipts and disbursements of cash and
all other debits and credits, general and auxiliary ledgers reflecting all
asset,\ liability, reserve, capital, income and expense accounts, including
interest accrued and interest received, and other required separate ledger
accounts; maintains a monthly trial balance of all ledger accounts; performs
certain accounting services for the Funds, including calculation of the net
asset value per Share, calculation of the dividend and capital gain
distributions, if any, and of yield, reconciliation of cash movements with the
Custodian, affirmation to the Custodian of all portfolio trades and cash
settlements, verification and reconciliation with the Custodian of all daily
trade activity; provides certain reports; obtains dealer quotations, prices from
a pricing service or matrix prices on all portfolio securities in order to mark
the portfolio to the market; and prepares an interim balance sheet, statement of
income and expense, and statement of changes in net assets for each Fund.

During the fiscal year ended March 31, 1999 Value Fund paid the Transfer
Agent and Fund Accountant $64,865 and $31,400, respectively pursuant to the
Transfer Agency Agreement and Fund Accounting Agreement. As of March 31, 1999,
Growth Fund, Pharmaceutical Fund and Technology Fund had not yet commenced
operations.

Independent Auditors
- --------------------

Ernst & Young LLP, 10 West Broad Street, Suite 2300, Columbus, Ohio 43215,
has been selected as independent auditors for the Funds for the fiscal year
ended March 31, 2000. Ernst & Young LLP will perform an annual audit of each
Fund's financial statements and provide other services related to filings with
respect to securities regulations. Reports of their activities will be provided
to the Group's Board of Trustees.

Legal Counsel
- -------------

Dechert Price & Rhoads, 1775 Eye Street, N.W., Washington, D.C. 20006, is
counsel to the Group.

ADDITIONAL INFORMATION

Description of Shares
- ---------------------

The Group is a Massachusetts business trust, organized on January 8, 1992.
The Group's Declaration of Trust is on file with the Secretary of State of
Massachusetts. The Declaration of Trust authorizes the Board of Trustees to
issue an unlimited number of Shares, which are Shares of beneficial interest,
with a par value of $0.01 per share. The Group consists of several funds
organized as separate series of Shares. The Group's Declaration of Trust
authorizes the Board of Trustees to divide or redivide any unissued Shares of
the Group into one or more additional series by setting or changing in any one
or more respects their respective preferences, conversion or other rights,
voting power, restrictions, limitations as to dividends, qualifications, and
terms and conditions of redemption, and to establish separate classes of Shares.

Shares have no subscription or preemptive rights and only such conversion
or exchange rights as the Board of Trustees may grant in its discretion. When
issued for payment as described in the Prospectus and this Statement of
Additional Information, the shares will be fully paid and non-assessable. In the
event of a liquidation or dissolution of the Group, Shareholders of each fund
are entitled to receive the assets available for distribution belonging to that
fund, and a proportionate distribution, based upon the relative asset values of
the respective funds, of any general assets not belonging to any particular fund
which are available for distribution, subject to any differential class
expenses.

<PAGE> 76

Rule 18f-2 under the 1940 Act provides that any matter required to be
submitted to the holders of the outstanding voting securities of an investment
company such as the Group shall not be deemed to have been effectively acted
upon unless approved by the holders of a majority of the outstanding Shares of
each fund affected by the matter. For purposes of determining whether the
approval of a majority of the outstanding Shares of a fund will be required in
connection with a matter, a fund will be deemed to be affected by a matter
unless it is clear that the interests of each fund in the matter are identical,
or that the matter does not affect any interest of the fund. Under Rule 18f-2,
the approval of an investment advisory agreement or any change in investment
policy would be effectively acted upon with respect to a fund only if approved
by a majority of the outstanding Shares of that fund. However, Rule 18f-2 also
provides that the ratification of independent public accountants (for funds
having the same independent accountants), the approval of principal underwriting
contracts, and the election of Trustees may be effectively acted upon by
Shareholders of the Group voting without regard to individual funds. Rule 18f-3
under the 1940 Act provides that Shareholders of each class shall have exclusive
voting rights on matters submitted to Shareholders relating solely to
distribution and shareholder service arrangements.

Under Massachusetts law, Shareholders could, under certain circumstances,
be held personally liable for the obligations of the Group. However, the
Declaration of Trust disclaims liability of the Shareholders, Trustees or
officers of the Group for acts or obligations of the Group, which are binding
only on the assets and property of the Group, and requires that notice of the
disclaimer be given in each contract or obligation entered into or executed by
the Group or the Trustees. The Declaration of Trust provides for indemnification
out of Group property for all loss and expense of any shareholder held
personally liable for the obligations of the Group. The risk of a shareholder
incurring financial loss on account of Shareholder liability is limited to
circumstances in which the Group itself would be unable to meet its obligations,
and thus should be considered remote.

Vote of a Majority of the Outstanding Shares
- --------------------------------------------

As used in the Prospectuses and this Statement of Additional Information, a
"vote of a majority of the outstanding Shares" of a Fund means the affirmative
vote, at a meeting of Shareholders duly called, of the lesser of (a) 67% or more
of the votes of Shareholders of a Fund present at a meeting at which the holders
of more than 50% of the votes attributable to Shareholders of record of the Fund
are represented in person or by proxy, or (b) the holders of more than 50% of
the outstanding votes of Shareholders of the Fund.

Additional Tax Information
- --------------------------

TAXATION OF THE FUNDS. Each Fund intends to qualify annually and to elect
to be treated as a regulated investment company under the Internal Revenue Code
of 1986, as amended (the "Code").

<PAGE> 77

To qualify as a regulated investment company, each Fund must, among other
things, (a) derive in each taxable year at least 90% of its gross income from
dividends, interest, payments with respect to securities loans and gains from
the sale or other disposition of stock, securities or foreign currencies or
other income derived with respect to its business of investing in such stock,
securities or currencies; (b) diversify its holdings so that, at the end of each
quarter of each taxable year, (i) at least 50% of the market value of the Fund's
assets is represented by cash and cash items (including receivables), U.S.
Government securities, the securities of other regulated investment companies
and other securities, with such other securities of any one issuer limited for
the purposes of this calculation to an amount not greater than 5% of the value
of the Fund's total assets and not greater than 10% of the outstanding voting
securities of such issuer, and (ii) not more than 25% of the value of its total
assets is invested in the securities (other than U.S. Government securities or
the securities of other regulated investment companies) of any one issuer, or of
two or more issuers which the Fund controls and which are determined to be
engaged in the same or similar trades or businesses or related trades or
businesses; and (c) distribute at least 90% of its investment company taxable
income (which includes, among other items, dividends, interest and net
short-term capital gains in excess of net long-term capital losses) and any net
tax-exempt interest income each taxable year.

As a regulated investment company, a Fund generally will not be subject to
U.S. federal income tax on its investment company taxable income and net capital
gains (the excess of net long-term capital gains over net short-term capital
losses), if any, that it distributes to Shareholders. Each Fund intends to
distribute to its Shareholders, at least annually, substantially all of its
investment company taxable income and net capital gains. Amounts not distributed
on a timely basis in accordance with a calendar year distribution requirement
are subject to a nondeductible 4% excise tax. To prevent imposition of the
excise tax, a Fund must distribute during each calendar year an amount equal to
the sum of (1) at least 98% of its ordinary income (not taking into account any
capital gains or losses) for the calendar year, (2) at least 98% of its capital
gains in excess of its capital losses (adjusted for certain ordinary losses, as
prescribed by the Code) for the one-year period ending on October 31 of the
calendar year, and (3) any ordinary income and capital gains for previous years
that were not distributed during those years. A distribution will be treated as
paid on December 31 of the current calendar year if it is declared by a Fund in
October, November or December to Shareholders of record on a date in such a
month and paid by the Fund during January of the following calendar year. Such
distributions will be treated as received by Shareholders in the calendar year
in which the distributions are declared, rather than the calendar year in which
the distributions are received. To prevent application of the excise tax, each
Fund intends to make its distributions in accordance with the calendar year
distribution requirement.

<PAGE> 78

DISTRIBUTIONS. Dividends paid out of a Fund's investment company taxable
income generally will be taxable to a U.S. Shareholder as ordinary income. A
portion of each Fund's income may consist of dividends paid by U.S. corporations
and, accordingly, a portion of the dividends paid by a Fund may be eligible for
the corporate dividends-received deduction. Properly designated distributions of
net capital gains, if any, generally are taxable to Shareholders as long-term
capital gains, regardless of how long the Shareholder has held the Fund's
Shares, and are not eligible for the dividends-received deduction. Shareholders
receiving distributions in the form of additional Shares, rather than cash,
generally will have a cost basis in each such Share equal to the net asset value
of a Share of the particular Fund on the reinvestment date. Shareholders will be
notified annually as to the U.S. federal tax status of distributions, and
Shareholders receiving distributions in the form of additional Shares will
receive a report as to the net asset value of those Shares.

Distributions by a Fund reduce the net asset value of the Fund's shares.
Should a taxable distribution reduce the net asset value below a Shareholder's
cost basis, the distribution nevertheless would be taxable to the Shareholder as
ordinary income or capital gain as described above, even though, from an
investment standpoint, it may constitute a partial return of capital. In
particular, investors should be careful to consider the tax implications of
buying shares just prior to a distribution by a Fund. The price of shares
purchased at that time includes the amount of the forthcoming distribution, but
the distribution will generally be taxable to them.

DISCOUNT SECURITIES. Investments by a Fund in securities that are issued at
a discount will result in income to the Fund equal to a portion of the excess of
the face value of the securities over their issue price (the "original issue
discount") each year that the securities are held, even though the Fund receives
no cash interest payments. This income is included in determining the amount of
income which a Fund must distribute to maintain its status as a regulated
investment company and to avoid the payment of federal income tax and the 4%
excise tax.

Some of the debt securities may be purchased by a Fund at a discount which
exceeds the original issue discount on such debt securities, if any. This
additional discount represents market discount for federal income tax purposes.
Generally, the gain realized on the disposition of any debt security acquired
after April 30, 1993 having market discount will be treated as ordinary income
to the extent it does not exceed the accrued market discount on such debt
security.

<PAGE> 79

OPTIONS AND HEDGING TRANSACTIONS. The taxation of equity options and
over-the-counter options on debt securities is governed by Code section 1234.
Pursuant to Code section 1234, the premium received by a Fund for selling a call
option is not included in income at the time of receipt. If the option expires,
the premium is short-term capital gain to the Fund. If the Fund enters into a
closing transaction, the difference between the amount paid to close out its
position and the premium received is short-term capital gain or loss. If a call
option written by a Fund is exercised, thereby requiring the Fund to sell the
underlying security, the premium will increase the amount realized upon the sale
of such security and any resulting gain or loss will be a capital gain or loss,
and will be long-term or short-term depending upon the holding period of the
security. With respect to a call option that is purchased by a Fund, if the
option is sold, any resulting gain or loss will be a capital gain or loss, and
will be long-term or short-term, depending upon the holding period of the
option. If the option expires, the resulting loss is a capital loss and is
long-term or short-term, depending upon the holding period of the option. If the
option is exercised, the cost of the option is added to the basis of the
purchased security.

Certain options in which a Fund may invest are "section 1256 contracts".
Gains or losses on section 1256 contracts generally are considered 60% long-term
and 40% short-term capital gains or losses; however, foreign currency gains or
losses (as discussed below) arising from certain Section 1256 contracts may be
treated as ordinary income or loss. Also, section 1256 contracts held by a Fund
at the end of each taxable year (and, generally, for purposes of the 4% excise
tax, on October 31 of each year) are "marked-to-market" (that is, treated as
sold at fair market value), resulting in unrealized gains or losses being
treated as though they were realized.

Generally, the hedging transactions undertaken by a Fund may result in
"straddles" for U.S. federal income tax purposes. The straddle rules may affect
the character of gains (or losses) realized by a Fund. In addition, losses
realized by a Fund on positions that are part of a straddle may be deferred
under the straddle rules, rather than being taken into account in calculating
the taxable income for the taxable year in which the losses are realized.
Because only a few regulations implementing the straddle rules have been
promulgated, the tax consequences to a Fund of engaging in hedging transactions
are not entirely clear. Hedging transactions may increase the amount of
short-term capital gain realized by a Fund which is taxed as ordinary income
when distributed to Shareholders.

A Fund may make one or more of the elections available under the Code which
are applicable to straddles. If a Fund makes any of the elections, the amount,
character and timing of the recognition of gains or losses from the affected
straddle positions will be determined under rules that vary according to the
election(s) made. The rules applicable under certain of the elections may
operate to accelerate the recognition of gains or losses from the affected
straddle positions.

<PAGE> 80

Because the straddle rules may affect the character of gains or losses,
defer losses and/or accelerate the recognition of gains or losses from the
affected straddle positions, the amount which may be distributed to
Shareholders, and which will be taxed to them as ordinary income or capital
gain, may be increased or decreased as compared to a fund that did not engage in
such hedging transactions.

Notwithstanding any of the foregoing, a Fund may recognize gain (but not
loss) from a constructive sale of certain "appreciated financial positions" if
the Fund enters into a short sale, offsetting notional principal contract or
forward contract transactions with respect to the appreciated position or
substantially identical property. Appreciated financial positions subject to
this constructive sale treatment are interests (including options and forward
contracts and short sales) in stock, partnership interests, certain actively
traded trust instruments and certain debt instruments. Constructive sale
treatment does not apply to certain transactions closed in the 90-day period
ending with the 30th day after the close of the taxable year, if certain
conditions are met.

Unless certain constructive sales rules (discussed more fully above) apply,
a Fund will not realize gain or loss on a short sale of a security until it
closes the transaction by delivering the borrowed security to the lender.
Pursuant to Code Section 1233, all or a portion of any gain arising from a short
sale may be treated as short-term capital gain, regardless of the period for
which a Fund held the security used to close the short sale. In addition, a
Fund's holding period of any security, which is substantially identical to that
which is sold short, may be reduced or eliminated as a result of the short sale.
Recent legislation, however, alters this treatment by treating certain short
sales against the box and other transactions as a constructive sale of the
underlying security held by a Fund, thereby requiring current recognition of
gain, as described more fully above. Similarly, if a Fund enters into a short
sale of property that becomes substantially worthless, the Fund will recognize
gain at that time as though it had closed the short sale. Future Treasury
regulations may apply similar treatment to other transactions with respect to
property that becomes substantially worthless.

The diversification requirements applicable to each Fund's assets may limit
the extent to which a Fund will be able to engage in transactions in options and
other hedging transactions.

Under the Code, gains or losses attributable to fluctuations in exchange
rates which occur between the time a Fund accrues receivables or liabilities
denominated in a foreign currency, and the time the Fund actually collects such
receivables or pays such liabilities, generally are treated as ordinary income
or ordinary loss. Similarly, on disposition of debt securities denominated in a
foreign currency and on disposition of certain options and futures contracts,
gains or losses attributable to fluctuations in the value of foreign currency
between the date of acquisition of the security or contract and the date of
disposition also are treated as ordinary gain or loss. These gains or losses,
referred to under the Code as "section 988" gains or losses, may increase or
decrease the amount of a Fund's investment company taxable income to be
distributed to its shareholders as ordinary income.

<PAGE> 81

Each Fund may invest in shares of foreign corporations (including through
ADRs) which may be classified under the Code as passive foreign investment
companies ("PFICs"). In general, a foreign corporation is classified as a PFIC
if at least one-half of its assets constitute investment-type assets, or 75% or
more of its gross income is investment-type income. If a Fund receives a
so-called "excess distribution" with respect to PFIC stock, the Fund itself may
be subject to a tax on a portion of the excess distribution, whether or not the
corresponding income is distributed by the Fund to Shareholders. In general,
under the PFIC rules, an excess distribution is treated as having been realized
ratably over the period during which a Fund held the PFIC shares. The Fund
itself will be subject to tax on the portion, if any, of an excess distribution
that is so allocated to prior Fund taxable years and an interest factor will be
added to the tax, as if the tax had been payable in such prior taxable years.
Certain distributions from a PFIC as well as gain from the sale of PFIC shares
are treated as excess distributions. Excess distributions are characterized as
ordinary income even though, absent application of the PFIC rules, certain
excess distributions might have been classified as capital gain.

A Fund may be eligible to elect alternative tax treatment with respect to
PFIC shares. Under an election that currently is available in some
circumstances, a Fund generally would be required to include in its gross income
its share of the earnings of a PFIC on a current basis, regardless of whether
distributions are received from the PFIC in a given year. If this election were
made, the special rules, discussed above, relating to the taxation of excess
distributions, would not apply. In addition, another election would involve
marking to market a Fund's PFIC shares at the end of each taxable year, with the
result that unrealized gains are treated as though they were realized and
reported as ordinary income. Any mark-to-market losses and any loss from an
actual disposition of PFIC shares would be deductible as ordinary losses to the
extent of any net mark-to-market gains included in income in prior years. SALE
OF SHARES. Upon the sale or other disposition of Fund Shares, or upon receipt of
a distribution in complete liquidation of a Fund, a Shareholder generally will
realize a taxable capital gain or loss which may be eligible for reduced capital
gains tax rates, generally depending upon the Shareholder's holding period for
the Shares. Any loss realized on a sale or exchange will be disallowed to the
extent the Shares disposed of are replaced (including Shares acquired pursuant
to a dividend reinvestment plan) within a period of 61 days beginning 30 days
before and ending 30 days after disposition of the Shares. In such a case, the
basis of the Shares acquired will be adjusted to reflect the disallowed loss.
Any loss realized by a Shareholder on a disposition of Fund Shares held by the
Shareholder for six months or less will be treated as a long-term capital loss
to the extent of any distributions of net capital gains received by the
Shareholder with respect to such Shares.

<PAGE> 82

In some cases, Shareholders will not be permitted to take sales charges
into account for purposes of determining the amount of gain or loss realized on
the disposition of their Shares. This prohibition generally applies where (1)
the Shareholder incurs a sales charge in acquiring the stock of a regulated
investment company, (2) the stock is disposed of before the 91st day after the
date on which it was acquired, and (3) the Shareholder subsequently acquires
Shares of the same or another regulated investment company and the otherwise
applicable sales charge is reduced or eliminated under a "reinvestment right"
received upon the initial purchase of Shares of stock. In that case, the gain or
loss recognized will be determined by excluding from the tax basis of the Shares
exchanged all or a portion of the sales charge incurred in acquiring those
Shares. This exclusion applies to the extent that the otherwise applicable sales
charge with respect to the newly acquired Shares is reduced as a result of
having incurred a sales charge initially. Sales charges affected by this rule
are treated as if they were incurred with respect to the stock acquired under
the reinvestment right. This provision may be applied to successive acquisitions
of stock.

FOREIGN WITHHOLDING TAXES. Income received by a Fund from sources within
foreign countries may be subject to withholding and other taxes imposed by such
countries.

BACKUP WITHHOLDING. A Fund may be required to withhold U.S. federal income
tax at the rate of 31% of all reportable payments, including dividends, capital
gain distributions and redemptions payable to Shareholders who fail to provide
the Fund with their correct taxpayer identification number or to make required
certifications, or who have been notified by the IRS that they are subject to
backup withholding. Corporate Shareholders and certain other Shareholders
specified in the Code generally are exempt from such backup withholding. Backup
withholding is not an additional tax. Any amounts withheld may be credited
against the Shareholder's U.S. federal income tax liability.

FOREIGN SHAREHOLDERS. The tax consequences to a foreign Shareholder of an
investment in a Fund may be different from those described herein. Foreign
Shareholders are advised to consult their own tax advisers with respect to the
particular tax consequences to them of an investment in a Fund.

<PAGE> 83

OTHER TAXATION. The Group is organized as a Massachusetts business trust
and, under current law, neither the Group nor any fund is liable for any income
or franchise tax in the Commonwealth of Massachusetts, provided that each fund
continues to qualify as a regulated investment company under Subchapter M of the
Code.

Fund Shareholders may be subject to state and local taxes on their Fund
distributions. In many states, Fund distributions which are derived from
interest on certain U.S. Government obligations may be exempt from taxation.

Yields and Total Returns
- ------------------------

YIELD CALCULATIONS. As summarized in the Prospectus of the Funds under the
heading "PERFORMANCE INFORMATION", yields on Fund Shares will be computed by
dividing the net investment income per share (as described below) earned by a
Fund during a 30-day (or one month) period by the maximum offering price per
share on the last day of the period and annualizing the result on a semi-annual
basis by adding one to the quotient, raising the sum to the power of six,
subtracting one from the result and then doubling the difference. The net
investment income per share earned during the period is based on the average
daily number of Shares outstanding during the period entitled to receive
dividends and includes dividends and interest earned during the period minus
expenses accrued for the period, net of reimbursements. This calculation can be
expressed as follows:

a - b
Yield = 2 [(------- + 1)exp(6) - 1]
cd

Where: a = dividends and interest earned during the period.

b = expenses accrued for the period (net of
reimbursements).

c = the average daily number of Shares outstanding
during the period that were entitled to receive
dividends.

d = maximum offering price per Share on the last day of
the period.

<PAGE> 84

For the purpose of determining net investment income earned during the
period (variable "a" in the formula), dividend income on equity securities held
by a Fund is recognized by accruing 1/360 of the stated dividend rate of the
security each day that the security is held by the Fund. Interest earned on any
debt obligations held by a Fund is calculated by computing the yield to maturity
of each obligation held by the Fund based on the market value of the obligation
(including actual accrued interest) at the close of business on the last
Business Day of each month, or, with respect to obligations purchased during the
month, the purchase price (plus actual accrued interest) and dividing the result
by 360 and multiplying the quotient by the market value of the obligation
(including actual accrued interest) in order to determine the interest income on
the obligation for each day of the subsequent month that the obligation is held
by the Fund. For purposes of this calculation, it is assumed that each month
contains 30 days. The maturity of an obligation with a call provision is the
next call date on which the obligation reasonably may be expected to be called
or, if none, the maturity date. With respect to debt obligations purchased at a
discount or premium, the formula generally calls for amortization of the
discount or premium. The amortization schedule will be adjusted monthly to
reflect changes in the market values of such debt obligations.

Undeclared earned income will be subtracted from the net asset value per
share (variable "d" in the formula). Undeclared earned income is the net
investment income which, at the end of the base period, has not been declared as
a dividend, but is reasonably expected to be and is declared as a dividend
shortly thereafter.

During any given 30-day period, the Adviser, the Sub-Adviser, Administrator
or Distributor may voluntarily waive all or a portion of their fees with respect
to a Fund. Such waiver would cause the yield of that Fund to be higher than it
would otherwise be in the absence of such a waiver.

TOTAL RETURN CALCULATIONS. Average annual total return is a measure of the
change in value of an investment in a Fund over the period covered, which
assumes any dividends or capital gains distributions are reinvested in Shares
immediately rather than paid to the investor in cash. A Fund computes the
average annual total return by determining the average annual compounded rates
of return during specified periods that equate the initial amount invested to
the ending redeemable value of such investment. This is done by dividing the
ending redeemable value of a hypothetical $1,000 initial payment by $1,000 and
raising the quotient to a power equal to one divided by the number of years (or
fractional portion thereof) covered by the computation and subtracting one from
the result. This calculation can be expressed as follows:

Average Annual ERV
Total Return = [(------)exp (1/n) - 1]
P

Where: ERV = ending redeemable value at the end of the period
covered by the computation of a hypothetical
$1,000 payment made at the beginning of the
period.

P = hypothetical initial payment of $1,000.

n = period covered by the computation, expressed in
terms of years.

<PAGE> 85

A Fund computes its aggregate total return by determining the
aggregate compounded rate of return during specified periods that likewise
equate the initial amount invested to the ending redeemable value of such
investment. The formula for calculating aggregate total return is as follows:

Aggregate Total ERV
Return = [(------] - 1]
P

ERV = ending redeemable value at the end of the period
covered by the computation of a hypothetical
$1,000 payment made at the beginning of the
period.

P = hypothetical initial payment of $1,000.

The calculations of average annual total return and aggregate total return
assume the reinvestment of all dividends and capital gain distributions on the
reinvestment dates during the period. The ending redeemable value (variable
"ERV" in each formula) is determined by assuming complete redemption of the
hypothetical investment and the deduction of all nonrecurring charges at the end
of the period covered by the computations.

Performance Comparisons
- -----------------------

Investors may judge a Fund's performance by comparing it to the performance
of other mutual funds or mutual fund portfolios with comparable investment
objectives and policies through various mutual fund or market indices, such as
those prepared by Dow Jones & Co., Inc. and Standard & Poor's Corporation, and
to data prepared by Lipper Analytical Services, Inc., a widely recognized
independent service which monitors the performance of mutual funds or Ibbotson
Associates, Inc. Comparisons may also be made to indices or data published in
IBC/Donaghue's MONEY FUND REPORT, a nationally-recognized money market fund
reporting service, Money Magazine, Forbes, Barron's, The Wall Street Journal,
The New York Times, Business Week, and U.S.A. Today. In addition to performance
information, general information about the Funds that appears in a publication,
such as those mentioned above, may be included in advertisements and in reports
to Shareholders. The Funds may also include in advertisements and reports to
Shareholders information comparing the performance of the Adviser or the
Sub-Adviser to other investment advisers; such comparisons may be published by
or included in Nelsons Directory of Investment Managers, Roger's, Casey/PIPER
Manager Database, CDA/Cadence, or Chase Global Data and Research.

Current yields or performance will fluctuate from time to time and are not
necessarily representative of future results. Accordingly, a Fund's yield or
performance may not be directly comparable to bank deposits or other investments
that pay a fixed return for a stated period of time. Yield and performance are
functions of the quality, composition and maturity of a Fund's portfolio, as
well as expenses allocated to a Fund. Fees imposed upon customer accounts by
third parties for cash management services will reduce a Fund's effective yield
to customers.

<PAGE> 86

From time to time, the Funds may include general comparative information,
such as statistical data regarding inflation, securities indices or the features
or performance of alternative investments, in advertisements, sales literature
and reports to shareholders. The Funds may also include calculations, such as
hypothetical compounding examples, which describe hypothetical investment
results in such communications. Such performance examples will be based on an
express set of assumptions and are not indicative of the performance of a Fund.

Miscellaneous
- -------------

The Funds may include information in their Annual Reports and Semi-Annual
Reports to Shareholders that (1) describes general economic trends, (2)
describes general trends within the financial services industry or the mutual
fund industry, (3) describes past or anticipated portfolio holdings for the
Funds or (4) describes investment management strategies for the Funds. Such
information is provided to inform Shareholders of the activities of the Funds
for the most recent fiscal year or half-year and to provide the views of the
Adviser, the Sub-Adviser, and/or Group officers regarding expected trends and
strategies.

The Financial Statements of the Willamette Value fund appearing in the
Annual (audited) Report to Shareholders for the period ended March 31, 1999
(audited) and the Semi-Annual Reports for Value Fund and Growth Fund for the
period ended September 30, 1999 (unaudited) are incorporated herein by
reference. No reports have yet been prepared for Pharmaceutical Fund and
Technology Fund.

Individual Trustees are elected by the Shareholders and, subject to removal
by the vote of two-thirds of the Board of Trustees, serve for a term lasting
until the next meeting of Shareholders at which Trustees are elected. Such
meetings are not required to be held at any specific intervals. Shareholders
owning not less than 10% of the outstanding Shares of the Group entitled to vote
may cause the Trustees to call a special meeting, including for the purpose of
considering the removal of one or more Trustees. Any Trustee may be removed at
any meeting of Shareholders by vote of two-thirds of the Group's outstanding
shares. The Declaration of Trust provides that the Trustees will assist
shareholder communications to the extent required by Section 16(c) of the 1940
Act in the event that a Shareholder request to hold a special meeting is made.

The Prospectuses and this Statement of Additional Information omit certain
of the information contained in the Registration Statement filed with the
Commission. Copies of such information may be obtained from the Commission upon
payment of any prescribed fee.

The Prospectuses and this Statement of Additional Information are not an
offering of the securities herein described in any state in which such offering
may not lawfully be made. No salesman, dealer, or other person is authorized to
give any information or make any representation other than those contained in
the Prospectuses and this Statement of Additional Information.

<PAGE> 87

APPENDIX

The nationally recognized statistical rating organizations (individually,
an "NRSRO") that may be utilized by the Adviser with regard to portfolio
investments for the Funds include Moody's Investors Service, Inc. ("Moody's")
and Standard & Poor's Corporation ("S&P") and Duff & Phelps, Inc. ("D&F"). Set
forth below is a description of the relevant ratings of each such NRSRO. The
description of each NRSRO's ratings is as of the date of this Statement of
Additional Information, and may subsequently change.

LONG TERM DEBT RATINGS (may be assigned, for example, to corporate and
municipal bonds)

DESCRIPTION OF MOODY'S DEBT RATINGS

Excerpts from Moody's description of its bond ratings are listed as
follows:

Aaa -- judged to be the best quality and they carry the smallest
degree of investment risk;

Aa -- judged to be of high quality by all standards -- together with
the Aaa group, they comprise what are generally known as high grade
bonds;

A -- possess many favorable investment attributes and are to be
considered as "upper medium" grade obligations;

Baa -- considered to be medium grade obligations, i.e., they are
neither highly protected nor poorly secured -- interest payments and
principal security appear adequate for the present but certain
protective elements may be lacking or may be characteristically
unreliable over any great length of time;

Ba -- judged to have speculative element, their future cannot be
considered as well assured;

B -- generally lack characteristics of the desirable investment;

Caa -- are of poor standing -- such issues may be in default or there
may be present elements of danger with respect to principal or
interest;

Ca -- speculative in a high degree, often in default;

C -- lowest rated class of bonds, regarded as having extremely poor
prospects.

Moody's also supplies numerical indicators 1, 2 and 3 to rating categories.
The modifier 1 indicates that the security is in the higher end of its rating
category; the modifier 2 indicates a mid-range ranking; and modifier 3 indicates
a ranking toward the lower end of the category.

<PAGE> 88

DESCRIPTION OF S&P'S DEBT RATINGS

Excerpts from S&P's description of its bond ratings are listed as follows:

AAA -- highest grade obligations, in which capacity to pay interest
and repay principal is extremely strong;

AA -- has a very strong capacity to pay interest and repay principal,
and differs from AAA issues only in a small degree;

A -- has a strong capacity to pay interest and repay principal,
although they are somewhat more susceptible to the adverse effects of
changes in circumstances and economic conditions than debt in higher
rated categories;

BBB -- regarded as having an adequate capacity to pay interest and
repay principal; whereas it normally exhibits adequate protection
parameters, adverse economic conditions or changing circumstances are
more likely to lead to a weakened capacity to pay interest and repay
principal for debt in this category than in higher rated categories.
This group is the lowest which qualifies for commercial bank
investment.

BB, B, CCC, CC, C -- predominantly speculative with respect to
capacity to pay interest and repay principal in accordance with terms
of the obligations; BB indicates the highest grade and C the lowest
within the speculative rating categories.

D -- interest or principal payments are in default.

S&P applies indicators "+," no character, and "-" to its rating categories.
The indicators show relative standing within the major rating categories.

<PAGE> 89

DESCRIPTION OF MOODY'S RATINGS OF SHORT-TERM MUNICIPAL OBLIGATIONS:

Moody's ratings for state and municipal short-term obligations will be
designated Moody's Investment Grade or MIG or VMIG. Such ratings recognize the
differences between short-term credit and long-term risk. Short-term ratings on
issues with demand features (variable rate demand obligations) are
differentiated by the use of the VMIG symbol to reflect such characteristics as
payment upon periodic demand rather than fixed maturity dates and payments
relying on external liquidity. Ratings categories for securities in these groups
are as follows:

MIG 1/VMIG 1 -- denotes best quality, there is present strong
protection by established cash flows, superior liquidity support or
demonstrated broad-based access to the market for refinancing;

MIG 2/VMIG 2 -- denotes high quality, margins of protection are ample
although not as large as in the preceding group;

MIG 3/VMIG 3 -- denotes high quality, all security elements are
counted for but there is lacking the undeniable strength of the
preceding grades;

MIG 4/VMIG 4 -- denotes adequate quality, protection commonly regarded
as required of an investment security is present, but there is
specific risk;

SQ -- denotes speculative quality; instruments in this category lack
margins of protection.

DESCRIPTION OF MOODY'S COMMERCIAL PAPER RATINGS:

Excerpts from Moody's commercial paper ratings are listed as follows:

Prime-1 -- issuers (or supporting institutions) have a superior
ability for repayment of senior short-term promissory obligations;

Prime-2 -- issuers (or supporting institutions) have a strong ability
for repayment of senior short-term promissory obligations;

Prime-3 -- issuers (or supporting institutions) have an acceptable
ability for repayment of senior short-term promissory obligations;

Not Prime -- issuers do not fall within any of the Prime categories.

<PAGE> 90

DESCRIPTION OF S&P'S RATINGS FOR CORPORATE AND MUNICIPAL BONDS:

Investment grade ratings:

AAA -- the highest rating assigned by S&P, capacity to pay interest
and repay principal is extremely strong;

AA -- has a very strong capacity to pay interest and repay principal
and differs from the highest rated issues only in a small degree;

A -- has strong capacity to pay interest and repay principal although
it is somewhat more susceptible to the adverse effects of changes in
circumstances and economic conditions than debt in higher rated
categories;

BBB --regarded as having an adequate capacity to pay interest and
repay principal -- whereas it normally exhibits adequate protection
parameters, adverse economic conditions or changing circumstances are
more likely to lead to a weakened capacity to pay interest and repay
principal for debt in this category than in higher rated categories.

Speculative grade ratings:

BB, B, CCC, CC, C -- debt rated in these categories is regarded as
having predominantly speculative characteristics with respect to
capacity to pay interest and repay principal -- while such debt will
likely have some quality and protective characteristics, these are
outweighed by large uncertainties or major risk exposures to adverse
conditions;

CI -- reserved for income bonds on which no interest is being paid;

D -- in default, and payment of interest and/or repayment of principal
is in arrears. Plus (+) or Minus (-) -- the ratings from "AA" to "CCC"
may be modified by the addition of a plus or minus sign to show
relative standing within the major relative standing within the major
rating categories.

<PAGE> 91
DESCRIPTION OF S&P'S RATINGS FOR MUNICIPAL NOTES AND SHORT-TERM MUNICIPAL
DEMAND OBLIGATIONS:

Rating categories are as follows:

SP-1 -- has a very strong or strong capacity to pay principal and
interest -- those issues determined to possess overwhelming safety
characteristics will be given a plus (+) designation;

SP-2 -- has a satisfactory capacity to pay principal and interest;

SP-3 -- issues carrying this designation have a speculative capacity
to pay principal and interest.

DESCRIPTION OF S&P'S RATINGS FOR SHORT-TERM CORPORATE DEMAND OBLIGATIONS AND
COMMERCIAL PAPER:

An S&P commercial paper rating is a current assessment of the likelihood of
timely repayment of debt having an original maturity of no more than 365 days.
Excerpts from S&P's description of its commercial paper ratings are listed as
follows:

A-1 -- the degree of safety regarding timely payment is strong --
those issues determined to possess extremely strong safety
characteristics will be denoted with a plus (+) designation;

A-2 -- capacity for timely payment is satisfactory -- however, the
relative degree of safety is not as high as for issues designated
"A-1;"

A-3 -- has adequate capacity for timely payment -- however, is more
vulnerable to the adverse effects of changes in circumstances than
obligations carrying the higher designations;

B -- regarded as having only speculative capacity for timely payment;

C -- a doubtful capacity for payment;

D -- in payment default -- the "D" rating category is used when
interest payments or principal payments are not made on the date due,
even if the applicable grade period has not expired, unless S&P
believes that such payments will be made during such grace period.

<PAGE> 92
PART C
-----------

OTHER INFORMATION
-----------------

ITEM 23. EXHIBITS

(a)(1) Declaration of Trust(1)

(a)(2) Establishment and Designation of Series of
Shares(3)

(b) By-Laws(2)

(c) Certificates for Shares are not issued. Articles
IV, V, VI and VII of the Declaration of Trust,
previously filed as Exhibit (a) hereto, define
rights of holders of Shares

(d)(1) Investment Advisory Agreement between Registrant
and Willamette Asset Managers, Inc.(2)

(d)(2) Investment Advisory Agreement between Registrant
and Willamette Asset Managers, Inc.(3)

(d)(3) Investment Advisory Agreement between Registrant
and Willamette Asset Managers, Inc.

(d)(4) Investment Advisory Agreement between Registrant
and Willamette Asset Managers, Inc.

(d)(5) Sub-Investment Advisory Agreement between Willamette
Asset Managers and Bank of New York.(3)

(d)(6) Sub-Investment Advisory Agreement between Willamette
Asset Managers, Inc. and First American Asset Management.

(d)(7) Sub-Investment Advisory Agreement between Willamette
Asset Managers, Inc. and First American Asset Management.

(e) Distribution Agreement between Registrant and
BISYS Fund Services LP(2)

(f) Not Applicable

(g) Custody Agreement between Registrant and Union
Bank of California(2)

(h)(1) Administration Agreement between the Registrant
and BISYS Fund Services Ohio, Inc.(2)

(h)(2) Fund Accounting Agreement between the Registrant
and BISYS Fund Services Ohio, Inc.(2)

<PAGE> 93

(h)(3) Transfer Agency Agreement between the Registrant
and BISYS Fund Services, Inc.(2)

(i) Legal opinion

(j) Not Applicable

(k) Not Applicable

(l) Not Applicable

(m) Amended Service and Distribution Plan(3)

(n) Not Applicable

(o) Not Applicable

- ------------------

1. Filed with initial Registration Statement on January 8, 1992.

2. Incorporated by reference to Post-Effective Amendment No. 33 to Registrant's
Registration Statement (File No. 33-44964) filed electronically with the
Securities and Exchange Commission on March 13, 1998.

3. Incorporated by reference to Post-Effective Amendment No. 43 to Registrant's
Registration Statement (File No. 33-44964) filed electronically with the
Securities and Exchange Commission on December 17, 1998.

ITEM 24. PERSONS CONTROLLED BY OR UNDER COMMON CONTROL WITH
REGISTRANT
Not applicable.

ITEM 25. INDEMNIFICATION

Article IV of the Registrant's Declaration of Trust states as
follows:

SECTION 4.3. MANDATORY INDEMNIFICATION.

(a) Subject to the exceptions and limitations
contained in paragraph (b)below:

(i) every person who is, or has been, a
Trustee or officer of the Trust shall be
indemnified by the Trust to the fullest
extent permitted by law against all
liability and against all expenses
reasonably incurred or paid by him
in connection with any claim, action,
suit or proceeding in which he becomes
involved as a party or otherwise by virtue
of his being or having been a Trustee or
officer and against amounts paid or incurred
<PAGE> 94

by him in the settlement thereof; and (ii)
the words "claim," "action," "suit," or
"proceeding" shall apply to all claims,
actions, suits or proceedings (civil,
criminal, administrative or other,
including appeals), actual or threatened;
and the words "liability" and "expenses"
shall include, without limitation, attorneys
fees, costs, judgments, amounts paid in
settlement, fines, penalties and other
liabilities.

(b) No indemnification shall be
provided hereunder to a Trustee or
officer:

(i) against any liability to the
Trust, a Series thereof, or the
Shareholders by reason of a final
adjudication by a court or other
body before which a proceeding was
brought that he engaged in willful
misfeasance, bad faith, gross
negligence or reckless disregard of
the duties involved in the conduct
of his office;

(ii) with respect to any matter as
to which he shall have been finally
adjudicated not to have acted in
good faith in the reasonable belief
that his action was in the best
interest of the Trust; or

(iii) in the event of a settlement
or other disposition not involving
a final adjudication as provided in
paragraph (b)(i) or (b)(ii)
resulting in a payment by a Trustee
or officer, unless there has been a
determination that such Trustee or
officer did not engage in willful
misfeasance, bad faith, gross
negligence or reckless disregard of
the duties involved in the conduct
of his office:

(A) by the court or other body
approving the settlement or
other disposition; or

(B) based upon a review of
readily available facts (as
opposed to a full trial-type
inquiry) by (1) vote of a
majority of the Disinterested
Trustees acting on the matter
(provided that a majority of
the Disinterested

<PAGE> 95

Trustees then in office
acts on the matter)
or (2) written opinion of
independent legal counsel.

(c) The rights of indemnification herein
provided may be insured against by
policies maintained by the Trust, shall
be severable, shall not affect any other
rights to which any Trustee or officer
may now or hereafter be entitled, shall
continue as to a person who has ceased
to be such Trustee or officer and shall
inure to the benefit of the heirs,
executors, administrators and assigns of
such person. Nothing contained herein
shall affect any rights to
indemnification to which personnel of
the Trust other than Trustees and
officers may be entitled by contract or
otherwise under law.

(d) Expenses of preparation and presentation
of a defense to any claim, action, suit
or proceeding of the character described
in paragraph (a) of this Section 4.3 may
be advanced by the Trust prior to final
disposition thereof upon receipt of an
undertaking by or on behalf of the
recipient to repay such amount if it is
ultimately determined that he is not
entitled to indemnification under this
Section 4.3, provided that either:

(i) such undertaking is secured by a
surety bond or some other appropriate
security provided by the recipient, or
the Trust shall be insured against
losses arising out of any such advances;
or

(ii) a majority of the Disinterested
Trustees acting on the matter (provided
that a majority of the Disinterested
Trustees acts on the matter) or an
independent legal counsel in a written
opinion shall determine, based upon a
review of readily available facts (as
opposed to a full trial-type inquiry),
that there is reason to believe that the
recipient ultimately will be found
entitled to indemnification

As used in this Section 4.3, a "Disinterested Trustee" is one who is not (i)

<PAGE> 96

an Interested Person of the Trust (including anyone who has been exempted
from being an Interested Person by any rule, regulation or order of the
Commission), or (ii) involved in the claim, action, suit or proceeding.

Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to trustees, officers and
controlling persons of the Registrant by the Registrant pursuant to
the Declaration of Trust or otherwise, the Registrant is aware that in
the opinion of the Securities and Exchange Commission, such
indemnification is against public policy as expressed in the Act, and
therefore, is unenforceable. In the event that a claim for
indemnification against such liabilities controlling persons of the
Registrant in connection with the successful defense of any act, suit
or proceeding) is asserted by such trustees, officers or controlling
persons in connection with the shares being registered, the Registrant
will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Act and will be governed by
the final adjudication of such issues.

ITEM 26. Business and Other Connections of Investment Adviser and its Officers
----------------------------------------------------------------------
and Directors
-------------

Name & Address Position with WAM Principal Occupation for past 5 yrs.
- -------------- ----------------- ------------------------------------
<S> <C> <C>

James T. Smith CEO Compliance Officer(1995)
220 NW 2nd #950 and CFO(1997) for Phillips
Portland, OR 97209 & Co. Securities, Inc. Joined
Phillips & Co. in 10/94. From
10/92 to 09/94 was the Sup. of
payroll & billing services for
Interim Services, Inc.

S. Christopher Clark Director/Owner Executive VP(1993) and
220 NW 2nd #950 Managing Director(1997) for
Portland, OR 97209 Phillips & Co. Securities, Inc.

Timothy C. Phillips Director/Owner CEO of Phillips & Co.
220 NW 2nd #950 Securities, Inc. since
Portland, OR 97209 February 1992.
</TABLE>

* The business address of Phillips & Co. Securities, Inc. is 220 N.W. 2nd #950,
Portland, Oregon 97209

<PAGE> 97

Business and Other Connections of Bank of New York
--------------------------------------------------

Name Title/Company
- ---- -------------
Richard Barth.................. Retired; Formerly Chairman and Chief
Executive Officer of Ciba-Geigy Corporation
(diversified chemical products)

Frank J. Biondi, Jr............ Chairman and Chief Executive Office of
Universal Studios (diversified entertainment
operator)

Harold E. Sells................ Retired; Formerly Chairman and Chief Executive
Pffice of Woolworth Corporation (retailing)

William R. Chaney.............. Chairman and Chief Executive Officer of
Tiffany & Co., (international designers,
manufacturers and distributors of jewelry and
fine goods)

Ralph E. Gomory................ President of Alfred P. Sloan Foundation, Inc.
(private foundation)

Richard J. Kogan............... President and Chief Executive Officer of
Schering-Plough Corporation (manufacturer of
pharmaceutical and consumer products)

John A. Luke, Jr............... Chairman, President and Chief Executive
Officer of Westvaco Corporation (manufacturer
of paper, packaging, and specialty chemicals)

John C. Malone................. President and Chief Executive Officer of
Tele-Communications, Inc., (cable television
multiple system operator)

Donald L. Miller............... Chief Executive Officer and Publisher of Our
World News, LLC (media)

H. Barclay Morley.............. Retired; Formerly Chairman and Chief Executive
Officer of Stauffer Chemical Company
(chemicals)

Catherine A. Rein.............. Senior Executive Vice President of
Metropolitan Life Insurance Company (insurance
and financial services)

<PAGE> 98

ITEM 27. PRINCIPAL UNDERWRITER

(a) BISYS Fund Services, Limited Partnership ("BISYS Fund
Services") acts as distributor for Registrant. BISYS
Fund Services also distributes the securities of Alpine
Equity Trust, American Performance Funds, AmSouth Mutual
Funds, The BB&T Mutual Funds Group, The Coventry Group,
ESC Strategic Funds, Inc., The Eureka Funds, Governor
Funds, Fifth Third Funds, Hirtle Callaghan Trust, HSBC
Funds Trust and HSBC Mutual Funds Trust, INTRUTS Funds
Trust, The Infinity Mutual Funds, Inc., Magna Funds,
Mercantile Mutual Funds, Inc., Metamarkets.com, Meyers
Investment Trust, MMA Praxis Mutual Funds, M.S.D.&T.
Funds, Pacific Capital Funds, Republic Advisor Funds
Trust, Republic Funds Trust, Sefton Funds Trust, SSgA
International Liquidity Fund, Summit Investment Trust,
USAllianz Funds, USAllianz Funds Variable Insurance
Products Trust, Valenzuela Capital Trust, Variable
Insurance Funds, The Victory Portfolios, The Victory
Variable Insurance Funds, and Vintage Mutual Funds, Inc.

(b) Information about Directors and officers of BISYS Fund
Services Limited Partnership is set forth below:

Name Position with Underwriter Position with Fund
- -------- ------------------------- -------------------
WC Subsidiary Corporation Sole Limited Partner None
150 Clove Road
Little Falls, NJ 07424

BISYS Fund Services, Inc. Sole General Partner None
3435 Stelzer Road
Columbus, OH 43219

Other BISYS distributors
- ------------------------

In addition to the following officers of the BISYS related distributors listed
below, each distributor has additional officers listed to the right ( business
address for each person and distributor unless noted otherwise is 3435 Stelzer
Road, Columbus, OH 43219 and unless noted otherwise each person holds no
position with the Fund):

Lynn Mangum Director
Dennis Sheehan Director
Kevin Dell Vice President/Secretary
William Tomko Sr Vice President
Robert Tuch Assistant Secretary

*Barr Rosenberg Funds Distributor, Inc. Irimga McKay- President
Barr Rosenberg Funds Greg Maddox -Vice President(1)

BNY Hamilton Distributors, Inc. William J. Tomko- President(2)
BNY Hamilton Funds, Inc. Richard Baxt -Sr Vice President(3)

<PAGE> 99

*Centura Funds Distributor, Inc. Walter B. Grimm- President
Centura Funds William J. Tomko- Sr Vice President

CFD Fund Distributors, Inc. Richard Baxt- President
Chase Funds

Concord Financial Group, Inc. Walter B. Grimm- President
ProFunds-

*Evergreen Distributor, Inc. D'Ray Moore- President
Evergreen Funds

*Performance Funds Distributor, Inc. Walter B. Grimm-President(4)
Performance Funds William J. Tomko- Sr Vice President

The One Group Services Company Mark Redman- President(5)
The One Group of Funds William Tomko-Sr Vice President (2)

Vista Funds Distributors, Inc. Richard Baxt- President
Chase Vista Funds Lee Schultheis-Sr Vice President
William J. Tomko- Sr Vice President

Kent Funds Distributors, Inc.

Mentor Distributors, LLC D'Ray Moore, President

*IBJ Funds Distributor, Inc. Walter B. Grimm, SVP

* address is 90 Park Avenue, Ny, NY

(1 Serves as Assistant Treasurer to Centura Funds
(2) Serves as President to BNY Hamilton Funds and Treasurer to One Group
of Funds
(3) Serves as Vice President to BNY Hamilton Funds (4) Serves as President of
Performance Funds (5) Serves as president to One Group of Funds

Non-BISYS Distributors
- ----------------------

(see Part C of post-effective amendments for indicated funds for directors and
officers of distributors listed below.)

Glickenhaus & Company
The Empire Builder Tax-Free Bond Fund

Integrity Investments
Valiant Funds
Shay Financial Services, Inc.
MSB Fund. Inc.
Asset Management Fund, Inc.
Institutional Investors Capital Appreciation Fund, Inc.

ITEM 28. Location of Accounts and Records
- -------- --------------------------------

<PAGE> 100

The accounts, books, and other documents required to be
maintained by Registrant pursuant to Section 31(a) of the
Investment Company Act of 1940 and rules promulgated thereunder
are in the possession of Willamette Asset Managers, Inc. 220 NW
2nd Avenue, Suite 950, Portland, Oregon 97209, (records relating
to its function as Adviser); The Bank of New York, 1 Wall Street,
New York, New York 10286 (records relating to its functions as
Sub-Adviser to Growth Fund); U.S. Bank National Association, 601
Second Avenue South, Minneapolis, Minnesota 55402, (records
relating to its functions as Sub-Adviser to Health Fund and
Technology Fund); BISYS Fund Services, Limited Partnership, 3435
Stelzer Road, Columbus, Ohio 43219 (records relating to its
functions as General Manager, Administrator and Distributor); and
BISYS Fund Services Ohio, Inc., 3435 Stelzer Road, Columbus, Ohio
43219 (records relating to its functions as Transfer Agent).

ITEM 29. MANAGEMENT SERVICES

Not Applicable.

ITEM 30. UNDERTAKINGS.

None

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933 and the
Investment Company Act of 1940, the Registrant has duly caused this
Post-Effective Amendment No. 64 to its Registration Statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the City of
Washington in the District of Columbia on the 1st day of March, 2000.

THE COVENTRY GROUP

By: /s/ Walter B. Grimm
---------------------
Walter B. Grimm
By: /s/ Patrick W.D. Turley
--------------------------
Patrick W.D. Turley, as attorney-in-fact

Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed below by the following persons in the
capacities and on the date indicated:

<PAGE> 101

Signature Title Date
- --------- ----- ----

/s/Walter B. Grimm President and Trustee March 1, 2000
- ------------------------ (Principal Executive Officer)
Walter B. Grimm**

/s/ John H. Ferring IV Trustee March 1, 2000
- ------------------------
John H. Ferring IV***

/s/ Maurice G. Stark Trustee March 1, 2000
- ------------------------
Maurice G. Stark*

/s/ Michael M. Van Buskirk Trustee March 1, 2000
- ------------------------
Michael M. Van Buskirk*

/s/ R. Jeffrey Young
- ------------------------- Chairman and Trustee March 1, 2000
R. Jeffrey Young****

/s/ Nadeem Yousaf Treasurer (Principal Financial March 1, 2000
- ------------------------ and Accounting Officer)
Nadeem Yousaf****

By: /s/ Patrick W.D. Turley
--------------------------------------
Patrick W.D. Turley, as attorney-in-fact

* Pursuant to power of attorney filed with Pre-Effective Amendment
No. 3 on April 6, 1992.

** Pursuant to power of attorney filed with Post-Effective Amendment
No. 26 on May 1, 1996.

*** Pursuant to power of attorney filed with Post-Effective Amendment
No. 39 on July 31, 1998.

**** Pursuant to power of attorney filed with Post-Effective Amendment
No. 63 on November 30, 1999.

<PAGE> 1
THE COVENTRY GROUP

ON BEHALF OF

WILLAMETTE PHARMACEUTICAL AND BIO-TECHNOLOGY FUND

INVESTMENT ADVISORY AGREEMENT

AGREEMENT, effective commencing on __________, 2000 between Willamette
Asset Managers, Inc. (the "Adviser") and The Coventry Group. (the "Trust") on
behalf of Willamette Pharmaceutical and Bio-Technology Fund (the "Fund").

WHEREAS, the Trust is a Massachusetts business trust of the series type
organized under a Declaration of Trust dated January 8, 1992, (the
"Declaration") and is registered under the Investment Company Act of 1940, as
amended (the "1940 Act"), as an open-end, diversified management investment
company, and the Fund is a new series of the Trust;

WHEREAS, the Trust wishes to retain the Adviser to render investment
advisory services to the Fund, and the Adviser is willing to furnish such
services to the Fund;

WHEREAS, the Adviser is registered as an investment adviser under the
Investment Advisers Act of 1940, as amended ("Advisers Act");

NOW THEREFORE, in consideration of the promises and mutual covenants
herein contained, it is agreed between the Trust and the Adviser as follows:

1. APPOINTMENT. The Trust hereby appoints the Adviser to act as
investment adviser to the Fund for the periods and on the terms set forth in
this Agreement. The Adviser accepts such appointment and agrees to furnish the
services herein set forth, for the compensation herein provided.

2. INVESTMENT ADVISORY DUTIES; AUTHORITY TO DELEGATE TO SUB-ADVISER.
Subject to the supervision of the Trustees of the Trust, the Adviser will (a)
provide a program of continuous investment management for the Fund in accordance
with the Fund's investment objectives, policies and limitations as stated in the
Fund's prospectus and Statement of Additional Information included as part of
the Trust's Registration Statement filed with the Securities and Exchange
Commission, as they may be amended from time to time, copies of which shall be
provided to the Adviser by the Trust; (b) make investment decisions for the
Fund; and (c) place orders to purchase and sell securities for the Fund. The
Adviser is authorized, at its own expense, to delegate to a sub-adviser such of
its responsibilities hereunder as may be specified in an agreement with such
sub-adviser, subject to such approvals by the Trustees and shareholders of the
Fund as are required by the 1940 Act. In the event the Adviser does so delegate
to a sub-adviser, the Adviser is further responsible for supervising the
activities and performance of the sub-adviser, for taking reasonable steps to
assure that the sub-adviser complies with the Fund's

<PAGE> 2

investment policies and procedures and with applicable legal requirements, and
for reporting to the Trustees regarding these matters.

In performing its investment management services to the Fund hereunder,
the Adviser will provide the Fund with ongoing investment guidance and policy
direction, including oral and written research, analysis, advice, statistical
and economic data and judgments regarding individual investments, general
economic conditions and trends and long-range investment policy. Subject to the
Fund's investment objective and policies, the Adviser will determine the
securities, instruments, repurchase agreements, options and other investments
and techniques that the Fund will purchase, sell, enter into or use, and will
provide an ongoing evaluation of the Fund's portfolio. The Adviser will
determine what portion of the Fund's portfolio shall be invested in securities
and other assets, and what portion if any, should be held uninvested.

The Adviser further agrees that, in performing its duties hereunder, it
will:

(a) comply with the 1940 Act and all rules and regulations thereunder,
the Advisers Act, the Internal Revenue Code (the "Code") and all other
applicable federal and state laws and regulations, and with any applicable
procedures adopted by the Trustees;

(b) use reasonable efforts to manage the Fund so that it will qualify,
and continue to qualify, as a regulated investment company under Subchapter M of
the Code and regulations issued thereunder;

(c) place orders pursuant to its investment determinations for the Fund
directly with the issuer, or with any broker or dealer, in accordance with
applicable policies expressed in the Fund's prospectus and/or Statement of
Additional Information and in accordance with applicable legal requirements;

(d) furnish to the Trust, or to the Fund's administrator, BISYS Fund
Services, ("Administrator") if so directed, whatever statistical information the
Trust or Administrator may reasonably request with respect to the Fund's assets
or contemplated investments. In addition, the Adviser will keep the Trust and
the Trustees informed of developments materially affecting the Fund's portfolio
and shall, on the Adviser's own initiative, furnish to the Trust from time to
time whatever information the Adviser believes appropriate for this purpose;

(e) make available to the Administrator, and the Trust, promptly upon
their request, such copies of its investment records and ledgers with respect to
the Fund as may be required to assist the Administrator and the Trust in their
compliance with applicable laws and regulations. The Adviser will furnish the
Trustees with such periodic and special reports regarding the Fund as they may
reasonably request;

(f) immediately notify the Trust in the event that the Adviser or any
of its affiliates: (1) becomes aware that it is subject to a statutory
disqualification that prevents the Adviser from serving as investment adviser
pursuant to this Agreement; or (2) becomes aware that it is the subject of an
administrative proceeding or enforcement action by the Securities and Exchange

-2-
<PAGE> 3

Commission ("SEC") or other regulatory authority. The Adviser further agrees to
notify the Trust immediately of any material fact known to the Adviser
respecting or relating to the Adviser that is not contained in the Trust's
Registration Statement regarding the Fund, or any amendment or supplement
thereto, but that is required to be disclosed thereon, and of any statement
contained therein that becomes untrue in any material respect;

(g) in making investment decisions for the Fund, use no inside
information that may be in its possession, nor will the Adviser seek to obtain
any such information.

3. ALLOCATION OF CHARGES AND EXPENSES. Except as otherwise specifically
provided in this section 3, the Adviser shall pay the compensation and expenses
of all its directors, officers and employees who serve as officers and executive
employees of the Trust or Fund (including the Trust's or Fund's share of payroll
taxes), and the Adviser shall make available, without expense to the Fund, the
service of its directors, officers and employees who may be duly elected
officers of the Trust, subject to their individual consent to serve and to any
limitations imposed by law. The Adviser shall also pay the fees of any
sub-adviser.

The Adviser shall not be required to pay any expenses of the Fund or
Trust other than those specifically allocated to the Adviser in this section 3.
In particular, but without limiting the generality of the foregoing, the Adviser
shall not be responsible, except to the extent of the reasonable compensation of
such of the Trust's or Fund's employees as are officers or employees of the
Adviser whose services may be involved, for any expenses of other series of the
Trust or for the following expenses of the Fund or Trust: organization and
certain offering expenses of the Fund (including out-of-pocket expenses, but not
including the Adviser's overhead and employee costs); fees payable to the
Adviser and to any other Fund advisers or consultants; legal expenses; auditing
and accounting expenses; interest expenses; telephone, telex, facsimile, postage
and other communications expenses; taxes and governmental fees; fees, dues and
expenses incurred by or with respect to the Fund in connection with membership
in investment company trade organizations; cost of insurance relating to
fidelity coverage for the Trust's officers and employees; fees and expenses of
the Fund's Administrator or of any custodian, subcustodian, transfer agent, fund
accounting agent, registrar, or dividend disbursing agent of the Fund; payments
for portfolio pricing or valuation services to pricing agents, accountants,
bankers and other specialists, if any; expenses of preparing share certificates,
if any; other expenses in connection with the issuance, offering, distribution
or sale of securities issued by the Fund; expenses relating to investor and
public relations; expenses of registering shares of the Fund for sale and of
compliance with applicable state notice filing requirements; freight, insurance
and other charges in connection with the shipment of the Fund's portfolio
securities; brokerage commissions or other costs of acquiring or disposing of
any portfolio securities or other assets of the Fund, or of entering into other
transactions or engaging in any investment practices with respect to the Fund;
expenses of printing and distributing prospectuses, Statements of Additional
Information, reports, notices and dividends to shareholders; costs of stationery
or other office supplies; any litigation expenses; costs of shareholders' and
other meetings; the compensation and all expenses (specifically including travel
expenses relating to the Fund's business) of officers, Trustees and employees of
the Trust who are not interested persons of the Adviser; and

-3-
<PAGE> 4

travel expenses (or an appropriate portion thereof) of officers or Trustees of
the Trust who are officers, Trustees or employees of the Adviser to the extent
that such expenses relate to attendance at meetings of the Board of Trustees of
the Trust with respect to matters concerning the Fund, or any committees thereof
or advisers thereto.

4. COMPENSATION. As compensation for the services provided and expenses
assumed by the Adviser under this Agreement, the Trust will arrange for the Fund
to pay the Adviser at the end of each calendar month an advisory fee computed
daily at an annual rate equal to 1.00% of the Fund's average daily net assets.
The "average daily net assets" of the Fund shall mean the average of the values
placed on the Fund's net assets as of 4:00 p.m. (New York time) on each day on
which the net asset value of the Fund is determined consistent with the
provisions of Rule 22c-1 under the 1940 Act or, if the Fund lawfully determines
the value of its net assets as of some other time on each business day, as of
such other time. The value of net assets of the Fund shall always be determined
pursuant to the applicable provisions of the Declaration and the Registration
Statement. If, pursuant to such provisions, the determination of net asset value
is suspended for any particular business day, then for the purposes of this
section 4, the value of the net assets of the Fund as last determined shall be
deemed to be the value of its net assets as of the close of the New York Stock
Exchange, or as of such other time as the value of the net assets of the Fund's
portfolio may lawfully be determined, on that day. If the determination of the
net asset value of the shares of the Fund has been so suspended for a period
including any month end when the Adviser's compensation is payable pursuant to
this section, then the Adviser's compensation payable at the end of such month
shall be computed on the basis of the value of the net assets of the Fund as
last determined (whether during or prior to such month). If the Fund determines
the value of the net assets of its portfolio more than once on any day, then the
last such determination thereof on that day shall be deemed to be the sole
determination thereof on that day for the purposes of this section 4.

5. BOOKS AND RECORDS. The Adviser agrees to maintain such books and
records with respect to its services to the Fund as are required by Section 31
under the 1940 Act, and rules adopted thereunder, and by other applicable legal
provisions, and to preserve such records for the periods and in the manner
required by that Section, and those rules and legal provisions. The Adviser also
agrees that records it maintains and preserves pursuant to Rules 31a-1 and Rule
31a-2 under the 1940 Act and otherwise in connection with its services hereunder
are the property of the Trust and will be surrendered promptly to the Trust upon
its request. And the Adviser further agrees that it will furnish to regulatory
authorities having the requisite authority any information or reports in
connection with its services hereunder which may be requested in order to
determine whether the operations of the Fund are being conducted in accordance
with applicable laws and regulations.

6. STANDARD OF CARE AND LIMITATION OF LIABILITY. The Adviser shall
exercise its best judgment in rendering the services provided by it under this
Agreement. The Adviser shall not be liable to the Adviser, the Trust, the Fund
or to any holder of the Fund's shares, for any error of judgment or mistake of
law or for any loss suffered by the Fund or the holders of the Fund's shares in
connection with the matters to which this Agreement relates, provided that
nothing in

-4-
<PAGE> 5

this Agreement shall be deemed to protect or purport to protect the Adviser
against any liability to the Trust, the Fund or to holders of the Fund's shares
to which the Adviser would otherwise be subject by reason of willful
misfeasance, bad faith or gross negligence on its part in the performance of its
duties or by reason of the Adviser's reckless disregard of its obligations and
duties under this Agreement. As used in this Section 6, the term "Adviser" shall
include any officers, directors, employees or other affiliates of the Adviser
performing services with respect to the Fund.

7. SERVICES NOT EXCLUSIVE. It is understood that the services of the
Adviser are not exclusive, and that nothing in this Agreement shall prevent the
Adviser from providing similar services to other investment companies or to
other series of investment companies, including the Trust (whether or not their
investment objectives and policies are similar to those of the Fund) or from
engaging in other activities, provided such other services and activities do
not, during the term of this Agreement, interfere in a material manner with the
Adviser's ability to meet its obligations to the Fund hereunder. When the
Adviser recommends the purchase or sale of a security for other investment
companies and other clients, and at the same time the Adviser recommends the
purchase or sale of the same security for the Fund, it is understood that in
light of its fiduciary duty to the Fund, such transactions will be executed on a
basis that is fair and equitable to the Fund. In connection with purchases or
sales of portfolio securities for the account of the Fund, neither the Adviser
nor any of its directors or officers (or persons acting in similar capacities)
or employees shall act as a principal or agent or receive any commission. If the
Adviser provides any advice to its clients concerning the shares of the Fund,
the Adviser shall act solely as investment counsel for such clients and not in
any way on behalf of the Trust or the Fund.

8. DURATION AND TERMINATION. This Agreement shall continue until
_________, 2002, and thereafter shall continue automatically for successive
annual periods, provided such continuance is specifically approved at least
annually by (i) the Trustees or (ii) a vote of a "majority" (as defined in the
1940 Act) of the Fund's outstanding voting securities (as defined in the 1940
Act), provided that in either event the continuance is also approved by a
majority of the Trustees who are not parties to this Agreement or "interested
persons" (as defined in the 1940 Act) of any party to this Agreement, by vote
cast in person at a meeting called for the purpose of voting on such approval.
Notwithstanding the foregoing, this Agreement may be terminated: (a) at any time
without penalty by the Fund upon the vote of a majority of the Trustees or by
vote of the majority of the Fund's outstanding voting securities, upon sixty
(60) days' written notice to the adviser or (b) by the Adviser at any time
without penalty, upon sixty (60) days' written notice to the Trust. This
Agreement will also terminate automatically in the event of its assignment (as
defined in the 1940 Act).

-5-
<PAGE> 6

of Trustees who are not interested persons of any party to this Agreement, cast
in person at a meeting called for the purpose of voting on such approval, if
such approval is required by applicable law.

10. PROXIES. Unless the Trust gives written instructions to the
contrary, the Adviser shall vote all proxies solicited by or with respect to the
issuers of securities in which assets of the Fund may be invested. The Adviser
shall use its best good faith judgment to vote such proxies in a manner which
best serves the interests of the Fund's shareholders.

11. NAME RESERVATION. The Trust acknowledges and agrees that the
Adviser has property rights relating to the use of the term "Willamette" and has
permitted the use of such term by the Trust and the Fund. The Trust agrees that,
unless otherwise authorized by the Adviser: (i) it will use the term
"Willamette" only as a component of the name of the Fund and for no other
purposes; (ii) it will not purport to grant to any third party any rights in
such name; (iii) at the request of the Adviser, the Trust will take such action
as may be required to provide its consent to use of the term by the Adviser, or
any affiliate of the Adviser to whom the Adviser shall have granted the right to
such use; and (iv) the Adviser may use or grant to others the right to use the
term, or any abbreviation thereof, as all or a portion of a corporate or
business name or for any commercial purpose, including a grant of such right to
any other investment company. Upon termination of this Agreement, the Trust
shall, upon request of the Adviser, cease to use the term "Willamette" as part
of the name of the Fund, or in connection with the Trust or any series of the
Trust. In the event of any such request by the Adviser that use of the term
"Willamette" shall cease, the Trust shall cause its officers, directors and
shareholders to take any and all such actions which the Adviser may request to
effect such request and to reconvey to the Adviser any and all rights to the
term "Willamette."

12. MISCELLANEOUS.

a. This Agreement shall be governed by the laws of the State of Oregon,
provided that nothing herein shall be construed in a manner inconsistent with
the 1940 Act, the Advisers Act, or rules or orders of the SEC thereunder.

b. The captions of this Agreement are included for convenience only and
in no way define or limit any of the provisions hereof or otherwise affect their
construction or effect.

c. If any provision of this Agreement shall be held or made invalid by
a court decision, statute, rule or otherwise, the remainder of this Agreement
shall not be affected hereby and, to this extent, the provisions of this
Agreement shall be deemed to be severable.

d. Nothing herein shall be construed as constituting the Adviser as an
agent of the Trust or the Fund.

-6-
<PAGE> 7

1992 to which reference is hereby made and a copy of which is on file at the
office of the Secretary of State of the Commonwealth of Massachusetts and
elsewhere as required by law, and to any and all amendments thereto so filed or
hereafter filed. The obligations of "The Coventry Group" entered into in the
name or on behalf thereof, or in the name or on behalf of any series or class of
shares of the Trust, by any of the Trustees, representatives or agents are made
not individually, but in such capacities, and are not binding upon any of the
Trustees, shareholders or representatives of the Trust personally, but bind only
the assets of the Trust, and all persons dealing with any series or class of
shares of the Trust must look solely to the assets of the Trust belonging to
such series or class for the enforcement of any claims against the Trust.

IN WITNESS WHEREOF, the parties hereto have caused this instrument to
be executed by their officers designated below as of ____, 2000.

THE COVENTRY GROUP

By
-----------------------------------
President

WILLAMETTE ASSET MANAGERS, Inc.

By:
-----------------------------------
President

-7-

<PAGE> 1
THE COVENTRY GROUP

ON BEHALF OF

WILLAMETTE TECHNOLOGY FUND

INVESTMENT ADVISORY AGREEMENT

AGREEMENT, effective commencing on __________, 2000 between Willamette
Asset Managers, Inc. (the "Adviser") and The Coventry Group. (the "Trust") on
behalf of Willamette Technology Fund (the "Fund").

WHEREAS, the Trust wishes to retain the Adviser to render investment
advisory services to the Fund, and the Adviser is willing to furnish such
services to the Fund;

WHEREAS, the Adviser is registered as an investment adviser under the
Investment Advisers Act of 1940, as amended ("Advisers Act");

NOW THEREFORE, in consideration of the promises and mutual covenants
herein contained, it is agreed between the Trust and the Adviser as follows:

<PAGE> 2

investment policies and procedures and with applicable legal requirements, and
for reporting to the Trustees regarding these matters.

The Adviser further agrees that, in performing its duties hereunder, it
will:

(b) use reasonable efforts to manage the Fund so that it will qualify,
and continue to qualify, as a regulated investment company under Subchapter M of
the Code and regulations issued thereunder;

-2-
<PAGE> 3

(g) in making investment decisions for the Fund, use no inside
information that may be in its possession, nor will the Adviser seek to obtain
any such information.

-3-
<PAGE> 4

-4-
<PAGE> 5

-5-
<PAGE> 6

12. MISCELLANEOUS.

b. The captions of this Agreement are included for convenience only and
in no way define or limit any of the provisions hereof or otherwise affect their
construction or effect.

d. Nothing herein shall be construed as constituting the Adviser as an
agent of the Trust or the Fund.

-6-
<PAGE> 7

IN WITNESS WHEREOF, the parties hereto have caused this instrument to
be executed by their officers designated below as of ____, 2000.

THE COVENTRY GROUP

By
-----------------------------------
President

WILLAMETTE ASSET MANAGERS, Inc.

By:
-----------------------------------
President

-7-

<PAGE> 1
THE COVENTRY GROUP

ON BEHALF OF

WILLAMETTE PHARMACEUTICAL AND BIO-TECHNOLOGY FUND

SUB-INVESTMENT ADVISORY AGREEMENT

AGREEMENT, effective commencing on April 1, 1999 among Willamette Asset
Managers, Inc. (the "Adviser"), First American Asset Management, a division of
U.S. Bank National Association ("Sub-Adviser"), and The Coventry Group (the
"Trust") on behalf of Willamette Pharmaceutical and Bio-Technology Fund (the
"Fund").

WHEREAS, the Trust and the Adviser wish to retain the Sub-Adviser to
render sub-investment advisory services to the Fund, and the Sub-Adviser is
willing to furnish such services to the Fund;

WHEREAS, the Sub-Adviser, a national banking association, is a bank, as
defined in Section 202(a)(2) of the Investment Advisers Act of 1940, as amended
("Advisers Act");

NOW THEREFORE, in consideration of the promises and mutual covenants
herein contained, it is agreed among the Adviser, the Trust and the Sub-Adviser
as follows:

1. APPOINTMENT. The Trust and the Adviser hereby appoint the
Sub-Adviser to act as sub-investment adviser to the Fund for the periods and on
the terms set forth in this Agreement. The Sub-Adviser accepts such appointment
and agrees to furnish the services herein set forth, for the compensation herein
provided.

2. SUB-INVESTMENT ADVISORY DUTIES. Subject to the supervision of the
Adviser and the Trustees of the Trust, the Sub-Adviser will (a) provide a
program of continuous investment management for the Fund in accordance with the
Fund's investment objectives, policies and limitations as stated in the Fund's
prospectus and Statement of Additional Information included as part of the
Trust's Registration Statement filed with the Securities and Exchange
Commission, as they may be amended from time to time, copies of which shall be
provided to the Adviser and to the Sub-Adviser by the Trust; (b) make investment
decisions for the Fund; and (c) place orders to purchase and sell securities for
the Fund.

In performing its investment management services to the Fund hereunder,
the Sub-Adviser, in accordance with the directions of the Adviser, will provide
the Fund with ongoing

<PAGE> 2

investment guidance and policy direction, including oral and written research,
analysis, advice, statistical and economic data and judgments regarding
individual investments, general economic conditions and trends and long-range
investment policy. Subject to the Fund's investment objective and policies, the
Sub-Adviser will determine the securities, instruments, repurchase agreements,
options and other investments and techniques that the Fund will purchase, sell,
enter into or use, and will provide an ongoing evaluation of the Fund's
portfolio. The Sub-Adviser will determine what portion of the Fund's portfolio
shall be invested in securities and other assets, and what portion if any,
should be held uninvested.

The Sub-Adviser acknowledges that, pursuant to the Investment Advisory
Agreement between the Adviser and the Trust with respect to the Fund, the
Adviser is responsible for supervising the activities and performance of the
Sub-Adviser, for taking reasonable steps to assure that the Sub-Adviser complies
with the Fund's investment policies and procedures and with applicable legal
requirements, and for reporting to the Trustees of the Trust regarding these
matters. In this regard, the Sub-Adviser agrees to facilitate the Adviser's
implementation of its "Supervisory Procedures for Sub-Advisors" attached hereto
as Exhibit A.

The Sub-Adviser further agrees that, in performing its duties
hereunder, it will:

(a) comply with the 1940 Act and all rules and regulations thereunder,
the Internal Revenue Code (the "Code") and all other applicable federal and
state laws and regulations, and with any applicable procedures adopted by the
Trustees;

(b) use reasonable efforts to manage the Fund so that it will qualify,
and continue to qualify, as a regulated investment company under Subchapter M of
the Code and regulations issued thereunder;

(d) furnish to the Trust, the Adviser, or to the Fund's administrator,
BISYS Fund Services, ("Administrator") if so directed, whatever statistical
information the Trust, Adviser or Administrator may reasonably request with
respect to the Fund's assets or contemplated investments. In addition, the
Sub-Adviser will keep the Adviser, the Trust and the Trustees informed of
developments materially affecting the Fund's portfolio and shall, on the
Sub-Adviser's own initiative, furnish to the Adviser and the Trust from time to
time whatever information the Sub-Adviser believes appropriate for this purpose;

(e) make available to the Adviser, the Administrator, and the Trust,
promptly upon their request, such copies of its investment records and ledgers
with respect to the Fund as may be required to assist the Adviser, the
Administrator and the Trust in their compliance with applicable laws and
regulations. The Sub-Adviser will furnish the Adviser and the Trustees with such
periodic and special reports regarding the Fund as they may reasonably request.

-2-
<PAGE> 3

(f) immediately notify the Adviser and the Trust in the event that the
Sub-Adviser or any of its affiliates: (1) becomes aware that it is subject to a
statutory disqualification that prevents the Sub-Adviser from serving as
sub-investment adviser pursuant to this Agreement; or (2) becomes aware that it
is the subject of an administrative proceeding or enforcement action by the
Securities and Exchange Commission ("SEC") or other regulatory authority. The
Sub-Adviser further agrees to notify the Trust immediately of any material fact
known to the Sub-Adviser respecting or relating to the Sub-Adviser that is not
contained in the Trust's Registration Statement regarding the Fund, or any
amendment or supplement thereto, but that is required to be disclosed therein,
and of any statement contained therein that becomes untrue in any material
respect; and

(g) in making investment decisions for the Fund, use no inside
information that may be in its possession, nor will the Sub-Adviser seek to
obtain any such information.

3. ALLOCATION OF CHARGES AND EXPENSES. Except as otherwise specifically
provided in this section 3, the Sub-Adviser shall pay the compensation and
expenses of all its directors, officers and employees who serve as officers and
executive employees of the Trust or Fund (including the Trust's or Fund's share
of payroll taxes), and the Sub-Adviser shall make available, without expense to
the Fund, the service of its directors, officers and employees who may be duly
elected officers of the Trust, subject to their individual consent to serve and
to any limitations imposed by law.

The Sub-Adviser shall not be required to pay any expenses of the Fund
or Trust other than those specifically allocated to the Sub-Adviser in this
section 3. In particular, but without limiting the generality of the foregoing,
the Sub-Adviser shall not be responsible, except to the extent of the reasonable
compensation of such of the Trust's or Fund's employees as are officers or
employees of the Sub-Adviser whose services may be involved, for any expenses of
other series of the Trust or for the following expenses of the Fund or Trust:
organization and certain offering expenses of the Fund (including out-of-pocket
expenses, but not including the Sub-Adviser's overhead and employee costs); fees
payable to the Adviser and Sub-Adviser and to any other Fund advisers or
consultants; legal expenses; auditing and accounting expenses; interest
expenses; telephone, telex, facsimile, postage and other communications
expenses; taxes and governmental fees; fees, dues and expenses incurred by or
with respect to the Fund in connection with membership in investment company
trade organizations; cost of insurance relating to fidelity coverage for the
Trust's officers and employees; fees and expenses of the Fund's Administrator or
of any custodian, subcustodian, transfer agent, fund accounting agent,
registrar, or dividend disbursing agent of the Fund; payments for portfolio
pricing or valuation services to pricing agents, accountants, bankers and other
specialists, if any; expenses of preparing share certificates, if any; other
expenses in connection with the issuance, offering, distribution or sale of
securities issued by the Fund; expenses relating to investor and public
relations; expenses of registering shares of the Fund for sale and of compliance
with applicable state notice filing requirements; freight, insurance and other
charges in connection with the shipment of the Fund's portfolio securities;
brokerage commissions or other costs of acquiring or disposing of any portfolio
securities or other assets of the Fund, or of entering into other transactions
or engaging

-3-
<PAGE> 4

in any investment practices with respect to the Fund; expenses of printing and
distributing prospectuses, Statements of Additional Information, reports,
notices and dividends to shareholders; costs of stationery or other office
supplies; any litigation expenses; costs of shareholders' and other meetings;
the compensation and all expenses (specifically including travel expenses
relating to the Fund's business) of officers, Trustees and employees of the
Trust who are not "interested persons," as defined in Section 2(a)(19) of the
1940 Act, of the Sub-Adviser; and travel expenses (or an appropriate portion
thereof) of officers or Trustees of the Trust who are officers, Trustees or
employees of the Sub-Adviser to the extent that such expenses relate to
attendance at meetings of the Board of Trustees of the Trust with respect to
matters concerning the Fund, or any committees thereof or advisers thereto.

4. COMPENSATION. As compensation for the services provided and expenses
assumed by the Sub-Adviser under this Agreement, the Adviser will pay to the
Sub-Adviser, out of the Adviser's own resources at no additional cost to the
Fund, at the end of each calendar month a sub-advisory fee computed daily at
annual rate equal to 0.50% of the Fund's average daily net assets. The "average
daily net assets" of the Fund shall mean the average of the values placed on the
Fund's net assets as of 4:00 p.m. (New York time) on each day on which the net
asset value of the Fund is determined consistent with the provisions of Rule
22c-1 under the 1940 Act or, if the Fund lawfully determines the value of its
net assets as of some other time on each business day, as of such other time.
The value of net assets of the Fund shall always be determined pursuant to the
applicable provisions of the Declaration and the Registration Statement. If,
pursuant to such provisions, the determination of net asset value is suspended
for any particular business day, then for the purposes of this section 4, the
value of the net assets of the Fund as last determined shall be deemed to be the
value of its net assets as of the close of the New York Stock Exchange, or as of
such other time as the value of the net assets of the Fund's portfolio may
lawfully be determined, on that day. If the determination of the net asset value
of the shares of the Fund has been so suspended for a period including any month
end when the Sub-Adviser's compensation is payable pursuant to this section,
then the Sub-Adviser's compensation payable at the end of such month shall be
computed on the basis of the value of the net assets of the Fund as last
determined (whether during or prior to such month). If the Fund determines the
value of the net assets of its portfolio more than once on any day, then the
last such determination thereof on that day shall be deemed to be the sole
determination thereof on that day for the purposes of this section 4.

5. BOOKS AND RECORDS. The Sub-Adviser agrees to maintain such books and
records with respect to its services to the Fund as are required by Section 31
under the 1940 Act, and rules adopted thereunder, and by other applicable legal
provisions, and to preserve such records for the periods and in the manner
required by that Section, and those rules and legal provisions. The Sub-Adviser
also agrees that records it maintains and preserves pursuant to Rules 31a-1 and
Rule 31a-2 under the 1940 Act and otherwise in connection with its services
hereunder are the property of the Trust and will be surrendered promptly to the
Trust upon its request. And the Sub-Adviser further agrees that it will furnish
to regulatory authorities having the requisite authority any information or
reports in connection with its services hereunder which may be

-4-
<PAGE> 5

requested in order to determine whether the operations of the Fund are being
conducted in accordance with applicable laws and regulations.

6. STANDARD OF CARE AND LIMITATION OF LIABILITY. The Sub-Adviser shall
exercise its best judgment in rendering the services provided by it under this
Agreement. The Sub-Adviser shall not be liable to the Adviser, the Trust, the
Fund or to any holder of the Fund's shares, for any error of judgment or mistake
of law or for any loss suffered by the Fund or the holders of the Fund's shares
in connection with the matters to which this Agreement relates, provided that
nothing in this Agreement shall be deemed to protect or purport to protect the
Sub-Adviser against any liability to the Adviser, the Trust, the Fund or to
holders of the Fund's shares to which the Sub-Adviser would otherwise be subject
by reason of willful misfeasance, bad faith or gross negligence on its part in
the performance of its duties or by reason of the Sub-Adviser's reckless
disregard of its obligations and duties under this Agreement. As used in this
Section 6, the term "Sub-Adviser" shall include any officers, directors,
employees or other affiliates of the Sub-Adviser performing services with
respect to the Fund.

7. SERVICES NOT EXCLUSIVE. It is understood that the services of the
Sub-Adviser are not exclusive, and that nothing in this Agreement shall prevent
the Sub-Adviser from providing similar services to other investment companies or
to other series of investment companies, including the Trust (whether or not
their investment objectives and policies are similar to those of the Fund) or
from engaging in other activities, provided such other services and activities
do not, during the term of this Agreement, interfere in a material manner with
the Sub-Adviser's ability to meet its obligations to the Fund hereunder. When
the Sub-Adviser recommends the purchase or sale of a security for other
investment companies and other clients, and at the same time the Sub-Adviser
recommends the purchase or sale of the same security for the Fund, it is
understood that in light of its fiduciary duty to the Fund, such transactions
will be executed on a basis that is fair and equitable to the Fund. In
connection with purchases or sales of portfolio securities for the account of
the Fund, neither the Sub-Adviser nor any of its directors or officers (or
persons acting in similar capacities) or employees shall act as a principal or
agent or receive any commission. If the Sub-Adviser provides any advice to its
clients concerning the shares of the Fund, the Sub-Adviser shall act solely as
investment counsel for such clients and not in any way on behalf of the Trust or
the Fund.

8. DURATION AND TERMINATION. This Agreement shall continue until
_________, 2002, and thereafter shall continue automatically for successive
annual periods, provided such continuance is specifically approved at least
annually by (i) the Trustees or (ii) a vote of a "majority of the Fund's
outstanding voting securities" (as defined in the 1940 Act), provided that in
either event the continuance is also approved by a majority of the Trustees who
are not parties to this Agreement or "interested persons" (as defined in the
1940 Act) of any party to this Agreement, by vote cast in person at a meeting
called for the purpose of voting on such approval. Notwithstanding the
foregoing, this Agreement may be terminated: (a) at any time without penalty by
the Adviser or by the Fund upon the vote of a majority of the Trustees or by
vote of the majority of the Fund's outstanding voting securities, upon sixty
(60) days' written notice to the Adviser or (b) by the Sub-Adviser at any time
without penalty, upon sixty (60) days' written

-5-
<PAGE> 6

notice to the Trust. This Agreement will also terminate automatically in the
event of its assignment (as defined in the 1940 Act).

9. AMENDMENTS. No provision of this Agreement may be changed, waived,
discharged or terminated orally, but only by an instrument in writing signed by
the party against which enforcement of the change, waiver, discharge or
termination is sought, and no amendment of this Agreement shall be effective
until approved by an affirmative vote of (i) a majority of the outstanding
voting securities of the Fund, and (ii) a majority of the Trustees, including a
majority of Trustees who are not interested persons of any party to this
Agreement, cast in person at a meeting called for the purpose of voting on such
approval, if such approval is required by applicable law.

10. PROXIES. Unless the Trust or the Adviser gives written instructions
to the contrary, the Sub-Adviser shall vote all proxies solicited by or with
respect to the issuers of securities in which assets of the Fund may be
invested. The Sub-Adviser shall use its best good faith judgment to vote such
proxies in a manner which best serves the interests of the Fund's shareholders.

11. NAME RESERVATION. The Sub-Adviser acknowledges and agrees that the
Adviser has property rights relating to the use of the terms "Willamette,"
"Willamette Family of Funds," "Willamette Value Fund" and "Willamette Small Cap
Growth Fund," Willamette Technology Fund" and "Willamette Pharmaceutical and
Bio-Technology Fund" ("Willamette Names") and has permitted the use of the
Willamette Names by the Trust and its series. The Sub-Adviser agrees that,
unless otherwise authorized by the Adviser: (i) it will use the term
"Willamette" only as a component of the name of the Fund and for no other
purposes; (ii) it will not purport to grant to any third party any rights in any
Willamette Name; and (iii) the Adviser may use or grant to others the right to
use a Willamette Name, or any abbreviation thereof, as all or a portion of a
corporate or business name or for any commercial purpose, including a grant of
such right to any other investment company. Upon termination of this Agreement,
the Sub-Adviser shall, at the request of the Adviser, cease to use all
Willamette Names in any of its materials or in any manner except with the
consent of the Adviser, which shall not be unreasonably withheld. In the event
of any such request by the Adviser that use by the Sub-Adviser of a Willamette
Name shall cease and in the absence of any such consent, the Sub-Adviser shall
cause its officers, directors and employees to take any and all such actions
which the Adviser may reasonably request to effect such request.

-6-
<PAGE> 7

12. MISCELLANEOUS.

a. This Agreement shall be governed by the laws of the State of Oregon,
provided that nothing herein shall be construed in a manner inconsistent with
the 1940 Act, or rules or orders of the SEC thereunder.

b. The captions of this Agreement are included for convenience only and
in no way define or limit any of the provisions hereof or otherwise affect their
construction or effect.

d. Nothing herein shall be construed as constituting the Sub-Adviser as
an agent of the Adviser, the Trust or the Fund.

e. The names "The Coventry Group" and "Trustees of the Coventry Group"
refer respectively to the Trust created and the Trustees, as trustees but not
individually or personally, acting from time to time under an Agreement and
Declaration of Trust dated as of January 8, 1992 to which reference is hereby
made and a copy of which is on file at the office of the Secretary of State of
the Commonwealth of Massachusetts and elsewhere as required by law, and to any
and all amendments thereto so filed or hereafter filed. The obligations of "The
Coventry Group" entered into in the name or on behalf thereof, or in the name or
on behalf of any series or class of shares of the Trust, by any of the Trustees,
representatives or agents are made not individually, but in such capacities, and
are not binding upon any of the Trustees, shareholders or representatives of the
Trust personally, but bind only the assets of the Trust, and all persons dealing
with any series or class of shares of the Trust must look solely to the assets
of the Trust belonging to such series or class for the enforcement of any claims
against the Trust.

IN WITNESS WHEREOF, the parties hereto have caused this instrument to
be executed by their officers designated below as of _____, 1999.

THE COVENTRY GROUP

By
----------------------------------
President

WILLAMETTE ASSET MANAGERS, Inc.

By:
----------------------------------
President

-7-
<PAGE> 8

First American Asset Management

By:
----------------------------------
Title:

-8-

<PAGE> 1
THE COVENTRY GROUP

ON BEHALF OF

WILLAMETTE PHARMACEUTICAL AND BIO-TECHNOLOGY FUND

SUB-INVESTMENT ADVISORY AGREEMENT

WHEREAS, the Trust and the Adviser wish to retain the Sub-Adviser to
render sub-investment advisory services to the Fund, and the Sub-Adviser is
willing to furnish such services to the Fund;

WHEREAS, the Sub-Adviser, a national banking association, is a bank, as
defined in Section 202(a)(2) of the Investment Advisers Act of 1940, as amended
("Advisers Act");

NOW THEREFORE, in consideration of the promises and mutual covenants
herein contained, it is agreed among the Adviser, the Trust and the Sub-Adviser
as follows:

In performing its investment management services to the Fund hereunder,
the Sub-Adviser, in accordance with the directions of the Adviser, will provide
the Fund with ongoing

<PAGE> 2

The Sub-Adviser further agrees that, in performing its duties
hereunder, it will:

(b) use reasonable efforts to manage the Fund so that it will qualify,
and continue to qualify, as a regulated investment company under Subchapter M of
the Code and regulations issued thereunder;

-2-
<PAGE> 3

(g) in making investment decisions for the Fund, use no inside
information that may be in its possession, nor will the Sub-Adviser seek to
obtain any such information.

-3-
<PAGE> 4

-4-
<PAGE> 5

requested in order to determine whether the operations of the Fund are being
conducted in accordance with applicable laws and regulations.

8. DURATION AND TERMINATION. This Agreement shall continue until
_________, 2002, and thereafter shall continue automatically for successive
annual periods, provided such continuance is specifically approved at least
annually by (i) the Trustees or (ii) a vote of a "majority of the Fund's
outstanding voting securities" (as defined in the 1940 Act), provided that in
either event the continuance is also approved by a majority of the Trustees who
are not parties to this Agreement or "interested persons" (as defined in the
1940 Act) of any party to this Agreement, by vote cast in person at a meeting
called for the purpose of voting on such approval. Notwithstanding the
foregoing, this Agreement may be terminated: (a) at any time without penalty by
the Adviser or by the Fund upon the vote of a majority of the Trustees or by
vote of the majority of the Fund's outstanding voting securities, upon sixty
(60) days' written notice to the Adviser or (b) by the Sub-Adviser at any time
without penalty, upon sixty (60) days' written

-5-
<PAGE> 6

notice to the Trust. This Agreement will also terminate automatically in the
event of its assignment (as defined in the 1940 Act).

-6-
<PAGE> 7

12. MISCELLANEOUS.

b. The captions of this Agreement are included for convenience only and
in no way define or limit any of the provisions hereof or otherwise affect their
construction or effect.

d. Nothing herein shall be construed as constituting the Sub-Adviser as
an agent of the Adviser, the Trust or the Fund.

IN WITNESS WHEREOF, the parties hereto have caused this instrument to
be executed by their officers designated below as of ____, 1999.

THE COVENTRY GROUP

By
-----------------------------------
President

WILLAMETTE ASSET MANAGERS, Inc.

By:
-----------------------------------
President

-7-
<PAGE> 8

First American Asset Management

By:
-----------------------------------
Title:

-8-

<PAGE> 1
[DECHERT PRICE & RHOADS LETTERHEAD]

February 25, 2000

The Coventry Group
3435 Stelzer Road
Columbus, OH 43219

Re: The Coventry Group - Willamette Pharmaceutical and
Bio-Technology Fund; Willamette Technology Fund

Dear Sirs:

We have acted as counsel for The Coventry Group ("Registrant")
and its series, Willamette Pharmaceutical and Bio-Technology Fund and Willamette
Technology Fund ("Funds"), and are familiar with Registrant's registration
statement with respect to the Funds under the Investment Company Act of 1940, as
amended, and with the registration statement relating to its shares under the
Securities Act of 1933, as amended (collectively, "Registration Statement").
Registrant is organized as a business trust under the laws of Massachusetts.

We have examined Registrant's Declaration of Trust and other
materials relating to the authorization and issuance of shares of beneficial
interest of Registrant, Post-Effective Amendment No. 66 to the Registration
Statement and such other documents and matters as we have deemed necessary to
enable us to give this opinion.

Based upon the foregoing, we are of the opinion that each
Fund's shares proposed to be sold pursuant to Post-Effective Amendment No. 66 to
the Registration Statement, when it is made effective by the Securities and
Exchange Commission, will have been validly authorized and, when sold in
accordance with the terms of such Amendment and the requirements of applicable
federal and state law and delivered by Registrant against receipt of the net
asset value of the shares of the particular Fund, as described in Post-Effective
Amendment No. 66 to the Registration Statement, will have been legally and
validly issued and will be fully paid and non-assessable by Registrant.

<PAGE> 2
The Coventry Group
February 25, 2000
Page 2

We hereby consent to the filing of this opinion as an exhibit
to Post-Effective Amendment No. 66 to the Registration Statement, to be filed
with the Securities and Exchange Commission in connection with the continuous
offering of each Fund's shares of beneficial interest, as indicated above, and
to references to our firm, as counsel to Registrant, in each Fund's prospectus
and Statement of Additional Information to be dated as of the effective date of
Post-Effective Amendment No. 66 to the Registration Statement and in any revised
or amended versions thereof, until such time as we revoke such consent.

Very truly yours,